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ABSTRACT 
Malignant catarrhal fever (MCF) is a fatal lymphoproliferative disease affecting 
ruminants. The disease is caused by infection of susceptible hosts with one of two 
gammaherpesviruses, Alcelaphine Herpesvirus -1 (AHV -1) or Ovine Herpesvirus -2 
(011V-2). 
On isolation AHV -1 infectivity is cell -associated and will induce MCF on 
inoculation into experimental animals. After serial passage cell -free infective virus is 
observed, but this virus cannot produce MCF experimentally. The aim of this project 
was to characterise the genomic alterations which occurred in one isolate, C500, 
associated with this altered pathogenicity. 
Viral DNA of virulent (PP) and cell -free attenuated (CFA) C500 derivatives was 
compared by restriction endonuclease profiling. Variability was observed using 
Sma I, as a 5kbp fragment was present in PP DNA but not CFA DNA. 
Conversely a 3.8kbp fragment was present in CFA DNA but absent from PP 
DNA. Homology was observed between these Sma I fragments. The Sma I 3.8kbp 
fragment was cloned (ATT -1), as were two Hind III equivalents of the PP 5kbp 
Sma I fragment (VIR -1 and VIR -2). These clones were mapped for several 
restriction endonucleases, subcloned and sequenced. 
The location of the C500 clones was assessed by Southern blotting and PCR. The 
structure of the C500 genome consisted of a central unique region of 
approximately 130kbp, flanked on either side by multiple copies of a 1050bp repeat 
unit, resulting in an overall genome size of 160kbp. The ATT -1 clone was found to 
be present twice in the CFA genome, located at both ends of the unique region, 
close to the terminal repeats, with both copies orientated in the same direction. The 
location of the VIR -1 and VIR -2 clones in the PP genome was not fully deteimined 
during this study, however, the results obtained suggested that the VIR -1 and VIR -2 
clones were located approximately 1.4kbp apart, at one end of the unique region, 
close to the terminal repeats. The mapping data suggested that two sequential 
deletions occur as the C500 virus is passaged in tissue culture, resulting in a total 
deletion of approximately 3.8kbp. This deletion correlates with loss of virulence. 
The sequence of the three C500 clones was compared to other known sequences 
at both nucleic acid and amino acid levels, but no significant homology was 
observed. One open reading frame (ORF), encoding a peptide designated peptide 
5, and an adjacent unsequenced region of 800óp were lost on attenuation of the 
C500 isolate, suggesting that this region encodes sequence essential to the 
development of MCF. The sequence of peptide 5 did not exhibit structural similarity 
to the peptides involved in the transforming potential of either of the related 
gammaherpesviruses Herpesvirus saimiri (HVS) or Epstein -Barr virus (EBV). 
However, the location of the ORF encoding peptide 5 in the C500 genome was 
similar to that of the transforming protein of HVS in the HVS genome 
One ORF, encoding a peptide designated peptide 1, was found to be conserved in 
OHV -2, and is a further indication of the close relationship between these two 
herpesviruses. Peptide 1 also exhibited limited structural homology to the 
transforming proteins of HVS, however, the presence of two copies of peptide 1 in 
the CFA C500 genome suggested that peptide 1 did not have a similar function to the 
HVS peptides. 
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Malignant catarrhal fever (MCF) is a fatal lymphoproliferative disease affecting 
cattle and several other ruminant species. The disease has a worldwide distribution, 
but its incidence is usually sporadic and low, with no particular reference to age, sex 
or breed (Plowright 1968). Epizootics have been observed in cattle, red deer (Cervus 
elaphus) and bison (Pierson et al 1973, Plowright et al 1975, Ruth et al 1977, Reid et 
al 1979). 
MCF was first recognised in Europe, and later in Africa, where substantial losses of 
cattle were reported following contact with wildebeest (reviewed by Heuschele et al 
1984). There have been reported cases of MCF in at least 39 species of ruminant 
worldwide (reviewed by Heuschele et al 1988). In Asia MCF is economically 
important as water buffalo (Bubalus bubalis) and Bali cattle/Banteng (Bos javanicus 
synonym Bos sandaicus) are particularly susceptible (Hatkin 1980, Daniels et al 
1988). With the development of deer farming in the UK, Australia and New Zealand 
it has become evident that deer are especially susceptible to MCF (Reid et al 1979, 
Denholm and Westbury 1982, Oliver et al 1988). 
The aetiology and pathogenesis of the disease is complex, with at least two viral 
agents capable of inducing MCF. In Africa the disease is caused by infection with 
the gammaherpesvirus Alcelaphine Herpesvirus -1 (AHV -1), which was first isolated 
from an apparently clinically normal blue wildebeest (Connochaetes taurinus) in 
1959 (Plowright et al 1960). Outside Africa MCF is normally induced by infection 
with Ovine Herpesvirus -2 (OHV -2), which has not been isolated nor fully 
characterised, but domestic sheep are the natural, unaffected host of this virus 
(Rossiter 198la, Baxter et al 1993). This virus is antigenically and genomically 
closely related to AHV -1. 
1.2 CLINICAL FEATURES 
The clinical features of MCF exhibited following infection of susceptible hosts with 
either aetiological agent are generally similar. The symptoms are, however, variable 
with the disease being categorised into "head and eye ", peracute, intestinal and mild 
forms. The majority of cases in cattle are of the "head and eye" form, while the 
peracute form is more frequent in deer (reviewed by Plowright 1986). 
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Clinical symptoms are generally observed by sudden onset of persistant pyrexia, 
where the temperature of the affected animal typically rises to 42 °C (Plowright 
1986). Severe congestion, necrosis and erosion of the nasal and oral mucosae are 
recorded in most cases of AHV -1 induced disease (reviewed by Plowright 1986). In 
OHV -2 induced disease these symptoms are less frequently demonstrated, and when 
observed are generally less severe (James et al 1975, Reid et al 1979, Denholm and 
Westbury 1982). A generalised enlargement of lymph nodes is evident in animals 
affected with MCF. Further symptoms include diarrhoea, dysentery, dermatitis and 
laminitis, all of which tend to occur more frequently in cattle and deer affected with 
OHV -2 induced disease (Mare 1977, Reid et al 1979, Denholm and Westbury 1982). 
Signs of central nervous system involvement such as muscular tremours and lack of 
co- ordination have been observed in animals infected with AHV -1 and OHV -2 
(Plowright 1986). 
In deer the disease is often peracute and clinical manifestations can be minimal prior 
to death. The development of clinical features such as conjunctivitis, necrosis of the 
muzzle and dry necrotic skin lesions may appear in acute and chronic cases in deer, 
depending on the length of survival (Reid et al 1984). 
MCF has been observed to develop as a result of experimental infection of rabbits 
using both aetiological agents (Daubney and Hudson 1936, Buxton and Reid 1980). 
The symptoms noted in this experimental model are largely similar to those exhibited 
in hosts naturally affected with the disease. A rectal temperature of greater than 40 °C 
was generally the first evident clinical sign, followed by the rabbits becoming dull 
and anorexic. Serous or catarrhal nasal and ocular discharges developed, 
accompanied by conjunctivitis. The submandibular and mesenteric lymph nodes 
were often enlarged. Lymphoid accumulations were often observed in the liver, 
lungs, stomach, intestine, periphery of the cornea, and mildly in the kidneys, heart, 
reproductive organs, brain and spinal cord. In addition haemorrhages and necrotic 
foci frequently affected the liver, lungs and mucosal surfaces (Buxton and Reid 
1984). 
Incubation times between contact with the viruses and the onset of clinical symptoms 
have not been established as there is no method of determining precisely when an 
affected animal contacted the virus. Pierson et al (1973) suggested that the 
incubation time of OHV -2 in susceptible hosts varied between a minimum of 60 to a 
maximum of 144 days. 
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established on the overwhelming majority of properties where multiple cases occured 
(reviewed by Plowright 1986). In addition several publications have reiterated that 
infection of cattle and deer is most likely during the lambing season (Reid and 
Buxton 1984 and 1985, Reid et al 1984) and the season of highest incidence for 
cattle, often reported as late winter and spring to early summer in temperate zones, 
would be consistent with this hypothesis (Plowright 1986). Rossiter (1981a) further 
implicated sheep as viral hosts by demonstrating that a high proportion of sheep sera 
tested positive for antibodies to AHV -1 by an indirect immunofluoresence test 
(Rossiter 1981b). These antibodies were detected in 162 of 167 sheep sera collected 
from 10 different flocks (Rossiter 1981a). In addition an OHV -2 specific polymerase 
chain reaction (PCR) demonstrated OHV -2 in peripheral blood lymphocytes of 6/6 
normal domestic sheep (Baxter et al 1993). 
1.3.3 Related gammaherpesviruses of bovidae 
In addition to wildebeest AHV -1 neutralising antibodies have been found in several 
other species of the subfamily Alcelaphinae. These include the hartebeest 
(Alcelaphus buselaphus) and at least 3 species in the genus Damaliscus (topi, 
tsessebe and blesbok), (reviewed by Plowright 1986). In addition to these 
neutralising antibodies, herpesviruses were isolated from free living hartebeest and 
topi (Damaliscus korrigum), (Mushi et al 1981), while in the USA herpesvirus was 
isolated from captive Cape hartebeest (Alcelaphus buselaphus camaa) and Jimela 
topi (Damaliscus lunatus jimela), (Heuschele et al 1984). A herpesvirus isolated 
from the hartebeest by Reid and Rowe (1973) was later classified as Alcelaphine 
Herpesvirus -2 (AHV -2), (Roizman et al 1981). 
In the subfamily Hippotraginae there is also widespread evidence of infection with 
AHV -1- related herpesviruses in species of addax and oryx. Virus neutralising 
antibodies were found in fringe -eared oryx (Oryx gazella biesa) sera (Mushi and 
Karstad 1981), and an AHV -1- related agent was isolated from a healthy scimitar - 
horned oryx (Oryx gazella dammah), (Heuschele et al 1984). A herpesvirus 
antigenically and genomically related to AHV -1 has also been isolated from a roan 
antelope (Hippotragus equinus) and designated Hippotragine herpesvirus -1 (Reid 
and Bridgen 1991). 
In addition to sheep, the presence of AHV -1 related viruses has been implicated in 
other members of the subfamily Caprinae. Neutralising antibody has been detected 
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in several species of goat, including the domestic goat (Capra bircus), and in both 
the alpine and nubian ibex (Capra ibex ibex and Capra ibex nubiana), (Heuschele et 
al 1984). 
The gammaherpesvirus Bovine Herpesvirus -4 (BHV -4) exhibited a low, but 
consistent, level of serological cross -reactivity with AHV -1 (Osorio et al 1985). 
Although the additional carriers described above harbour herpesviruses related to 
AHV -1, they can apparently be grazed or housed with species susceptible to MCF 
with no detrimental effect. As yet, only the wildebeest and the domestic sheep can be 
incriminated as a source of herpesviruses which result in MCF in susceptible hosts. 
1.4 HOSTS SUSCEPTIBLE TO MCF 
All breeds of cattle and domestic buffalo are at all ages susceptible to MCF. Judging 
from the frequency of cases reported in zoological collections, the species most 
susceptible to AHV -1 disease are the Asiatic cattle, banteng (Bos javanicus) and 
Indian Guar (B. gaurus). Some African antelope are also particularly susceptible to 
AHV -1 induced MCF such as the kudu (Tragelaphus stresiceros) and the sitatunga 
(T. spekei), (Plowright 1986). 
The Cervidae appear to be much more susceptible than cattle to OHV -2 infection, as 
severe outbreaks of OHV -2 induced MCF affecting axis deer (Cervus axis), 
barasingha deer (C. duvauceli), red deer (C. elaphus), sika deer (C. nippon), Rusa 
deer (C. timorensis), roe deer (Capreolus capreolus) and Pere David's deer 
(Elaphanus davidianus) have been reported (Reid and Buxton 1984, Plowright 
1986). 
The remainder of the 39 species which demonstrate susceptibility to MCF are 
reviewed by Heuschele et al (1988). 
Experimentally rabbits, hamsters, guinea -pigs, and rats have demonstrated 
susceptibility to AHV -1 and OHV -2 (Daubney and Hudson 1936, Buxton and Reid 
1980, Jacoby et al 1988b). Experimental transmission is discussed further in section 
1.6. 
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1.5 NATURAL TRANSMISSION 
The mode of natural transmission from the reservoir host to the susceptible ruminant 
is probably via nasal and ocular secretions in the form of aerosols. This theory is 
substantiated by the observation that AHV -1 can be transmitted to rabbits by 
administering cell -free (CF) virus ihtranasally (Mushi and Rurangirwa 1981) and that 
CF AHV -1 virus has been isolated from the nasal and ocular secretions of wildebeest 
calves which were less than three months old (Mushi et al 1980a). In the case of 
OHV -2, since the virus has not yet been isolated, the method of transmission has not 
been elucidated, but is expected to be similar to that of AHV -1. 
Studies to compare the stability of cell- associated (CA) and CF AHV -1 in the 
environment revealed that CA virus was very fragile, but CF virus could survive 
outwith the host for more than 13 days under conditions of high humidity (Mushi and 
Rurangirwa 1981). When infected with AHV -1, cattle act as a dead end host for the 
virus. Studies illustrated that, although cattle shed AHV -1 in nasal and ocular 
secretions, all infectivity was cell- associated. This suggested that the inability of 
AHV -1 to spread by contact between cattle is probably due to the absence of CF 
virus in secretions (Mushi and Rurangirwa 1981). 
1.6 EXPERIMENTAL TRANSMISSION 
AHV -1 infection has been transmitted to rabbits using brain tissue or blood from 
affected cattle as inoculum (Daubney and Hudson 1936). Experimental transmission 
of AHV -1 from cattle to deer using whole blood from infected cattle has also been 
achieved (Whitenack et al 1981). Successful transmission to neonatal hamsters, rats 
and guinea -pigs by inoculation of rabbit lymphoid cells infected with AHV -1 has 
been accomplished, however, with weaned animals only guinea -pigs were susceptible 
(Jacoby et al 1988a and b). Transmission to sheep was observed as a result of 
inoculation with blood from MCF affected cattle, but clinical and pathological signs 
of MCF were not observed (Kalunda et al 1981b). 
Experimental transmission of OHV -2 MCF has been more erratic and difficult to 
achieve than that of AHV -1, requiring at least eight to ten times more blood as 
inoculum than transmission of AHV -1 (Pierson et al 1979). OHV -2 induced MCF 
has been transmitted, using blood from the affected animal as inoculum, from cattle 
Liggitt and De Martini (1980b) suggested that the pathogenic mechanism of MCF 
may be analagous to a "graft versus host" reaction. Hunt and Billups (1979) 
proposed viral- induced lymphoid cell transformation on the basis that the primary 
feature of the infection is generalised lymphocytic proliferation and infiltration of 
most organs and tissues, and also because the histopathological features of MCF are 
similar to those induced by known oncogenic herpesviruses (e.g. Herpesvirus 
saimiri). Denholm and Westbury (1982) subscribed to this theory, while also 
suggesting an alternative unsupported hypothesis involving uncontrolled proliferation 
of T lymphocytes due to viral destruction or inactivation of T suppressor 
lymphocytes. Mushi et al (1980b) examined the idea that the effects of MCF are due 
to immuno -compromisation by treating infected rabbits with levamisole (a potent 
anthelmintic which restores T lymphocyte function), but this did not affect the 
outcome of the disease. 
The hypothesis which satisfies most of the features of MCF was proposed by Reid 
and Buxton (1985), who suggested that a profound virus- induced immune regulatory 
dysfunction could be the fundamental lesion. The T lymphocyte hyperplasia was 
found to be a side -effect of immune deregulation rather than a cause of death since 
treatment of rabbits with cyclosporin A (a potent T lymphocyte suppressor) resulted 
in abrogation of the hyperplasia but did not prevent death in rabbits (Buxton et al 
1984). Cells cultured from a cow, a deer and an experimentally infected rabbit (all 
exhibiting signs of OHV -2 induced MCF) were characterised as large granular 
lymphocytes (LGL) with natural killer (NK) cell properties. It was found that as few 
as 100 of these cultured rabbit cells could transmit MCF, implying that a high 
proportion of the cultured cells carried the agent of MCF (Reid et al 1985). Reid and 
Buxton (1985) further proposed that interleukin -2 (IL -2), or a similar cytokine, is 
produced by infected LGLs, and this causes a benign and probably polyclonal T 
lymphocyte hyperplasia, possibly aided by malfunction of the T lymphocyte 
suppressor role that LGLs are recognised to possess (Biron and Welsh 1982). 
Finally, the tissue damage may arise from unrestricted NK activity of infected LGL, 
or what should more appropriately be termed lymphokine activated killer (LAK) 
activity, causing cytolysis of normal cells. 
To investigate further the role of these LGL in the pathogenesis of MCF a 
lymphoblastoid cell -line was derived following an attempt at fusion of lymph node 
cells from a rabbit clinically affected with OHV -2 induced MCF to cells of ovine 
origin. The resultant lymphoblastoid cell -line resembled LGL morphologically, 
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carried OHV -2 and transmission of MCF was achieved using this cell -line as 
inoculum (Reid et al 1983). Similar cell -lines were subsequently derived from 
affected cattle and deer (Reid et al 1989a) and characterised using a panel of 
monoclonal Ab to bovine and ovine surface Ag which are also cross -reactive with 
deer. Results showed that all lymphoblastoid cell -lines were T lymphocytes with 3/4 
cattle lines CD4- /CD8 + /T19 -, 1/4 CD4+ /CD8 -/T19- and 2/2 deer lines 
CD4- /CD8-/T19+ (Burrells and Reid 1991). 
1.8 ANTIBODY TO AHV -1 
Evidence of infection with AHV -1, OHV -2 and related viruses in other hosts has 
depended largely on the detection of antibody reactive with AHV -1. Plowright 
(1967) demonstrated that virus neutralising antibodies (VN Ab) to AHV -1 were 
present in all free -living wildebeest in East Africa. Various methods to detect Ab to 
AHV -1 were attempted (Plowright 1968, Rossiter et al 1977, and 1978, Rossiter and 
Jesset 1980, Rossiter 1981b), with an indirect immunofluorescence (lIF) test being 
the most successful (Rossiter 1981a). Sheep sera were examined using this IlF test, 
and 162 out of 167 sheep from 10 different flocks showed positive results, suggesting 
that the majority of sheep are infected with an agent antigenically related to AHV -1 
(Rossiter 198la). Immunoblotting analysis, using the AHV -1 strain WC11 
(Plowright et al 1965), showed that sheep sera recognised some of the same epitopes 
as wildebeest sera (Herring et al 1989). 
1.9 MOLECULAR DETECTION OF AHV -1 AND RELATED VIRUSES 
In recent years the detection of both forms of MCF has focussed on direct detection 
of virus rather than serological methods. Hsu et al (1990a) developed a method for 
detection of AHV -1 using the polymerase chain reaction (PCR) which successfully 
detected viral DNA from as few as 10 infected tissue culture cells (corresponding to 
picogram amounts of AHV -1 DNA). In addition, Katz et al (1991) developed a 
nested PCR which detected both AHV -1 and AHV -2. The feasibility of employing 
these tests as diagnostic aids has not, however, been appraised. 
The detection of OHV -2 in domestic sheep and clinical cases of OHV -2 induced 
MCF has been achieved using PCR (Baxter et al 1993). The sequence used to 
generate the oligonucleotides used in this PCR was OHV -2 specific. Briefly, a 
cytotoxic lymphoblastoid cell -line was developed by culturing cells from an animal 
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affected with OHV -2 induced MCF on feeder monolayers (Reid et al 1983 and 
1989a). A genomic library was prepared from this cell -line and was probed with 
AHV -1 fragments (Bridgen and Reid 1991). A clone which exhibited partial 
homology to AHV -1 was characterised and sequence unique to OHV -2 was 
identified. This sequence was used to generate the OHV -2 specific oligonucleotides 
employed in a sensitive PCR to detect OHV -2. 
1.10 IMMUNITY AND ATTEMPTS TO IMMUNISE SUSCEPTIBLE HOSTS 
1.10.1 The immune response of reservoir hosts. 
This section refers almost exclusively to infection of the wildebeest with AHV -1. 
Comparative studies of OHV -2 have not been achieved due to the inability to isolate 
the OHV -2 virus. 
A study of free -living wildebeest showed that the wildebeest calf is infected with 
AHV -1 either in utero or soon after birth by natural transmission (Plowright 1965a). 
The transmission of high titre maternal Ab via the colostrum does not protect the 
calves against active infection and viraemia occurs (Plowright 1967). Viraemia is 
more common in calves than in adults, and among adults detectable viraemia is most 
common in pregnant animals, probably because the virus becomes latent after initial 
infection and is only reactivated under conditions of exceptional stress and pregnancy 
(Plowright 1965a and b). The finding that betamethasone, an immunosuppressive 
corticosteroid, led to recrudesence of viraemia in wildebeest further confirms latency 
of the virus in this host (Rweyemamu et al 1974). 
1.10.2 Immunity of susceptible hosts. 
OHV -2 and AHV -1 induced MCF result in death of susceptible hosts in more than 
95% of cases. On the rare occasions where cattle have been observed to survive 
infection with AHV -1 the recovered animals acquired a solid resistance to parenteral 
challenge (Plowright 1968). One particular cow which recovered from MCF 
subsequently passed infection congenitally to four calves. MCF was observed in two 
of these calves, and viraemia was observed in the other two. The mother did not 
develop clinical signs of MCF during pregnancy (Plowright et al 1972). This 
observation suggested that the animal was latently infected, with recrudescence 
occurring in pregnancy in a similar manner to that observed in wildebeest. Latency 
in recovered animals was also reported by Rweyemamu et al (1976). 
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1.10.3 Attempts to immunise susceptible hosts. 
Plowright et al (1975) attempted to protect cattle using inactivated AHV -1 virus in 
various forms. Formalised Ag, combined with Freunds incomplete adjuvant 
regularly induced a good neutralising antibody response, but this was not found to be 
protective, as vaccinated animals developed MCF on parenteral challenge with 
virulent virus. Plowright suggested that subsequent vaccination studies should 
attempt to stimulate cell- mediated rather than humoral immunity (Plowright et al 
1975). 
Edington and Plowright (1980) demonstrated immunity to cell -free but not cell - 
associated challenge in rabbits. The vaccine used consisted of cell -free AHV -1 virus 
inactivated with formalin or acetylethylamine and combined with Frends complete 
adjuvant. Russell (1980) also reported immunity to cell -free AHV -1 in 4/6 rabbits 
vaccinated with inactivated, cell -free virulent virus. Rossiter developed a complex 
protocol which protected against cell- associated virulent virus in 4/4 rabbits 
following initial challenge, and 2/4 when rechallenged 43 weeks later (Rossiter 
1982a). 
The AHV -1 related virus isolated from hartebeest, AHV -2, was used to attempt to 
immunise against AHV -1. An isolate of AHV -2, K30, became attenuated after serial 
passage in tissue culture. This attenuated variant of K30 was used to inoculate 6 
cattle. All 6 cattle developed serum neutralising Ab to the AHV -1 laboratory isolate 
WC11 but the cattle were not protected from AHV -1 challenge. The vaccination 
procedure was partially successful for AHV -2 as 2 of the 3 challenged with virulent 
K30 survived (Reid and Rowe 1973). 
In summary, there have been several attempts to immunise susceptible hosts, some of 
which have been moderately successful but there is at present no vaccination 
programme. The observation that subclincally infected animals may become carriers 
and transmit virus to their offspring in a method similar to that of wildebeest 
congenital transmission must be considered in attempts to develop a vaccine. 
There is no standard treatment for animals with MCF, therefore, in the absence of 
vaccines, the prevention of MCF relies on separation of susceptible animals from 
transmitter animals. 
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1.11 CLASSIFICATION OF AHV -1 
1.11.1 Introduction 
The virus which induces MCF in Africa was first isolated from a blue wildebeest in 
1959 (Plowright et al 1960). In this initial paper the virus was described as 
producing a cytopathology reminiscent of herpes simplex and varicella zoster in 
monolayer cell cultures. Affinity of this wildebeest- derived virus to the herpes group 
was further implied with respect to its size, morphology, relationship to the host cell 
and its sensitivity to ether and chloroform (Plowright et al 1965). This virus was 
subsequently designated Alcelaphine Herpesvirus -1 (AHV -1), (Reid et al 1975). 
Ovine Herpesvirus (OHV -2) has not been isolated in culture in a similar manner to 
AHV -1. Viral cytopathic effects have not been detected in cell cultures derived from 
affected tissues of rabbits or deer, nor in bovine or ovine cells co- cultivated with such 
cells (Reid et al 1979, Westbury and Denholm 1982). Various viruses have been 
identified in animals affected with OHV -2 induced MCF, but none of these viruses 
has reproduced MCF on reinoculation into cattle, suggesting that such viral 
infections have been fortuitous and have no causal relationship with the disease 
(reviewed by Reid et al 1984). A cytotoxic T- lymphocyte cell -line derived from a 
rabbit affected with experimentally induced MCF had characteristics similar to cell - 
lines generated from cotton top marmosets infected with Herpesvirus ateles and 
Herpesvirus saimiri (Reid et al 1983). A subsequent report described additional 
lymphoblastoid cell -lines derived from OHV -2 affected cattle and deer (Reid et al 
1989a). DNA was extracted from these lymphoblastoid cell -lines, and homology to 
AHV -1 was observed (Bridgen 1991, Bridgen and Reid 1991). This homology, 
coupled with the serological data (Rossiter 1981a, Herring et al 1989, Reid et al 
1989b) led to OHV -2 being classified as a herpesvirus (Roizman et al 1992). 
The family Herpesviridae has been extensively studied and subsequently subdivided 
both in terms of biological criteria and molecular structure. The remainder of this 
section describes the properties of the family Herpesviridae, with reference to 
AHV -1. 
1.11.2 Definition of a herpesvirus 
Membership of the family Herpesviridae is based on the architecture of the virion. 
Herpes virions vary in size from 120 -300nm in diameter and consist of a core 
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containing linear, double stranded DNA, an icosahedral capsid surrounded by an 
amorphous region known as the tegument, and an envelope containing viral spikes 
(Roizman 1990). Genomic analysis has confirmed that AHV -1 has a double stranded 
DNA core (Bridgen et al 1989), while electron microscopic observations showed 
extracellular virions of enveloped and non -enveloped particles ranging in size from 
140 to 220nm. A viral tegument was also observed around an inner icosahedral 
capsid of approximately 100nm (summarised by Seal et al 1988). Thus 
morphologically AHV -1 is a candidate for inclusion in the herpesvirus family. 
1.11.3 Nomenclature of herpesviruses 
The herpesvirus study group of the International Committee for the Taxonomy of 
Viruses (ICTV) recommended a binomial system of nomenclature which they 
summarised to three main points: (i) the first name should reflect the family (when 
the name should end in -id) or the subfamily (when it should end in -ine) of the 
primary host; (ii) the second name should be herpesvirus and (iii) different 
herpesviruses with the same primary host should be given sequential arabic numbers 
(Roizman 1982). 
The wildebeest is a member of the family bovidae, subfamily alcelaphinae. AHV -1 
has also been referred to as Bovid herpesvirus -3 in some literature (Ludwig 1983), 
however since Bovidae is such a large and complex family Reid et al (1975) 
suggested the usage of the subfamily name Alcelaphinae to designate the virus which 
causes wildebeest- derived MCF. This nomenclature was proposed since AHV -1 was 
first isolated from a wildebeest (Plowright et al 1960) and also since a similar virus 
had been isolated from a hartebeest (Reid and Rowe 1973), another member of the 
subfamily Alcelaphinae. This hartebeest- derived virus, distinct from AHV -1, has 
been designated Alcelaphine Herpesvirus -2 (AHV -2), (Reid et al 1975, Roizman et 
al 1981). The sheep- associated agent was originally designated Caprine herpesvirus- 
3 (CHV -3), since domestic sheep belong to the subfamily Caprinae (Bridgen and 
Reid 1991). However, to avoid confusion the virus was re- designated Ovine 
Herpesvirus 2 (Roizman et al 1992). 
1.11.4 Biological properties of herpesviruses 
The known herpesviruses appear to share four significant biological properties which 
are as follows: (i) all herpesviruses specify a large array of enzymes involved in 
nucleic acid metabolism and possibly processing of proteins; (ii) both the synthesis of 
viral DNAs and the assembly of capsids occur in the nucleus; (iii) production of 
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infectious progeny virus is invariably accompanied by the irreversible destruction of 
the infected cell and (iv) herpesviruses are able to remain latent in their natural hosts. 
Although the herpesviruses share these properties, they also vary greatly in their 
biological properties with respect to host range, efficiency of multiplication, the cell 
type in which they remain latent and the clinical manifestations of the disease they 
cause (Roizman 1990). 
The biological criteria used for the original classification of herpesviruses into 
subfamilies were based on simple measurements or observations that could be readily 
determined in many laboratories (Roizman et al 1981). The herpesviruses were 
divided into three subfamilies which are described below. 
Alphaherpesvirinae 
The members of this subfamily are classified on the basis of a variable host range, a 
relatively short reproductive cycle, rapid spread in culture, efficient destruction of 
infected cells and the capacity to establish latent infections primarily, but not 
exclusively, in sensory ganglia (summarised by Roizman 1990). An example of an 
alphaherpesvirus is human herpesvirus -1 (herpes simplex virus -1, HSV -1). 
Betaherpesvirinae 
A non -exclusive characteristic of the members of this subfamily is a restricted host 
range. The reproductive cycle is long, the infection progresses slowly in culture with 
the infected cells frequently becoming enlarged (cytomegalia) and the virus can 
establish latency in secretory glands, kidneys and other tissues (summarised by 
Roizman 1990). An example of a betaherpesvirus is human herpesvirus -5 (human 
cytomegalovirus, HCMV). 
Gammaherpesvirinae 
The experimental host range of the members of this subfamily is usually limited to 
the species to which the natural host belongs. In vitro, members typically replicate in 
lymphoblastoid cells and some also cause lytic infection in some types of epithelioid 
and fibroblastoid cells. Viruses in this group tend to be specific for either B or T 
lymphocytes, but exceptions occur. In the lymphocyte the infection is frequently 
either at a pre -lytic or lytic stage, but without production of infectious progeny, and 
latent virus can be frequently demonstrated in lymphoid tissue. This subfamily was 
originally subdivided into 7-1-herpesviruses, members of which were typically B- 
lymphotropic (e.g. human herpesvirus -4, Epstein -Barr virus or EBV) and 7y -2- 
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herpesviruses, members of which were typically isolated from T- lymphocytes (e.g. 
Saimirine herpesvirus -2, Herpesvirus saimiri or HVS), (Honess 1984). Recently the 
ICTV approved that this subfamily be divided into two genera, namely 
Lymphocryptovirus (formerly 7-1- herpesviruses) and Rhadinovirus (formerly 'y -2- 
herpesviruses), (Roizman et al 1992). 
1.11.5 Biological classification of AHV -1 
AHV -1 is classified as a gammaherpesvirus of the rhadinovirus genus. Other viruses 
in this genus are Ateline herpesvirus -2, Saimirine herpesvirus -2, Bovine herpesvirus- 
4 and Murid herpesvirus -1 (mouse herpesvirus strain, 68) as defined by Roizman et 
al (1992). Saimirine herpesvirus -2 and Ateline herpesvirus -2 are more commonly 
referred to as Herpesvirus saimiri (HVS) and Herpesvirus ateles (HVA) respectively. 
The herpesviruses in the rhadinovirus genus do not appear to cause disease in their 
natural hosts. In susceptible hosts, the histopathological features of AHV -1 infection 
are very similar to those of known oncogenic viruses such as HVS and HVA, (which 
might be expected since the these viruses are from the same genus as AHV -1). 
Biological similarity to EBV (a lymphocryptovirus) was observed (Hunt and Billups 
1979), as well as to Herpesvirus sylvilagus (Patel and Edington 1980). Patel and 
Edington (1981) compared AHV -1 to these viruses in terms of the cell- association of 
virus infectivity, recovery of virus from leucocytes and lymphocytic tissues and the 
excessive lymphoproliferation associated with such viral infections. 
1.11.6 Properties of herpesvirus genomes 
The size of herpesvirus DNAs varies from approximately 124 to 235 kilobase pairs 
(kbp). Independent isolates of the same virus species may also vary in size by as 
much as 10kbp but this size difference most frequently reflects the number of 
terminal and/or internal reiterated sequences (Roizman et al, 1992). 
In base composition the herpesvirus genomes show a broad, but non -exclusive 
correlation to the biological subgroupings such that alphaherpesvirinae have mean 
compositions of >60% G +C, betaherpesvirinae occupy the middle of the range and 
the rhadinoviruses (formerly 'y- 2- herpesviruses) account for the majority of viruses 
with coding sequences of <50% (G +C), (Honess 1984). Herpesvirus DNA also 
varies with respect to the extent of homogeneity of base sequence distribution along 
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the genome e.g. human herpesvirus -1 is very homogeneous while HVS has extensive 
inhomogeneity (Roizman et al 1992). 
The genomes of gammaherpesviruses are deficient in the dinucleotide CpG, 
regardless of their G +C contents, as seen in EBV (which has a G +C content of 60 %) 
and HVS (which has a G +C content of 45 %), (Baer et al 1984, Fleckenstein and 
Mulder 1980). This depletion probably arises from the mutagenic effects of 
methylation during latency in a dividing cell (Honess et al 1989). 
A method of classification of herpesviruses based on their genomic organisations 
results in six different groupings (A -F), based on the location and nature of the 
reiterated sequences in the genome, as illustrated in figure 1.1. 
AHV -1 has been classified as a member of group B (see figure 1.1) on the basis of its 
genomic structure (Bridgen et al 1989, Roizman et al 1992). The arrangement of the 
DNA in B genomes is such that the terminal sequence is directly repeated numerous 
times at both termini (Roizman et al 1992). 
1.11.7 Molecular biology of rhadinoviruses with genomic arrangement B 
Herpesvirus saimiri (HVS) is the most extensively characterised member of the 
rhadinovirus genus. The sequence of the entire HVS genome has been published 
during the course of this study (Albrecht et al 1992), allowing comparison of the 
AHV -1 and HVS genomes. HVS is regarded as the prototype rhadinovirus ( Honess 
1984). 
HVS is a common infectious agent of squirrel monkeys, which induces malignant 
lymphomas or acute lymphocytic leukaemias in several new world primate species 
(Melendez et al 1968 and 1969). Caesium chloride density centrifugation of HVS 
DNA revealed two types of genome. One type, the H genome, consisted of high 
density reiterated sequences with a G +C content of 71 %. The second type, the M 
genome, consisted of 70% unique sequences referred to as light (L -) DNA, with a 
G +C content of 36 %. The remaining 30% of the M genome was comprised of 
reiterated sequences of heavy (H -) DNA with a G +C composition of 71 %, equal to 
that of the H genome. The H -DNA of the H genomes and the M genomes was found 
to be homologous. The H genomes were defective, i.e. no infectious virus 
was 
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cytopathic changes observed in permissive cells transfected with M genomes 
(Fleckenstein et al 1975). 
The H -DNA sequences were found to consist of tandem arrays of repeat units which 
were terminally arranged at both ends of the HVS M genome. The total H -DNA 
content of the M genome was found to be approximately constant (Bornkamm et al 
1976). The M genome is approximately 160kbp in size with most of the genetic 
information contained in the 112kbp L -DNA segment (Fleckenstein and Mulder 
1980, Knust et al 1983). The repeat unit of HVS is 1.444kbp in length with 30 -34 
copies per M genome (Bankier et al 1985, Stamminger et al 1987). The general 
features of this genomic structure are most simply explained if unit length genomes 
are matured from concatameric products of replication, and that signals which initiate 
and complete the cleavage /packaging reaction are present once on each repeat unit. 
Thus the cleavage /packaging reaction is initiated by a random selection of a H -DNA 
recognition site, with the second cleavage site limited such that the length of the 
molecule is approximately constant (Stamminger et al 1987). The number of repeat 
units observed at the termini of HVS genomes varied from as few as one to as many 
as 30 ( Bankier et al 1985). 
The sequences located at the junction regions between H -DNA and L -DNA of HVS 
have been studied (Murthy et al 1989, Stamminger et al 1987). The left H- DNA -L- 
DNA border is not clearly recognised, since a 116bp G +C rich fragment with 
homology to repeat DNA lies between concatameric H -DNA repeats and the A +T 
rich L -DNA sequences (Albrecht et al 1992). In contrast the right L- DNA -H -DNA 
transition was localised to a single nucleotide (Stamminger et al 1987). The HVS 
genome exhibited three small, internal repeat segments in addition to the terminal 
repeats (Albrecht et al 1992). 
The other members of the rhadinovirus subfamily generally resemble HVS with 
regard to their genomic organisation. Herpesvirus ateles (HVA) was demonstrated to 
consist of H and M genomes when analysed by caesium chloride density 
centrifugation. The H -DNA had a G +C content of 75 %, with the M genomes being 
comprised of L -DNA (37.5% G +C) flanked by approximately 25 identical repeat 
units. The HVA L -DNA exhibited 35% homology to HVS L -DNA, while the H- 
DNAs of the two genomes exhibited no homology (Fleckenstein et al 1978). 
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Murid herpesvirus -4 (formerly murine herpesvirus 68) also resembled HVS in that it 
consisted of a unique region of 118.2kbp flanked by a variable number of copies of a 
1.23kbp repeat unit (Efstathiou et al 1990b). The G +C content of the unique region 
of this genome was estimated to be 45% from limited nucleotide sequence analysis 
(Efstathiou et al 1990a). 
The Bovine herpesvirus -4 (BHV -4) genome is similar to that of HVS and consists of 
a unique coding region (L -DNA) of 108kbp flanked by (G +C) rich tandem repeats of 
1.95, 2.35 and 2.75kbp (H -DNA), (Ehlers et al 1985, Bublot et al 1990). The 
genomic organisation of BHV -4 demonstrated overall collinearity with the HVS and 
EBV genomes (Bublot et al 1992). The right junction between the unique and 
repeated sequences of the BHV -4 genome is relatively constant amongst BHV -4 
strains, but the left junction is not so well conserved (Bublot et al 1990). 
Leporid herpesvirus -1 (Herpesvirus sylvilagus), a gammaherpesvirus capable of 
inducing a lymphoproliferative disease in cottontail rabbits, has also been included as 
having genomic arrangement B. The genome was found to consist of a unique region 
of approximately 120kbp, flanked by a variable number of 533óp tandem repeats 
with a G +C content of 83% (Cohrs and Rouhandeh 1987, Medveczky et al 1989a). 
Marmodid herpesvirus -1 (woodchuck herpesvirus) has terminally located repeat units 
of 1.5kbp. The unique region was 130kbp (Gilles and Ogston 1991). This similarity 
to HVS led to the authors suggesting Marmodid herpesvirus -1 should be included in 
the rhadinovirus genus. 
Genomic studies of Alcelaphine Herpesvirus -1 have been carried out using the 
attenuated strain, WC11 (Plowright et al 1965). Caesium chloride density 
centrifugation of this isolate revealed two peaks resembling the M and H DNA 
components found in HVS (Herring et al 1983). The M genome had a G +C content 
of 50 %, and the H genome had a G +C content of 71 %. The genome was 
approximately 160kbp in length, with 130kbp comprising the unique region, and the 
remaining 30kbp constituting the repeated region. The WC11 genome contained 
three different sized repeat units. The major repeat unit was 950bp, and was present 
15 -20 times per molecule, with the two other repeat units, of 1800 and 1050bp 
respectively, each being present 4 -5 times per molecule (Bridgen et al 1989). These 
repeats were terminally located in the WC11 genome (Bridgen 1991). 
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A sect. n.1 :assaze, cell-associali4 AITST-1 isolate C500 (Plowright et al 1975) 
was demonstrated to oroduce hybridisation profiles similar to those generated for the ire sequence of 7,1,-(211. The C500 terminal repeats were comprised of multiple 
s s'Eule E DI repeat unlit (ri gen et 1989). 
1.11..3 Comparison of the enomes of rha:dinoviruses and lymphocryptoviruses 
Rn.adin: 5 lynipnocryptovirases are both y-herpesviruses, and the 
19± of these genera, HITS :and EBV, have been completely sequenced, 
allowinu an of genomic 'OTZLI.isaidort of these two virt:ses (Albrecht et al 
1992, Baer The two viruses were known to differ in the nature and 
log ri r f r.:itr respective repeated re ons as EBV has the genomic arrangement C 
in f1r 1.1. HVS follows arrangement B. Ti he genomes differ sliPbtly in size 
with thf- E.B v no= being 17" " p, an e HVS being 160kbp (Baer et al 1984, 
Albrecnt ez 1992). 
Similarity between the EBV tel HVS getornes was summarised by Albrecht et al 
(1992), by demonstrating that the majority of HVS genes have counterparts in the 
:21`a at lie level of amino acid seqHence similarities, and all of these genes 
are arr rr ed :n collinear order. One difference observed between the EBV and HVS 
genom involves the genes which encode proteins relevant for transformation and 
persistance. No HVS equivalents were observed for all the EBV u uclear antigen 
(EBNA) genes, nor for the latent membrane protein (LMP) or the terminal protein 
ge mes (Baer et al 19 Albreci et al 1992). The HVS genone was illustrated to 
contain a gene which encodes a HVS transforming protein (STP) which was not 
related to any EBV sequence (Murthy et al 1989). 
1.12 MOLECULAR CHARACIERLSATION OF AI1V-1 
AHV-1 has been characterised as being distinct from AHV-2 at a molecular level by 
Sarison of restriction endonuclease profiles using six different enzymes (Seal et 
al 1989). Similar comparisons of AHV-1 and 011V-2 have not been possible due to 
the inability to isolate intact 011V-2. Limited molecular comparison of Ally-1 and 
OHV-2 was carried out by probing tymphoblastoid cell-line DNA with AHV-1 
probes (Bridgen and Reid 1991, discussed previously in section 1.11.1). The OHV-2 
fragments recognised varied slightly in size from the AHV-1 fragments used as 
probes. This illustrated that, while AHV-1 and 011V-2 share homology, the two 
viruses are distinct. 
20 
Shih et al (1989) compared the profiles of eight isolates which were associated with 
MCF using the restriction endonucleases Hind III and Eco RI. These isolates 
included the laboratory isolates WC11 (which had been recovered from a blue 
wildebeest) and C500 (which had been recovered from an ox reacting with AHV -1 
induced MCF), (Plowright et al 1965 and 1975). The other six herpesviruses studied 
were isolated from captive antelopes. Two distinct patterns were observed using 
Hind III and Eco RI, exemplified by the WC11 and C500 isolates. The antelope 
samples resembled either the WC11 or the C500 profiles. 
The analysis of AHV -1 DNA as described by Bridgen et al (1989) did not identify 
any six base cutting restriction endonucleases which cleaved the AHV -1 L -DNA 
from the H -DNA. This was in contrast to the restriction profile observed on Sma I 
digestion of HVS DNA. Sma I cleaved the H -DNA from L -DNA, but there were no 
internal Sma I sites in the L -DNA. This facilitated greatly the analysis of the L -DNA 
with other restriction endonucleases (Knust et al 1983). 
Limited sequence of the AHV -1 genome was generated by Hsu et al (1990b). A 
3.5kbp fragment was sequenced, revealing a complete open reading frame (ORF) of 
2,058óp and a partial ORF of 630óp. A low degree of homology was observed to 
EBV. The G +C content of this region of the genome was 47 %. Oligonucleotides for 
use in the polymerase chain reaction (PCR) were designed from this region of the 
WC11 genome, and as few as 10 infected WC11 cells (representing picogram 
amounts of AHV -1 DNA) were detected (Hsu et al 1990a). 
1.13 IDENTIFICATION AND CHARACTERISATION OF THE REGION OF 
THE HVS GENOME RESPONSIBLE FOR TRANSFORMATION 
The HVS rhadinovirus prototype showed strain variability in the leftmost 
7 -10kbp 
segment of L -DNA. This region of the genome is highly variable 
both in size and in 
nucleotide sequence amongst isolates of HVS (Medveczky et al 
1984). HVS strain 
variability led to classification into three groups, A, B and C (originally 
non -A, non - 
B) with the rightmost 93% of the L -DNA being almost completely 
homologous 
among all strains (Medveczky et al 1984 and 1989). 
HVS strain 11 became 
attenuated on repeated passage at 39 °C, followed by plaque 
purification at 34 °C, 
generating strain 11att. The llatt genome contained a deletion of 
2.3kbp at the left 
junction between repetitive and unique DNA when compared 
to the parental strain 
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(Koomey et al 1984). The left terminal variable region was further studied by 
introducing deletions into a cloned left terminal 7.4kbp fragment, then co- 
transfecting with the parental strain 11. In the S4 deletion mutants generated, a 
contiguous fragment of 4.5kbp sequence was found to be unnecessary for in vitro 
culture (Desrosiers et al 1984). However, the mutants bearing this deletion were also 
non -oncogenic. Replacing the sequences lost in both the 1 latt and S4 mutants also 
restored the oncogenicity, leading to the conclusion that the left terminal region of 
the genome was required for oncogenicity (Desrosiers et al 1985). The HVS strain 
SMHI also became attenuated as a result of serial passage in vero cells, generating 
the variant SMHI -VERO. A region of approximately 6kbp from the 5' terminal 
region of the genome had been deleted in the non -oncogenic variant. In addition a 
5.6kbp fragment had been inserted into the H -DNA. This segment represented an 
inverted repetition of DNA encoded at the 3' end of the L -DNA. 
The complete sequence of HVS strain 11 (subgroup A) illustrates the exact location 
of the ORF which encodes the protein responsible for the transforming ability of this 
isolate (Murthy et al 1989, Albrecht et al 1992). An equivalent ORF in HVS strain 
488 (subgroup C) was identified (Biesinger et al 1990). This ORF encodes the 
peptide responsible for the transforming ability of strain 488 (Jung et al 1991). The 
two peptides from strain 11 and strain 488 demonstrated limited structural homology 
(Jung et al 1991). Although this information was not available at the commencement 
of this study, the work described in the previous paragraph suggested that, if AHV -1 
was collinear to HVS, then the region of AHV -1 likely to encode factors responsible 
for virulent infection of susceptible hosts would be the left terminal L-DNA 
sequence, when AHV -1 is displayed in the same orientation as HVS. 
The map of the AHV -1 WC 11 isolate derived by Bridgen (1991) was not complete at 
the termini of the molecule, nor was it orientated with regard to HVS. In addition the 
WC11 isolate was known to be attenuated (Plowright et al 1965). Comparison of 
HVS strain 11 and its non -oncogenic variant 11 -att revealed a deletion of 2.3kbp 
from the leftmost region of L -DNA in the attenuated derivative (Koomey et al 1984). 
If attenuation of AHV -1 resulted in a similar deletion then the terminal region of 
WC 11 may lack sequence encoding proteins related to the transforming proteins of 
HVS. In order to determine the region of the AHV -1 genome responsible for 
virulence it was necessary to study a virulent isolate, rather than WC 11. The C500 
isolate of AHV -1 was initially recovered from an ox reacting with MCF ( Plowright et 
al 1975). Cell culture propagation of C500 virus results in cell -associated (CA) 
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virulent virus becoming cell -free (CF) and virulent, then cell -free and attenuated 
(CFA), (Russell 1980, H.W. Reid, personal communication). Comparison of the 
virulent and attenuated C500 derivatives at a molecular level may demonstrate 
variability similar to that observed between the virulent and attenuated variants of 
HVS. 
1.14 PROPOSED OBJECTIVES 
The aim of this project was to investigate the genomic rearrangements which result in 
the loss of virulence of the C500 isolate of AHV -1 during in vitro propagation. This 
was approached initially by examination of restriction profiles of virulent and 
attenuated C500 derivatives with the intention of identifying any variable regions. 
Analysis of variable regions may provide evidence of altered reading frames and 
present an insight into the peptides which are important in establishment of infection 
and the development of MCF in susceptible hosts. 
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Chapter 2 
Materials and Methods 
2.1 SUPPLIERS 
All suppliers and their addresses are listed in appendix 1. All chemicals were 
supplied by either BDH, Fisons or Sigma unless stated otherwise. 
2.2 FREQUENTLY USED SOLUTIONS 
TE: 10mM Tris, 1mM EDTA; adjusted to pH8.0 with HC1. 
20xSSC: 3M NaCl, 0.3M sodium citrate; adjusted to pH7.0 with HCl. 
RNase A: 10mg m1-1. Heated to 1009C for 15 min, cooled to room temperature 
and stored in aliquots at -20 °C. 
Phenol: Equilibrated with 1M Tris -HC1 pH8.0, then with 0.1M Tris -HC1 
pH8.0. B- hydroxyquinoline added to 0.1% (w /v) and aliquots stored at 
- 20 °C. 
Chloroform: Chloroform and isoamyl alcohol mixed in a ratio of 24:1 (v /v); stored 
in a dark bottle at room temperature. 
TEG: 25mM Tris -HC1 pH8.0, 10mM EDTA, 50mM glucose. 
PBS: 137mM NaC1, 26.8mM KC1, 8.1mM Na2HPO4, 1.47mM KH2PO4. 
2.3 GROWTH MEDIA 
2.3.1 Bacterial growth media 
The quantities of all media components are given in grams per litre final volume of 
medium, except in cases where final molarities of components are stated. 
L- broth: 
L -agar: 
10g Difco Bacto tryptone, 5g Difco yeast extract, 5g NaCl. 
as for L- broth, but including 15g Difco agar. 
Minimal agar: 0.04M Na2HPO4, 0.02M KH2PO4, 0.02M NH4C1, 0.009M NaCl, 15g 
agar, 1mM MgSO4, 0.1mM CaC12, 1mM Thiamine -HC1, 0.2% (w /v) 
glucose. 
Ampicillin: When required media were supplemented with 5014 m1-1 ampicillin. 
2.3.2 Viral growth media 
Virus was grown routinely in Iscove's modification of Dulbecco's medium (IMDM) 
(Gibco) supplemented with penicillin at 100 IU ml -1, streptomycin at 501.tg ml-', 
fungazone (Roussel) at 2 IU m1-1, and 5 x 10-5M 2- mercaptoethanol. Foetal 
bovine 
serum (FBS) was added at concentrations varying from 5 -15% (v /v). 
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2.4 Escherichia coli STRAINS 
The Escherichia coli strains used in this study are listed in figure 2.1. 
2.5 CLONING VECTORS 
The cloning vectors used in this study are listed in figure 2.2 
2.6 VIROLOGICAL TECHNIQUES 
2.6.1 Preparation and storage of viral inoculum 
Virulent virus was initially propagated in rabbits by intravenous inoculation of a pool 
of lymph nodes from a rabbit reacting with MCF following infection with C500. 
When the animal reacted by demonstrating the classical symptoms of MCF the 
affected lymph nodes and spleen were harvested. Single -cell suspensions were 
prepared and stored in IMDM supplemented as described in 2.3.2. These single -cell 
suspensions were either stored in liquid nitrogen in media containing 15% (v /v) FBS 
and 0 % (v /v) Dimethyl Sulphoxide (DMSO) or inoculated directly onto a bovine cell 
monolayer and serially passaged. (The animal work and isolation of the virus was 
carried out by Dr H.W. Reid). 
2.6.2 Cultivation of virus 
Viral isolates were propagated in monolayer cultures of bovine thyroids and bovine 
turbinates, both of which are low passage cells . All isolates were cultivated at 37 °C 
in IMDM as described in 2.3.2, with 5% (v /v) FBS added. Cultures were harvested 
when approximately 50 -80% of the monolayer exhibited cytopathic effects (cpe). 
2.6.3 Assessment of virulence 
Bovine turbinate monolayer cultures in 25cm2 flasks were infected with the test virus 
and cultured at 37 °C until approximately 50% of the monolayer exhibited cpe. The 
cells were scraped from the plastic and resuspended in approximately 2m1 of the 
supernatant fluid. One ml was removed for inoculation into a rabbit while the 
remainder was mixed with an equal volume containing 20% DMSO and 50% FBS 
prior to storage in liquid nitrogen. 
Rabbits were inoculated into the lateral ear vein with the test virus and examined 
daily for clinical signs and rectal temperature. Rabbits were considered to have 
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reacted when the rectal temperature exceeded 40 °C, at which time there was also a 
marked reduction in the quantity of food and water ingested. On the second day of 
reactin rabbits were killed by gaseous anaesthesia and examined for gross 
pathological changes. Rabbits which did not react by the 90th day were considered 
not to have beeen infected and the experiment was discontinued. 
2.6.4 Preparation of DNA from cell -associated (CA) virus 
CA virus was harvested when over 80% of the cells exhibited cpe. Since the cpe 
resulted in the majority of the monolayer cells becoming rounded or forming loosely 
attached syncytia these cells were easily incorporated into the supernatant and any 
residual cells were removed from the flask walls via rocking briefly with sterile glass 
beads. The culture supernatant was then spun at 3000g for 10 min at room 
temperature (RT) to pellet the cells, which were then washed in PBS. The cell pellets 
were resuspended and lysed in 0.5% (v /v) Nonidet P40 (NP40) in RSB (10mM NaC1, 
1mM MgC12, 10mM Tris -HC1, pH7.5) by gentle homogenisation. Chromatin and 
cellular debris were removed by centrifugation at 1000g for 10 min at RT. The 
supernatant was then layered over 25% sucrose in RSB and the viral nucleocapsids 
were isolated by centrifugation at 114,000g for 30 min at RT. The resultant pellet 
was resuspended in TNE (10mM Tris -HC1, 100mM NaC1, 1mM EDTA, pH8.0) and 
digested with proteinase K (Boehringer Mannheim) at 200µg m1-1 in the presence of 
1% SDS for 2 hr at 37 °C with agitation. Contaminants were extracted with phenol 
and the DNA precipated with ethanol. 
2.6.5 Preparation of DNA from cell -free (CF) virus. 
CF virus was harvested when over 50% of the cells exhibited cpe. The cells were 
detached with glass beads and the culture supernatant was first clarified by 
centrifugation at 4,000g for 20 min at 4 °C, then pelleted by centrifugation at 42,000g 
for 30min at 4 °C. The pellet was resuspended in TNE and thereafter treated 
with 
proteinase K (Boehringer Mannheim) and extracted following the method described 
for CA virus. 
2.7 BACTERIOLOGICAL TECHNIQUES 
2.7.1 Growth and maintenance of E. coli 
Bacteria were grown and maintained on solid and liquid 
media using standard 
techniques as described by Maniatis et al (1982). Cells 
were maintained on L -agar or 
minimal agar plates for 2 -3 weeks at 4 °C, while longer 
term storage was achieved by 
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freezing at -70 °C in L -broth supplemented with a final concentration of 15% 
glycerol. 
2.7.2 Preparation of competent cells 
Competent bacterial cells were prepared by either of two methods: 
i) Fresh competent cells were prepared according to an adaptation of the method 
described in Maniatis et al (1982), based on the original method of Mandel and Higa 
(1970). 
An overnight culture of one of the E. coli strains described in figure 2.1 was diluted 
1:50 in L -broth and grown at 37 °C with agitation until an OD600 of 0.5 was reached. 
The cells were cooled on ice for 10 minutes, harvested by centrifugation at 3000g for 
10 min and resuspended in 0.5 volumes of cold (4 °C) sterile 75mM CaC12. The cells 
were incubated on ice for 30 min then pelleted as before and resuspended in 0.08 
volumes of cold sterile 75mM CaCl2. The cells were left on ice for at least an hour 
before use and were kept for a maximum of 5 days at 4 °C or for 2 -3 months at -70 °C, 
after the addition of glycerol to a final concentration of 10 %. 
ii) Competent cells were also prepared and stored by the method of Chung et al 
(1989). 
An overnight culture was again diluted 1:50 in L -broth and grown to an OD600 of 0.3- 
0.4. The cells were cooled on ice for 15 min then harvested by centrifugation at 
3000g for 10 min. The pellet was resuspended in 0.1 volumes of L -broth containing 
10% (w /v) PEG (molecular weight approximately 8000), 5% DMSO and 25mM 
MgC1,. Cells were then stored in aliquots at -70 °C for 4 -6 months. 
2.8 NUCLEIC ACID AND MOLECULAR TECHNIQUES 
2.8.1 Small scale preparation of plasmid DNA 
Double stranded plasmid DNA was prepared from 10m1 overnight cultures grown 
under antibiotic selection by the method described by Maniatis et al (1982), based on 
the original method of Birnboim and Doly (1979). 
1.5ml of the culture was pelleted by centrifugation at 9000g for 30 sec then 
resuspended in 100 [11 TEG. 200111 of a freshly prepared solution of 1% (w /v) SDS, 
0.2M NaOH was then added to the contents of the tube, mixed by inversion then 
incubated for 5 min on ice. Cellular debris, protein and genomic DNA were then 
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precipitated by the addition of 150µ1 of 3 Potassium and 5M acetate, pH4.8, for 5 
min on ice then pelleted ;; cen gatio l at 9000g for 5 min_ The supernatant 
containing the supercoiled plasmid DNA was extracted with phenol:co i:oroform (6:4) 
then precipitated by the addition of lml of ethanol. The DNA was resuspended in 
501.11 of TE. 
2.8.2 Large scale preparation of plasmid DNA 
A single bacterial colony was inoculated into 5µ1 of L -broth containing 50m9 m1-1 
ampicillin and grown overnight at 37 °C with shaking. This culture was then used to 
inoculate 500m1 of L -broth (containing 50µ9m1-1 ampicillin) and y .,wn overnight at 
37 °C with shaking. Bacterial cells were harvested by centrifugation at 4000g for 10 
min at 4 °C. Cells from 250m1 of culture were lysed by resuspension in 20m1 TEG 
containing lmg m1-1 of freshly prepared lysozyme and incubated for 10 min on ice, 
followed by the addition of 40m1 of freshly prepared 0.2M NaOH, 1 '/ (w/v) SDS and 
a further 10 min incubation on ice. Chromosomal DNA, high molecular weight RNA 
and protein/membrane/SDS complexes were precipitated by the addition of 3M 
potassium and 5M acetate, pH4.8. The precipitate was pelleted by centrifugation at 
22,000g for 10 min at 4 °C, and the supernatant recovered. Plasmid DNA was 
recovered by the addition of 0.6 volumes of propan -2-ol and precipitated by 
centrifugation at 15,000g for 15 min at RT. The pellet was subsequently washed in 
70% ethanol and resuspended in 8m1 TE. Exactly lg of caesium chloride was added 
to every ml of this solution and 0.8:41 of ethidium bromide solution (10mg m1-1) was 
then added for every 10m1 of the caesium chloride -DNA solution. This resulted in a 
final density of 1.55g m1-'. Protein and cellular debris were removed from this 
solution by centrifugation at 3000g at RT. The supernatant was then transferred into 
Beckman "quickseal" tubes and centrifuged to equilibrium at 165,000g in a Beckman 
Ti70 rotor for 48 hr at 20 °C. After centrifugation two bands located near the centre of 
the tube were visible in ordinary light. The upper band, consisting of chromosomal 
and nicked plasmid DNA, was collected first to prevent contamination of the lower 
band, using an 18 -gauge hypodermic needle. The lower band, containing 
closed 
circular plasmid DNA was then collected in the same way. Ethidium bromide 
was 
removed from the plasmid DNA solution by extracting with water- 
saturated buzan-l- 
ol, then the DNA was precipitated by the addition of 1 volume of 
water and 6 
volumes of ethanol. 
2.8.3 Quantification of DNA 
The concentration of DNA preparations was assessed by a 
measurement of OD.60 
using a spectrophotometer. An OD260 of 1 corresponds to 
501.1g m1-' double stranded 
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DNA. DNA preparations free from protein possessed an OD260:0D280 ratio 
approaching 2.0. 
2.8.4 Restriction endonuclease digestion of DNA 
DNA was digested with restriction endonucleases at a final dilution of approximately 
10 units µg-1. All restriction endonucleases and their relevant 10X buffers were 
purchased from Boehringer Mannheim and used as per manufacturers instructions. 
RNase was added at a final concentration of 2011g ml-1 when required and the volume 
made up to between 10 and 2O111 with sterile distilled water. The reactions were 
incubated for 90 min at the temperature recommended by the manufacturer. 
2.8.5 Ligation of DNA 
Ligation reactions were prepared using appropriate amounts of vector DNA, insert 
DNA (at a ratio of 1:4 vector:insert where possible), 10X concentrated ligation buffer 
(660mM Tris -HC1, 50mM MgC12, 10mM dithiothrietol, 10mM ATP, pH7.5) and 1 -3 
units of T4 ligase (Boerhinger Mannheim). Reactions were carried out in a volume of 
5 -20111 (made up with sterile distilled water) and incubated for 1 -4 hr at RT or for 16- 
20 hr at 12 °C. 
2.8.6 Dephosphorylation of DNA 
The terminal 5' phosphates were removed from DNA by treatment with calf intestinal 
alkaline phosphatase (CIP), (Boehringer Mannheim). Dephosphorylation reactions 
were prepared using target DNA, 10X CIP buffer (0.5M Tris -HC1 pH9.0, 10mM 
MgC12, 1mMZnC12, 10mM spermidine) and 0.01 units of CIP per µg of DNA in a 
final volume of 10 -2O111 (made up with sterile distilled water). Incubations were 
carried out according to Sambrook et al (1989) with protruding 5' termini being 
incubated for 30 min at 37 °C, while blunt or recessed termini were first incubated for 
15 min at 37 °C, after which a second aliquot of CIP was added and the incubation 
carried out for a further 45 min at 55 °C. Following incubation the CIP was 
inactivated by heating for 10 min at 75 °C in the presence of 5mM EDTA prior to 
extraction with phenol:chloroform then chloroform. The DNA was precipated by 
adding 0.1 volumes 3M Sodium Acetate and 2 volumes ethanol. 
2.8.7 Transformation of competent E. coli 
Up to 50ng of ligated plasmid DNA was added to 20011 of competent cells. The 
DNA and cells were subsequently incubated for 30 min on ice, then heat -shocked for 
4 min at 37 °C. 800111 of L -broth was then added and the cells incubated for 1 hr at 
37 °C to allow expression of antibiotic resistance. The cells were pelleted and 
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resuspended in 200µ1 of L -broth with aliquots of 30 and 80111 then spread on L -agar 
plates containing 5014 ml -1 ampicillin, 24µg ml -1 isopropyl -D- 
thiogalactopyranosidase (IPTG),(Nova Biochem), and 2014 ml-1 X- galactose (X -gal), 
(Nova Biochem), for selection of recombinants. 
2.8.8 Transfer of bacterial colony DNA to nitrocellulose 
Bacterial colonies were transferred to nitrocellulose and the DNA bound by the 
method described in Maniatis et al (1982) with modifications. 
Colonies selected as containing recombinant plasmids using IPTG and X -gal (i.e. 
white colonies as opposed to blue) were screened by transferring to a fresh L -agar 
plate and a replica L -agar plate, overlaid with a nitrocellulose filter, using sterile 
toothpicks. The filters used were Hybond -C extra (Amersham). Both plates were 
incubated at 37 °C overnight. The filter was then treated by placing over 3MM 
Whatman chromatography paper impregnated with the following solutions. First the 
filter was treated with 0.5M NaOH, 1.5M NaCl for 7 min, then twice with 1M Tris- 
HC1 (pH7.4) for 2 min, and finally with 1M ammonium acetate for 4 min. Once dried 
the filter was baked in a vacuum oven at 80 °C for 1 hr, then washed in 5X SSC, 
0.5% (w /v) SDS, 1mM EDTA for 30 min at 50 °C. Cellular debris was removed by 
rubbing the filters gently with dampened tissues. 
2.8.9 Agarose gel electrophoresis of DNA 
Nucleic acid grade " ultrapure" agarose (BRL) was used at concentrations of 0.6 -1.2% 
(w /v) in either Loening "E" buffer (180mM Tris, 150mM NaH2PO4, 5mM EDTA, 
pH7.6 -7.8) or TAE buffer (40mM Tris- acetate, 2mM EDTA pH7.5 -7.8). Ethidium 
bromide was added to molten agarose at a final concentration of 0.2mg ml -1. 0.1 
volumes of DNA loading buffer (0.1% (w /v) bromophenol blue, 0.25% (w /v) xylene 
cyanol, 75mM EDTA, 25% sucrose) was added to DNA samples prior to loading, 
and electrophoresis was carried out at 1 -4 volts cm-1 in the relevant buffer until the 
required resolution was achieved. Size estimation was achieved by co- electrophoresis 
of a lkbp ladder (G1BCO -BRL), and the fragment sizes of this ladder are illustrated 
in figure 2.3. Agarose gel tanks were purchased from Biorad and Pharmacia. DNA 
fragments were visualised by fluorescence of bound ethidium bromide in ultra violet 
(uv) light of 302nm wavelength. 
2.8.10 Southern transfer of DNA to nylon filters 
Transfer of DNA from agarose gels to nylon filters was carried out following 
a 
modification of the method of Smith and Summers (1980). 
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Figure 2.3 
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The gel was incubated in 0.25M HC1 for 10 min to depurinate the DNA (if fragments 
did not exceed 15kbp the depurination step was omitted) then rinsed in distilled 
water and incubated in denaturing solution (0.5M NaOH, 1.5M NaCI) for 30 min. 
The gel was subsequently neutralised by incubation in 1M Ammonium acetate for 1 
hr. Transfer to "Hybond N" nylon membrane (Amersham) was carried out by placing 
the membrane (previously soaked in neutralising solution) on top of the gel, followed 
by 3 sheets of Whatman 3MM chromatography paper (also previously soaked in 
neutralising solution). Finally a 3cm stack of paper towels and a lkg weight were 
placed on top of the filter paper. Transfer was allowed to proceed for 3 -18 hr after 
which the filter was washed briefly in 2X SSC, air dried and fixed to the membrane 
by uy irradiation (0.4 J cm-1). 
2.8.11 Polyacrylamide gel electrophoresis of DNA 
Polyacrylamide gel electrophoresis (PAGE) of DNA was based on the method 
described by Sambrook et al (1989). 
7.5% polyacrylamide gels were prepared using appropriate volumes from a 30% 
acrylamide stock (29.2% (w /v) acrylamide, 0.8% (w /v) bisacrylamide) and 5X 
Loening "E" buffer (see 2.8.9), with the volume being made up with distilled water. 
N, N, N' ,N',- tetramethylethylenediamine (TEMED) and ammonium persulphate 
(APS), ( Biorad) were added to give final concentrations of 0.1% (v /v) and 0.1% 
(w /v) respectively, and the gel was poured immediately after their addition. Gels 
were cast and run in the "mini protean" gel system (Biorad) at 200 volts constant 
voltage setting. 
2.8.12 Silver staining of polyacrylamide gels 
Nucleic acid fragments were silver stained using a modification 
of the technique 
described by Herring et al (1982). 
Following electrophoresis the gel was fixed in 100m1 
of 10% (v /v) ethanol and 0.5% 
(v /v) ethanoic acid. The gel was then stained in 11.2mM 
AgNO3 for 10 min. After a 
quick wash in distilled water the bands were developed 
by the addition of a solution 
of 0.75M NaOH containing 0.25% (v /v) formaldehyde 
for 2 -5 min. When the desired 
intensity was achieved the developing solution 
was removed and the reaction stopped 
by washing in 75mM Na2CO3. All the steps 
in this staining procedure were carried 
out with gentle agitation. 
34 
2.8.13 Recovery of DNA from agarose gels 
DNA fragments were recovered from agarose gels by either of two methods 
depending on the size of the fragment: 
i) DNA fragments were recovered from agarose gels using powdered glass following 
the technique described by Vogelstein and Gillespie (1979). This process was carried 
out using the commercially available "Gene clean 2" kit (Stratech Scientific Ltd). 
Briefly, an agarose slice containing the required DNA was excised from the gel and 
dissolved in 2 -3 volumes of 3M Nal at 50 -55 °C. 510 "glass- milk" (a specially 
formulated silica matrix in water) was then added and the contents of the tube were 
vortexed then left for 5 min at RT to allow the DNA to bind to the glass. The DNA - 
glass matrix was then pelleted at 9000g for 5 sec and washed in "NEW wash" (a 
solution containing NaCl, Tris, EDTA and ethanol) 3 times. The DNA was eluted in 
5µl of sterile distilled water at 50 °C for 3 min and the "glass- milk" pelleted by 
centrifugation at 9000g for 30 sec. This technique was used for fragments greater 
than 300bp. 
ii) DNA fragments were recovered from agarose gels using the commercially 
available agarase (GELase, Cambio Ltd). 
GELase was used to recover DNA fragments from low melting point (LMP) agarose 
(BRL) gels of 1.5 -2.0% agarose. The gel slice containing the required DNA was 
excised from the gel and 50X GELase buffer was added at a concentration of 2µl per 
10014 gel slice. After incubation at 65 -70 °C to melt the agarose GELase was added 
according to the manufacturers instructions, and the tube was incubated at 40 °C. The 
DNA was recovered by the addition of 1 vol of 5M ammonium acetate and 2 
volumes of ethanol followed by centrifugation at 9000g for 10 min. 
2.8.14 Preparation of digoxygenin labelled DNA probe 
Probe DNA was labelled with digoxygenin (DIG) using the 
commercially available 
"DIG DNA labelling and detection kit" (Boehringer Mannheim). 
DNA was prepared following the methods described in 
2.8.4, 2.8.9 and 2.8.13 where 
appropriate, then was labelled by random primed 
incorporation (Feinberg and 
Vogelstein 1983) of DIG. The DNA was denatured 
by boiling for 10 min, then 
incubated with 1111 random hexanucleotide mix, 
1111 dNTP labelling mix and 1 unit 
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of klenow enzyme for 1 -24 hr at 37 °C. This labelling reaction results in incorporation 
of DIG -11 -dUTP every 20 -25 nucleotides in the newly synthesised DNA. 
2.8.15 Preparation of digoxygenin labelled DNA probe using specific primers 
An adaptation of the manufacturers recommended labelling reaction for the "DIG 
DNA labelling and detection kit" was used to label small DNA fragments (50- 500óp) 
cloned into plasmids (either pBS+ or pBS SK +) containing M13 universal and 
reverse primer sequences. 
The target plasmid was first linearised by restriction to prevent labelling of plasmid 
DNA beyond the insert. The DIG labelling reaction was carried out by adding 1111 of 
the relevant sequencing primer, 1111 of dNTP mix and 1 unit of klenow enzyme to the 
linearised plasmid in a final volume of 10111. The reaction was incubated at 37 °C for 
1 -24hr. This adaptation was used to generate more specific probe (since priming is at 
one site only) and to avoid losses of small fragments incurred during recovery from 
agarose. 
2.8.16 Preparation of digoxygenin labelled RNA probe 
Probe RNA was labelled using digoxygenin -11- uridine -5- triphosphate 
(DIG -11- 
UTP) (Boehringer Mannheim). 
This method was used to generate probes of 100 -600bp from 
fragments cloned into 
pBS+ or pBS SK +, both of which contained recognition 
sequences for the T3 and T7 
RNA promoters. The template DNA was first linearised 
and denatured. Labelling 
with DIG -II -UTP was carried out by adding 3.5mM DIG -11 
-UTP to 6.5mM UTP, 
10mM ATP, 10 mM GTP and 10mM CTP to produce 
a l0X "NTP mix ". Forty units 
of T3 or T7 RNA polymerase (Boehringer Mannheim) 
and 2µl of 10X transcription 
buffer (0.4M Tris -HC1, pH8.0, 60mM MgC12, 
100mM dithiothreitol, 20mM 
spermidine, 100mM NaC1) were added to 
the linearised DNA, along with 2111 10X 
"NTP mix ", 2111 RNAse inhibitor (Boehringer 
Mannheim) and sterile water to make 
the volume up to 2Oµ1. The reaction was 
incubated for 2 h at 37 °C and the probe then 
frozen at -20°C until required. This method 
of labelling was used to give higher 
yields of probe. 
2.8.17 Hybridisation of DIG labelled probes 
Hybridisations were carried out essentially 
as recommended by the manufacturers 
(Boehringer Mannheim). 
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Filters were prehybridised by incubating with hyridisation solution (5X SSC, 5% 
(w /v) "blocking reagent ", 0.1% (w /v) N- lauroylsarcosine, Na -salt, 0.02% (w /v) SDS, 
50% (v /v) formamide). This solution was then removed and replaced with 2.5ml per 
100cm 2 of fresh hybridisation solution containing freshly denatured probe. 
Hybridisation was carried out for 16 -20 hr at 42 °C. Filters were washed twice in 2X 
SSC, 0.1% (w /v) SDS for 5 min at RT, then twice in 0.1X SSC, 0.1% (w /v) SDS for 
15 min at 68 °C. 
2.8.18 Detection of bound DIG labelled probes 
Immunological detection of bound DIG labelled probe was carried out according to 
the manufacturers instructions with minor alterations. All steps were carried out with 
gentle agitation unless otherwise stated. 
Filters were blocked in a solution of TN buffer (100mM Tris -HCI, 150mM NaCl) 
containing 0.5% (w /v) "blocking reagent" for 30 min. The filters were then incubated 
in 10 -20m1 TN buffer containing a 1:5000 (v /v) dilution of anti -DIG alkaline - 
phosphatase conjugate. Unbound antibody- conjugate was removed by washing twice 
in TN buffer for 15 min. The filters were then equilibrated in TNM (100mM Tris- 
HCl, 100mM NaCl, 50mM MgC12, pH9.5) before adding the colour solution which 
consisted of 4511l "NTB" solution and 3511l "X- phopsphate" in 20m1 TNM. ( "NTB" 
consists of 75mg ml-1 nitroblue tetrazolium salt in dimethylformamide while "X- 
phosphate" consists of 50mg m1-1 in 5- bromo -4- chloro- 3- indolyl phosphate, 
toludinium salt, in dimethylformamide). The filters were left static in the dark for lhr 
to 3 days until the colour had developed to the required intensity. The reaction was 
stopped by washing briefly in TE, after which the filters were air dried. 
2.8.19 Di -deoxy chain termination sequencing of DNA using T7 polymerase 
T7 polymerase sequencing was carried out using the commercially available T7 
sequencing kit (Pharmacia), which provided all the reagents necessary to carry out 
DNA sequencing reactions by the di -deoxy termination method of Sanger et al 
(1977), except for [35S] dATP, which was obtained from Amersham. Preparation of 
DNA was as described in 2.7.1 -2, and all sequencing was carried out using double 
stranded DNA as template. All procedures were carried out as recommended by the 
manufacturers. 
Approximately lµg per reaction was first denatured by adding 0.4M NaOH and 
incubating for 10 min at RT. The DNA was then precipitated by the addition of 0.3 
volumes of 3M sodium acetate 0.7 volumes distilled water and 6 volumes of ethanol. 
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2111 of "annealing buffer" (a buffered solution containing MgC12 and dithiothreitol) 
and 2111 of primer (1.6mM) were added to the DNA, mixed gently, then incubated for 
20 min at 37 °C to anneal primer to template, or heated to 65 °C for 10 min then left to 
anneal while cooling to RT . Once the annealing reactions had cooled the labelling 
and termination reactions were carried out. An "enzyme premix" was prepared by 
adding 3 units of T7 polymerase in "enzyme dilution buffer (a buffered solution 
containing glycerol, bovine serum albumin and dithiothreitol) to 1111 (1011Ci) of [35S] 
dATP, 3111 of "labelling mix A" (dCTP, dGTP and dTTP in solution) and 1µ1 of 
distilled water. 6111 of "enzyme premix" was added to the annealed template and 
primer and incubated for 5 min at RT during which time the newly synthesised DNA 
was labelled by incorporation of [35S] dATP. Chain termination was effected by the 
addition of 4111 from this reaction to each of 4 tubes containing 2.5111 of "G ", "A ", 
"T ", and "C" mixes respectively (each mix contained deoxy and di -deoxy forms of 
the respective base) and incubating for 5 min at 37 °C. 5111 of "stop solution" was 
added to each tube prior to storage at -20 °C. 
The sequencing samples were resolved by PAGE. 6% acrylamide gel solution was 
prepared from a 40% acrylamide stock (38% (w /v) acrylamide, 2% (w /v) bis- 
acrylamide) with urea added to a final concentration of 7M and 10X TBE (1M Tris- 
HC1, 0.865M boric acid, 20mM EDTA) at a dilution of 1:10. 0.1% (w /v) APS and 
0.05% (v /v) TEMED were added immediately before pouring the gel. 
Electrophoresis in 1X TBE buffer was carried out using S2 (BRL) apparatus at 50 
watts constant power setting. The gels were pre -run for 30 min before loading freshly 
denatured samples (heated to 80 °C for 2 min). Further samples were added as 
required and electrophoresis continued for 5 -8 hr. The gels were fixed by immersing 
in 10% (v /v) methanol, 10% (v /v) ethanoic acid then transferred to Whatman 3MM 
filter paper and dried under vacuum at 76 °C for 30 min. 
Detection of [35S]- labelled nucleic acids in sequencing gels was achieved by 
exposure to medical x -ray film (Fuji) in radiography cassettes. The x -ray film was 
developed and fixed in "Photosol" CDL8 developer and "Photosol" CF40 fixer 
(Photosol products were purchased from Genetic Research Instrumentation Limited). 
2.8.20 Polymerase chain reaction 
Amplification reactions were performed according to the procedure 
described by 
Saiki et al (1985 and 1988), following guidelines described by Innis et 
al (1990) with 
minor modifications. 
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Polymerase chain reactions (PCR) were set up by adding final concentrations of 
0.2mM dNTPs, 0.25mM of two 20bp oligonucleotide primers, 1X PCR buffer 
(10mM Tris -HC1, 1.5mM MgC12, 50mM KC1, 0.1mg ml -1 gelatine) and 2.5 units Taq 
polymerase (Boehringer Mannheim) to freshly denatured target DNA in a final 
volume of S0µ1. The target DNA was 100ng of PP1, PP2, CA or CFA genomic 
DNA. The reactions were overlaid with S0111 of sterile mineral oil before being 
amplified using a Perkin Elmer Cetus Thermal DNA Cycler or a Hybaid ampligene 
temperature cycler. 
The PCR conditions varied according to several factors. The annealing temperature 
was determined by calculating the Tm of both oligonucleotides, with each A and T 
accounting for 2 °C, and each G and C accounting for 4 °C. Annealing was carried out 
at 5 °C below the lower Tm of the two oligonucleotides. The extension phase of the 
cycle varied depending on the predicted size of the product, with 1 minute being 
added on for every lkbp synthesised. All PCR reactions followed a cycle of 
denaturation at 94 °C for 1 minute, annealing at various temperatures for 1 minute, 
and extension at 72 °C for varying times. Figure 2.4 lists the variable factors involved 
in these reactions. 
PCR fragments were analysed by agarose gel electrophoresis or polyacrylamide gel 
electrophoresis depending on the size of the fragment. Confirmation that the correct 
fragment was produced on PCR cycling was achieved by Southern transfer and 
subsequent hybridisation using DIG labelled probes. 
2.8.21 The use of PCR to generate DIG -labelled probes 
PCR was used to prepare highly specific DIG -labelled probes in large quantities. The 
PCR reactions were set up and carried out as described in 2.8.20, with DIG 
-dUTP 
incorporated into the 2mM dNTP l0X stock at a ratio of 35:65 (DIG -dUTP:dTTP). 
The reaction then proceeded following a typical cycle as described 
in 2.8.20, repeated 
fifteen times. The resultant probe was analysed by agarose electrophoresis 
to assess 
the purity and either recovered from agarose (following 
either of the methods 
described in 2.8.13) or used directly. 
2.8.22 Di -deoxy chain termination sequencing of DNA 
using Taq polymerase 
Taq polymerase sequencing of DNA was carried 
out using the commercially 
available fmol DNA sequencing system (Promega). 
This method employs PCR to 
prepare samples using the di -deoxy termination method 
of Sanger et al (1977). The 
sequencing reactions carried out all involved 
incorporation of [35S] dATP 
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Figure 2.4 
Reaction Annealing Extension time Number of cycles 
Temperature (+ extension per cycle) 
A 50°C 3min (+ lOsec) 25 
B 45°C 3miri (+ lOsec) 30 
C 45°C 3min (+ 30sec) 30 
D 55°C 3min (+ lOsec) 30 
E 45°C lmin 30sec 30 
F 45°C 2min (+ 5sec) 30 
G 40°C l min 15 
H 55°C lmin 30 
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(Amersham) and followed the manufacturers instructions, with all additional reagents 
supplied in the kit. 
Approximately 1µg of plasmid DNA was used per reaction, and to this was added 
3.Opmol primer, 1011Ci [35S] dATP, 5µ1 5X fmol sequencing buffer (250mM Tris- 
HCI, 10mM MgC12), 5U sequencing grade Taq polymerise and sterile dH2O to a 
final volume of 174 4p1 of this was added to each of 4 tubes containing 2µl of 'G', 
'A', 'T' and 'C' nucleotide mixes. The nucleotide mixes were comprised of deoxy and 
di -deoxy nucleotides, with the dGTP being 7 deaza dGTP to reduce hydrogen 
bonding and therefore resolve compressions. The sequencing reactions were 
subsequently carried out following a cycle of 95 °C for 30 seconds, 45 °C for 30 
seconds, then 72 °C for 1 minute. After 30 cycles 3111 of "stop solution" (10mM 
NaOH, 95% formamide, 0.05% bromophenol blue, 0.05% xylene cyanole) was added 
to each tube. The sequencing reactions were resolved by PAGE in an identical 
manner to that described in 2.8.19. 
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Chapter 3 
Identification, cloning and characterisation 
of variable regions of C500 
3.1 INTRODUCTION 
The C500 isolate of AHV -1 was derived from the blood of an ox reacting with 
MCF following presumptive exposure to wildebeest (Plowright et al 1975). This 
isolate of AHV -1 was shown to retain virulence for a limited number of passages in 
tissue culture, in both cell- associated and cell -free forms (Russell 1980). The C500 
isolate became attenuated (i.e. failed to induce typical MCF symptoms following 
inoculation into rabbits) on continual serial passage in tissue culture (unpublished 
data). This allowed comparison of virulent and attenuated derivatives of a single 
Ally-1 isolate at a molecular level. This chapter describes the derivatives of C500 
employed in this study and the initial experiments carried out to compare these 
derivatives. 
3.2 C500 TISSUE CULTURE DERIVATIVES 
The C500 virus was typically cell- associated (CA) and virulent for the first fifteen 
to twenty passages in monolayered cells of bovine lineage. Virus infectivity 
subsequently was largely present in a cell -free (CF) form but retained virulence for 
a relatively transient phase of approximately five passages before losing 
pathogenicity for rabbits. The cytopathic effects (cpe) of both the virulent and the 
attenuated C500 derivatives on bovine turbinate cells are illustrated in figures 3.1a 
and 3.1b respectively. Infection with the virulent, cell- associated virus typically 
results in the formation of syncytia and a few rounded cells, whilst infection 
with 
the attenuated, cell -free virus results in single rounded cells with 
few or no 
syncytia. Infection with both C500 derivatives finally resulted in 
deterioration of the 
bovine monolayer. With cell- associated virus this generally occurred 
4 -6 days after 
infection, compared to 2 -4 days with cell -free virus. The different 
cpe observed on 
infection with these two C500 derivatives is consistent, 
implying that the virus has 
undergone biological alterations. 
The study of the genomic alterations which take place 
in the switch from virulence 
to attenuation was performed by comparison of 
the C500 derivatives. When this 
study began, the C500 virus was available 
as virulent, CA virus, virulent CF 
virus and attenuated CF virus (CFA). In 
addition to these three derivatives low 
passage C500 CA virus was biologically 
cloned by three serial limiting 
dilutions. This population was subsequently 
denoted PP. Comparative studies 
of AHV -1 also included (where appropriate) WC11, 
a strain which was completely 
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Figure 3.1 
Infection of bovine turbinate cells with C500 virus 
Figure 3.1a Infection with virulent, cell- associated C500 virus 
(magnification X100). 
Figure 3.1b Infection with attenuated, cell-free C500 virus 
(magnification X60). 
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attenuated following prolongued in vitro propagation (Plowright et al 1965). The 
five AHV -1 derivatives compared in this study are summarised in figure 3.2. 
3.3 MOLECULAR COMPARISON OF THE C500 DERIVATIVES 
Purified DNA from the four C500 derivatives was compared by restriction 
endonuclease (RE) digestion using five enzymes which had six -base recognition 
sites. To provide a high degree of resolution and to allow small differences to be 
observed the digests were resolved using polyacrylamide gel electrophoresis 
and visualised by silver staining. 
The RE used to compare the four C500 derivatives in the first instance were 
Hind III, Eco RI, Barn HI and Xho I. Digestion with these enzymes failed to identify 
any appreciable differences in the restriction profiles of the four C500 derivatives 
(data not shown). This result was predictable since the aforementioned enzymes 
all lack sites in the terminal repeat region. The termini of the C500 molecule, as 
described in section 1.11.7, consist of a variable number of repeats of a 1050bp 
unit. In a given population of virions the number of repeat units at each end of the 
genome can vary significantly, hence an RE which lacks sites in the repeat unit 
produces terminal fragments of variable sizes. The result of using such enzymes is 
that a ladder of fragments is formed for each end of the molecule. Hind III, 
Eco RI, Barn HI and Xho I all must lack sites in the repeat unit as all produced 
double ladders which caused a masking effect thus making the profiles of these 
enzymes difficult to interpret. 
When the four C500 derivatives were digested with Sma I, an enzyme which 
recognises sites in the repeat unit, two differences were observed on silver 
staining, as illustrated in figure 3.3. Firstly, a fragment of approximately 5kbp, 
present in the three virulent derivatives i.e. PP, CA and CF, was absent from the 
CFA derivative. Secondly, a fragment of approximately 3.8kbp was observed in 
the CA, CF and CFA derivatives but not in the PP derivative. The observation 
that the 5kbp fragment was present in all the virulent derivatives but was absent 
from the attenuated derivative suggested that loss of this fragment may be related to 
loss of virulence. Before this possibility could be further examined it was necessary 
to ascertain whether loss of this fragment was a genuine feature of attenuation or an 
artefact of one particular CFA derivative. A second, independent C500 attenuated 
derivative, CFA 2, was digested with Sma I, as was WC11, and these digests 
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Figure 3.2 





















Comparison of Sma I digests of PP, CA, CF and CFA C500 virus 
5.Okb. 3.8kó. 
1 2 3 4 5 
Track 1 - 1kb ladder 
Track 2 - PP digested with Sma I 
Track 3 - CA digested with Sma I 
Track 4 - CF digested with Sma I 
Track 5 - CFA digested with Sma I 
These samples were analysed using 7.5% acrylamide 
46 
were resolved alongside the original CFA preparation (CFA 1) and CA virus 
on 0.8% agarose. The profiles of these four samples were difficult to interpret 
on uy illumination of intercalated ethidium bromide therefore the gel was 
blotted and probed with DIG -labelled DNA from CA virus. The filter illustrated 
in figure 3.4 clearly demonstrates that the 5kbp fragment is absent from CFA 1, 
CFA 2 and WC 11. 
3.4 HOMOLOGY BETWEEN THE VARIABLE REGIONS 
Digestion of the four C500 derivatives with Sma I revealed variation in the 
restriction profiles regarding fragments of 5 and 3.8kbp. The relationship 
between these fragments was initially examined by assessing whether the fragments 
were homologous. The 3.8kbp Sma I CFA fragment was recovered from agarose 
then labelled with DIG. The labelled DNA was used to probe a Southern blot of 
Sma I digests of PP, CA, CF and CFA genomic DNA (see figure 3.5), and 
homology was observed between the 5kbp PP Sma I fragment and the 3.8kbp CFA 
Sma I fragment. The 3.8kbp CFA probe hybridised to CA and CF fragments of 5 
and 3.8kbp, a CFA fragment of 3.8kbp, and PP fragments of 5 and 8.6kbp. (The 
8.6kbp PP fragment will be discussed further in chapter 5). 
3.5 CLONING AND MAPPING OF THE 3.8KBP SMA I FRAGMENT 
The 3.8kbp CFA Sma I fragment was excised from a 0.8% agarose gel and 
recovered using powdered glass. The vector selected to clone this fragment was 
the general purpose bacterial plasmid Bluescribe (pBS +), which was prepared by 
Sma I digestion and treatment with CIP. The 3.8kbp fragment was ligated into the 
prepared pBS+ and the resultant plasmid was transformed into JM101 bacterial 
cells then plated out onto L -agar containing X -gal, IPTG and L -amp. A 
single colony from this transformation was grown up and the plasmid extracted 
by the method described in 2.8.1. The resultant plasmid was digested 
with Sma I 
to produce an insert of 3.8kbp. This insert was excised from 
the plasmid and 
subsequently labelled with DIG. When used to probe a Sma 
I digest of CFA this 
probe hybridised to a single fragment of 3.8kbp, confirming 
that the correct fragment 
had been cloned. This clone was designated ATT -1, as it 
was the first clone to be 
derived from the attenuated C500 derivative. 
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Figure 3.4 
Comparison of Sr.na. I digests of attenuated AHV 1 variants 
1 2 3 4 
'Track I- CA dízeste.d with Sma I 
Mark 2 - CF_AI digested with Sma I 
; - CFA2 digested with Sma I 
T:wk s - ,,%C1 1 digested with Sma I 
were probed DIG-labelled CA DNA 
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Figure 3.5 




1 2 3 4 5 
1 
Track 1 - 1kb ladder 
Track 2 - PP digested with Sma I 
Track 3 - CA digested with Sma I 
Track 4 - CF digested with Sma I 
Track 5 - CFA digested with Sma I 
Tracks 2 -5 were probed with ATT-1 DNA labelled with DIG 
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The mapping of the ATT -1 clone was carried out by digestion with a series of REs 
which recognise unique or infrequent sites in pBS +. The details of how this mapping 
was achieved are described in appendix 2.1, and the resultant map is shown in 
figure 3.6. 
3.6 CLONING AND MAPPING OF AN ATT -1 HOMOLOGUE FROM PP 
C500 VIRUS 
The ATT -1 clone hybridised to a 5kbp Sma I fragment in the PP derivative. This 
5kbp fragment was common to PP, CA and CF, therefore attempts were made to 
clone this fragment into pBS +. Repeated attempts to clone this fragment were 
unsuccessful therefore an alternative strategy was employed. PP DNA was digested 
with several other REs and the digests were resolved using 0.6% agarose, 
transferred to nylon and probed with the 5kbp fragment, which had been labelled 
with DIG. The 5kbp probe hybridised to a ladder of fragments when PP was 
digested with Kpn I or Pst I, but hybridised to a doublet of 3.6kbp in a Hind III 
digest. This doublet was recovered from agarose, ligated into pBS +, and used to 
transform JM101 bacterial cells. Three transformants were observed and one of 
these was grown overnight in L -agar with L -amp. The plasmid was extracted from 
this culture following the method described in 2.8.1 and the insert was isolated 
by digestion with Hind III, then labelled with DIG. This probe hybridised to PP 
Sma I fragments of 5 and 8.6kbp (the 8.6kbp fragment will be discussed further in 
chapter 5). This clone was designated VIR -1 as it was the first clone to be 
derived from virulent C500 virus. 
The mapping of the VIR -1 clone was carried out by digestion with a series of RE 
with unique or infrequent recognition sites in pBS +. The experiments carried 
out to map this clone are described in appendix 2.2, and the resultant map of the 
VIR -1 clone is shown on figure 3.7. 
3.7 THE DEGREE OF HOMOLOGY BETWEEN ATT -1 AND VIR -1 
3.7.1 Introduction 
The original 5kbp Sma I PP fragment had been shown to be homologous 
to the 
3.8kbp Sma I CFA fragment. The two clones, VIR -1 and ATT 
-1, contained DNA 
from these homologous regions of PP and CFA respectively, 
and therefore were 
expected to exhibit a degree of homology. The termini 








































































































































































































































arbitrarily labelled 5' and 3'. Comparison of the RE profiles of the two clones 
suggested that homology might occur towards their 3' ends on the basis of 
fragment sizes. The 5' ends of the two clones differed with regard to both the 
recognition sites present and their locations. 
3.7.2 Comparison of similar sized fragments by hybridisation 
The nature of the derivation of the ATT -1 and VIR -1 clones suggested that a degree 
of homology existed between the two. This was confirmed when the ATT -1 insert, 
labelled with DIG, was used to probe the VIR -1 insert, and hybridisation was 
observed (data not shown). The degree of homology was initially assessed by 
comparing the restriction profiles of the two clones (see appendix 2 for 
fragment sizes). The two clones did not exhibit total homology as ATT -1 
contained recognition sites for Kpn I, while VIR -1 did not. Conversely VIR -1 
contained sites for Sac I, while ATT -1 did not. Several restriction fragments of 
identical size, however, were observed on digestion with Pst I/Hind III (fragment 
sizes of 435, 342 and 216bp) and with Pvu II (fragment size 844bp). These 
identically sized fragments were shown to be homologous by using the VIR -1 435, 
342 and 216bp fragments (which are represented by fragments A, B and C 
respectively in figure 3.13) to probe Pst I/Eco RI digests of ATT -1 and VIR -1 (as a 
control). The fragments were labelled with DIG and homology was observed as 
illustrated in figure 3.8, filters labelled 2, 3 and 4. The remaining two filters in this 
figure were used to assess whether the DNA at the 3' -end of ATT -1 recognised 
sequences in VIR -1 (filter 1) and, conversely, to assess whether the DNA at the 5'- 
end of VIR -1 recognised sequences in the ATT -1 clone. In both instances no 
hybridisation was observed to the target DNA, demonstrating that the 5' and 3' ends 
of the clones differed. The Pst I/Hind III and Pvu II homologous fragments were 
aligned, as demonstrated in figure 3.9, suggesting that the minimum region of 
homology between the clones was approximately 1700bp. 
3.7.3 Identification of the region where homology is lost 
From the linear comparison of the two clones as illustrated in figure 
3.9 the 5' ends 
of the two clones vary significantly with regard to the 
location of several 
restriction sites. This variation was thought to be too extensive 
to be due to point 
mutations and, as described in 3.7.2, the 5' end of the 
VIR -1 clone (fragment G 
in figure 3.13) was not homologous to any part 
of the ATT -1 clone. The lack of 
homology extended 3' to this Pst I fragment 
as fragment F in figure 3.13 also 
failed to exhibit homology to the ATT -1 clone, 
whilst conversely ATT -1 fragment 
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Figure 3.8 
Probing digests of AIT-1 and VIR 1 with AIT-1 and VIR 1 subfragments 






Tracks y - VIR 1 digests 
Tracks a - ATT 1 digests 
Probe 1 - figure 3.12, fragment A 
Probe 2 - figure 3.13, fragment A 
Probe 3 - figure 3.13, fragment B 
Probe 4 - figure 3.13, fragment C 














































































































































H (figure 3.12) exhibited no homology to VIR -1. These hybridisation 
experiments led to the conclusion that the homology between the two clones is 
lost upstream of the Pvu II site closest to the 5' end of both clones. This homology 
loss is not due to misalignment of the two clones and suggests rearrangement of the 
genomic C500 DNA has occurred. 
3.8 CLONING AND MAPPING OF AN ATT -1 HOMOLOGUE FROM CA 
C500 VIRUS 
The 5kbp Sma I PP fragment hybridised to a doublet of 3.6kbp when used to probe a 
Hind III digest of the PP derivative. One of these fragments had been inserted into 
pBS+ and characterised (see section 3.6), and could therefore be distinguished from 
the second Hind III fragment. This second fragment was cloned into pBS SK+ 
after recovery from CA DNA digested with Hind III. (The relationship of the two 
3.6kbp Hind III fragments with regard to the PP and CA derivatives will be 
discussed in chapter 5). The insert from the pBS SK+ clone was excised using Hind 
III, recovered from agarose using powdered glass then labelled with DIG. This 
probe hybridised to fragments of 5 and 3.8kbp when used to probe a Sma I digest 
of CA, the same fragments which the original PP Sma I 5kbp fragment recognised 
in this derivative, from which it was concluded that a homologous fragment had 
been cloned. This clone was designated VIR -2 as it was the second clone to be 
isolated from virulent C500 virus. 
The VIR -2 clone was mapped using REs known to have sites 
in one or both of 
ATT -1 and VR -1. The experiments carried out to map this clone are described 
in 
appendix 2.3, and the resultant map of VIR -2 is shown in 
figure 3.10. 
3.9 THE DEGREE OF HOMOLOGY BETWEEN ATT 
-1, VIR -1 AND VIR -2 
The known homology between ATT -1 and VIR 
-1, as described in section 3.7, was 
used as a basis to determine the degree of homology 
between VIR -2 and each of 
these clones. The three clones are compared 
in figure 3.11, and the derivation of 
the similarities presented here is described 
in the remainder of this section. 
The VIR -2 clone produced fragments 
of 216bp, 342óp and 435bp when 
digested with Pst I/Hind III. Fragments 
of identical size were observed when both 
ATT -1 and VIR -1 were digested 










































































































































































































































experiments showed these three fragments contained homologous DNA in all 
three clones. Pst I/Hind III digestion of VIR -2 also produced a larger Pst I 
fragment (fragment D in figure 3.16), identical in size to ATT -1 Pst I fragment 
E (figure 3.12) which was located over the region of homology loss between 
ATT -1 and VIR -1. Comparison of the Kpn I profiles of the three clones 
illustrated that while VIR -1 contained no sites for Kpn I, ATT -1 and VIR -2 both 
contained two sites for Kpn I, which resulted in a centrally located homologous 
fragment of 340óp. These comparisons suggested that VIR -2 was more similar 
to ATT -1 than to VIR -1. 
The similarity between ATT -1 and VIR -2 appeared to span almost the entire ATT -1 
clone 5' to the Hind III site as the Kpn I, Pst I and Sph I profiles exhibit (see 
figure 3.11). The 5' -ends of the two clones were found to differ in that ATT -1 was 
terminated by a Sma I site which had no equivalent in the VIR -2 clone, therefore 
the two clones were homologous upstream of the Hind III site in the ATT -1 clone 
until within 175bp of the 5' end of the ATT -1 clone. 
The results described in the previous paragraph indicate that a far greater degree 
of similarity exists between ATT -1 and VIR -2 than exists with either of the above 
and VIR -1. The exact location of the sites of homology loss could only be achieved 
by sequencing the three clones. 
3.10 VECTORS SELECTED FOR THE SUBCLONING OF ATT -1, VIR -1 
AND VIR -2 
The sequencing of ATT -1, VIR -1 and VIR -2 was facilitated by subcloning 
selected 
fragments into bacterial plasmid vectors. Prior to subcloning 
large scale 
preparations of ATT -1, VIR -1 and VIR -2 were prepared 
following the method 
described in 2.8.2. The vectors selected for subcloning 
were pBS+ and pBS SK+ 
as both contain sequences recognised by the M13 
universal and reverse primers. 
These primers are orientated on opposing strands 
at either end of the multiple 
cloning sites of these vectors which therefore 
enables sequencing of both strands 
of the insert. The subclones were transformed 
into JM109 bacterial cells, 
amplified in L -broth containing 401.1g ml-1 
of L -amp and recovered following the 
method described in 2.8.1. The subclones 
were checked by labelling their inserts 
with DIG then using these DIG -labelled 
fragments to probe restriction digests of 
the relevant clone (i.e. ATT -1, VIR -1 or 
VIR -2). 
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3.11 PRIMERS USED TO COMPLETE THE SEQUENCING OF ATT -1, 
VIR -1 AND VIR -2 
Subcloning of the three C500 clones did not enable sequencing of the entire 
inserts therefore oligonucleotides were used to complete gaps and orientate clones 
where appropriate. All oligonucleotides (Oswell DNA) were 20bp in length and 
their sequences are presented in appendix 3. 
3.12 THE SUBCLONING AND SEQUENCING OF THE ATT -1 CLONE 
3.12.1 The subcloning of ATT -1 
The majority of the ATT -1 clone was subcloned using the restriction 
endonucleases (REs) Hind 1H, Pst I, Kpn I and Pvu II. The resultant subclones are 
demonstrated in figure 3.12a, denoted as fragments A -H. Initially the ATT -1 
clone was digested with Pst I and fragments C, D and E were ligated into pBS +. 
Fragment B was isolated by digestion of ATT -1 with Pst I in conjunction with Hind 
III and inserted into pBS+ digested with the same two enzymes. Fragment A was 
subcloned by digesting ATT -1 with Hind III then self -ligating the larger fragment 
which corresponded to pBS+ ligated to fragment A at the 3' end via the Sma I site 
used in the original cloning of ATT -1. Fragments F and G were created by double 
digestion of the subclone containing fragment E with Pst I and Pvu if The 
polylinker of pBS+ does not have a RE site for Pvu II, however this enzyme is a 
blunt -ended cutter, as is Sma I, which does have a site in the polylinker of pBS +. 
The two Pvu II/Pst I fragments were therefore cloned into pBS+ digested with 
Pst I and Sma I. The remaining two subclones, containing fragments H and I, 
were subcloned from a Kpn I digest of ATT -1. Fragment H was ligated into 
pBS +, and fragment I was cloned by self ligation of the ATT -1 Kpn I 
fragment 
which corresponded to pBS+ ligated to fragment I at the 5' end via 
the Sma I site 
used in the original cloning of ATT -1. 
3.12.2 The sequencing of ATT -1 
The subclones containing fragments A, B, C, D, 
F and H (as illustrated in figure 
3.12a) were all completely sequenced using the M13 
universal and reverse primers. 
The sequence of fragments A, B and F were achieved 
by resolving samples by 
electrophoresis of acrylamide sequencing gels for 
8 hours using the "long mixes" 
supplied in the T7 sequencing kit. The orientation 
of fragments C and D could not 
be deduced from sequencing the relevant 















































































































































































































































inserted into Pst I sites at both the 5' and 3' ends therefore primer 3 and primer 8 
(figure 3.12b) were used to sequence from fragments B and E into this region. 
Primer 1 was used both to sequence the region between fragments F and H and to 
orientate fragment H. Fragment I was initially sequenced using the M13 universal 
and reverse primers, however, resolving samples in excess of 8 hours did not 
reveal the entire sequence of this clone therefore primer 2 and primer 4 were used 
as illustrated in figure 3.12b. The complete sequence and primer locations of the 
ATT -1 clone are presented in appendix 3.1. 
3.13 THE SUBCLONING AND SEQUENCING OF VIR -1 
3.13.1 The subcloning of VIR -1 
The VIR -1 clone contained 7 sites for the RE Pst I therefore this enzyme was used 
in the first instance to subclone VIR -1 into appropriately sized fragments for 
sequencing. The fragments subcloned are illustrated in figure 3.13a. Fragments 
A, B and C were cloned in an identical manner to that of the corresponding ATT -1 
clones, B, C and D, as described in 3.12.1. Pst I fragments D, E and F were 
subcloned into pBS +. The subclone containing fragment D was digested with Pvu II 
in conjunction with Pst I to yield fragments H and I, which were subcloned into 
pBS SK+ digested with Pst I and Sma I, since Pvu II and Sma I are 
both blunt - 
ended cutters. The remaining fragment, G, was subcloned by self -ligation 
of the 
largest fragment produced on Pst I digestion of MR-1, as this consisted 
of fragment 
G ligated to pBS+ from the original cloning of VIR -1. 
3.13.2 The sequencing of VIR -1 
The subclones containing the inserts A, B, C, E, F, 
H and I (illustrated in figure 
3.13a) were sequenced using the M13 universal 
and reverse primers. All clones 
were sequenced in both directions. Primers 3 and 
8 were employed to orientate 
fragments B and C, while primers 5 and 7 were 
used to orientate fragments E and 
F. Fragment G was initially sequenced using 
the M13 universal and reverse primers, 
however, this region was too large to sequence 
using these primers alone. Primers 
6 and 9 were employed to sequence 
the central region of this clone. The 
complete sequence and primer locations of 
VIR -1 are presented in appendix 3.2. 
3.13.3 Sequence features of VIR -1 
The location of primer 9 is 109bp 
from the Hind III terminus of fragment G and 
located immediately before a repeated 























































































































































































































51bp sequence which was directly repeated five times, with an additional partial 
repeat of 26óp immediatedly upstream of the first copy. The sequence data of this 
region is presented in aligned form in figure 3.14, with minor differences indicated 
by boxed areas. The VIR -1 clone also yielded another region of repeated DNA, 
located in fragments I and E, comprising of an 85óp region which is directly 
repeated once. The sequence of this region is presented in figure 3.15, with 
differences again illustrated by boxes. 
The repeat regions exhibited in this clone are similar to repeated regions in 
related y- herpesviruses (Baer et al 1984, Albrecht et al 1992). EBV contains 
many small repeated units in addition to the major repeated regions of the genome 
(see figure 1.1), for example at one point a 60óp region is repeated three times, 
whilst further downstream a 33óp unit is repeated five times (Baer et al 1984). 
HVS also contains three small repeated regions in addition to the terminal repeats, 
one of 900óp, one of 550óp and one comprising of an ABABA configuration with 
A being 19bp long and B being 15bp long (Albrecht et al 1992). The significance 
of these repeats is not understood. 
3.14 THE SUBCLONING AND SEQUENCING OF VIR -2 
3.14.1 The subcloning of VIR -2 
The subcloning of VIR -2 was carried out in an almost identical 
manner to that of 
the subcloning of ATT -1, as described in 3.12.1, due to the 
high degree of similarity 
between the two clones. Figure 3.16a illustrates the fragments 
A -I which were 
subcloned. The VIR -2 clone varies from ATT -1 at the 
5' end in that homology is lost 
upstream of the 5' Pst I site. The 5' terminus of VIR 
-2 was cloned by inserting a Pst 
I fragment of 496bp into pBS +. 
3.14.2 The sequencing of VIR -2 
The subclones denoted by the letters A, 
B, C, F and H were all sequenced as 
described for their ATT -1 equivalents. 
Fragment E was sequenced using M13 
universal and reverse primers with samples 
being resolved for eight hours to 
complete the sequence. The region between 
fragments F and H was sequenced 
using primer 1, and primers 2 and 
4 were used to complete the sequence of 
fragment I. The complete sequence and 
primer locations of the VIR -2 clone are 












































































































































































































































































































































































































































































































































































































3.15 COMPARISON OF THE SEQUENCES OF ATT -1, VIR -1 AND VIR -2 
Dot matrix analysis (Maizel and Lenk 1981) of the similarities between the three 
clones was carried out using programmes which form part of the University of 
Wisconsin genetics computer group (GCG) sequence analysis software package 
which was available on the SEQNET molecular biology computer facility based 
at the SERC Daresbury laboratory, Warrington, U.K. The clones were compared 
to each other using the GCG COMPARE programme, and the results were 
converted to graphical form using the DOTPLOT programme. The results of these 
programmes are presented as figures 3.17a, b and c. These figures demonstrate that 
the regions of DNA which exhibited homology by hybridisation are identical in 
sequence, and that the sequence homology is abruptly lost at two specific points, 
one between VTR -1 and ATT -1 & VIR -2 and the other between ATT -1 and VIR -2. 
The DNA homologous to all three clones extends for 1923bp. The additional 
sequence present in both ATT -1 and VIR -2 extends for a further 1219bp, resulting 
in a total homology of 3142bp between these two clones. 
The sequence 50bp before and 50bp after the two sites of homology loss is 
illustrated in figures 3.18a and 3.18b. These figures demonstrate that in both cases 
the sequence prior to thesite of homology loss is identical and that this identity is 
abruptly lost. 
A 9bp sequence, CTGCCTTTG was observed prior to the two sites of homology 
loss, ending 3 lbp before the VIR -1 /ATT -1 breakpoint, and 25bp before the 
VIR -2 /ATT -1 breakpoint. The probability of two identical 9bp sequences 
occurring in a 3.8kbp sequence (i.e. ATT -1), assuming all four bases were present in 
equal proportion, is 0.0002, suggesting that the presence of this sequence may 
be 
significant. In addition a sequence of CCNTGGG was present 
3' to the 
CTGCCTTTG sequence before both breakpoints, with 7bp between 
the two 
sequences in figure 3.18a, compared to the sequences being contiguous 
in 3.18b. 
The final G of the CCNTGGG sequence was located 
17 and 18bp from the 
breakpoints in figures 3.18a and b respectively. A consensus 
sequence derived 
from the common features of the DNA sequence 5' 
to the two sites of loss of 
homology would be CTGCCTTTG(n)1 CCNTGGG(n)2, 
with (n)1 being 0 or 7bp, 
and (n)2 being 17 or 18bp. 
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Figure 3.17a Dotplot comparison of ATT 1 and VIR 1 
i? ` s 
ch 
m 
. i . '': . II 
( S 
..1 
ATT 1 1-3832 
ti 
Figure 3.17b Dotplot comparison of ATT 1 and VIR 2 
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Figure 3.18a The site of homology loss between VIR-1 and ATT-1 
VIR-1 1874 5' 
ATT-1 2509 5' 
AAAGACCCACTACTCTT 
CTTACCGGAGGTACCTG 
GCTCTCCCCGTGTGCCTTACAACTGAAGTGCTG 3' 1973 
AAACAAGTTTGAGACCAGCTTTACAGGAGCTAC 3' 2608 
Figure 3.18b The site of homology loss betwen VIR-2 and ATT-1 
VIR-2 5' 3039 
ATT-1 5' 3728 
GCAATTGGTTTATATAA 
TGCCGAGATCTCGGACC 
CAATTGGCAACCTAACCTTTCCCCACCAGAGCG 3' 3192 
TCTCTGCGGACGCCACGCCCCTTTCCCCGGGTC 3' 3827 
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The sequences 3' to the sites of loss of homology bear little sequence similarity, 
although a pyrimidine rich region was observed in three of the four 3' sequences. 
The VIR -1 clone exhibited a sequence beginning 6bp 3' to the site of homology loss 
in which 18/21 residues were pyrimidines. ATT -1 did not contain an equivalent 
pyrimidine region 3' to this breakpoint. Pyrimidine rich regions were also 
observed 3' to the site of homology loss between VIR -2 and ATT -1. In VIR -2 a 
sequence beginning 28bp 3' from this site exhibited pyrimidines in 14/18 residues, 
while ATT -1 exhibited pyrimidines in 14/16 residues beginning 30bp 3' from this 
site. 
The significance and function of these common sequence features located to either 
side of the sites of homology loss was not established. The presence of conserved 
sequences may indicate recognition sequences for functional proteins. 
3.16 DISCUSSION 
One aim of this project was to identify the genomic changes which are involved in 
the transition from virulence to attenuation. The experiments described in this 
chapter resulted in the identification of a region of the C500 genome which is 
variable between virulent and attenuated virus, although it is not necessarily the 
region of the genome responsible for virulence. 
The 3.8kbp Sma I CFA fragment was cloned into pBS +. Attempts to clone the 
homologous PP 5kbp fragment were consistently unsuccessful. This failure may 
have been due to size constraints (as the proposed insert was 5kbp compared to the 
plasmid size of 3.2kbp), coupled with the fact that the cloning enzyme, Sma I, was 
a blunt -ended cutter. Linking fragments to generated restriction sites with 
overhangs to facilitate cloning was not attempted due to insufficient quantities of 
PP DNA (see chapter 5). Alternative explanations for the failure to clone this 
fragment included the possibility that the insert may encode and express a protein 
toxic to the bacterial cells which were used to amplify recombinant plasmids. A 
further possibility was that the fragment may contain repeated sequences 
which 
could result in an unusual conformation, hence the difficulties 
observed on 
cloning. The problems in cloning this 5kbp fragment were 
overcome by cloning 
two 3.6kbp Hind III fragments which exhibited homology 
to the 5kbp Sma I 
fragment. 
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The three clones, ATT -1, VIR -1 and VIR -2 were mapped with a range of REs and 
homology was assessed by comparison of the RE profiles and by hybridisation 
experiments. The three clones were shown to exhibit limited homologies to each 
other with the VIR -2 and ATT -1 clones being the most similar. 
Sequencing the three clones revealed that the region of homology between VIR -1 
and the other two clones is abruptly lost 1923óp from the 3'- terminus of this 
clone. This loss of homology is believed to be due to rearrangement occurring in the 
transition from virulence to attenuation. Similarly the homology between the ATT - 
1 and the VIR -2 clones is lost 3262óp from the 3'- terminus of the VIR -2 clone. 
The observation that comparison of the three clones exhibits two distinct sites of 
homology loss suggests that at least two genomic rearrangements occur during in 
vitro propagation of the C500 isolate of AHV -1. 
The observation that the sequences 50bp before and after the two sites of homology 
loss exhibit common features suggests that a similar mechanism may be involved 
in creating these breakpoints. 
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Chapter 4 
The location of the ATI 1 clone 
in the CFA genome 
4.1 INTRODUCTION 
The previous chapter of this thesis described the identification of a region of the C500 genome in which the arrangement of the DNA sequence differs between 
virulent and attenuated derivatives. Comparison of the two clones (VIR -1 and 
VIR -2) from virulent C500 virus and a clone (ATT -1) from attenuated C500 virus 
demonstrated two sites at which homology was lost, one between VIR -1 and VIR -2 
and the other between VIR -2 and ATT -1. The events taking place at these regions of 
homology loss could be further understood by locating the three clones in the 
relevant C500 derivatives and by studying the regions adjacent to these clones. This 
chapter describes the experiments carried out to locate the ATT -1 clone in the CFA 
C500 genome and to examine the DNA adjacent to this clone. The WC11 laboratory 
isolate of AHV -1 had been studied in detail prior to the work undertaken in this 
thesis and a map of the majority of this genome was available (Bridgen 1991) 
therefore this was used as a starting point in the mapping studies described below. 
4.2 HYBRIDISING ATT -1 TO WC11 RESTRICTION DIGESTS 
The WC11 isolate of AHV -1 was originally isolated from a blue wildebeest. 
Continual serial passage of this AHV -1 isolate in tissue culture resulted in loss of 
virulence for both cattle and rabbits (Plowright et al 1965). Similarly, the CFA C500 
derivative exhibited attenuation when used to infect rabbits (H.W. Reid, personal 
communication), therefore the CFA C500 genome was expected to be the most 
closely related C500 derivative to WC11. A map of WC11 for the restriction 
enzymes Hind III, Eco RI, Xho I, Sma I, Bam HI and Sal I is presented in figure 4.1 
( Bridgen 1991). 
WC11 DNA was digested with Barn HI, Sma I, Eco RI and Xho I respectively, with 
only Sma I cutting within the repeat region. These digests were resolved using 0.6% 
agarose, transferred to nylon filters then probed with DIG -labelled ATT -1 insert. The 
probe hybridised to a l0kbp Barn HI fragment, a 3.7kbp Sma I fragment, an Eco RI 
fragment of >15kbp and a Xho I fragment of >15kbp, as shown in figure 4.2. These 
results were difficult to interpret for three reasons. Firstly, the mapping of the WC11 
genome was incomplete at the termini of the molecule therefore any of the above 
fragments may have been terminally located, particularly the 10kbp Bam HI fragment 
and the 3.7kbp Sma I fragment. In addition, Sma I digestion of WC11 resulted in 




































































































































































































































































WC11 restriction digests probed with ATT-1 
3'80 
1 2 3 4 5 
Track 1 - 1kb ladder 
Track 2 - WC11 digested with Eco 
Rl 
Track 3 - WC11 digested with 
Xho I 
Track 4 - WC11 digested with 
Sma I 
Track 5 - WC11 digested with 
Bam HI 
Tracks 2 -5 were probed with ATT-1 
labelled with DIG 
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recognised by ATT -1 was not achieved on the basis of this analysis. Finally, the 
results of probing Eco RI and Xho I WC 11 digests with ATT -1 were inconclusive as 
the sizes of the fragments recognised by the probe were greater than the largest of the 
molecular markers used. 
4.3 COMPARATIVE HYBRIDISATIONS OF ATT -1 TO C500 
RESTRICTION DIGESTS 
The results described above did not locate ATT -1 in the WC11 genome. The ATT -1 
clone was derived from the C500 CFA derivative, which, like WC11, was a cell -free 
attenuated AHV -1 isolate. ATT -1 was used to probe Barn HI, Eco RI and Xho I CFA 
digests respectively to compare the ATT -1 hybridisation profiles of the WC11 and 
CFA genomes. In addition, the virulent PP C500 derivative (see figure 3.2) was also 
digested with these three enzymes and probed with DIG -labelled ATT -1 insert to 
determine whether ATT -1 would hybridise to similar sized fragments in virulent and 
attenuated C500 virus. These hybridisations illustrated that with both C500 
derivatives digestion with each enzyme and subsequent probing with ATT -1 
produced a ladder of fragments (see figure 4.3). The PP and CFA profiles were not 
identical with any of the three REs e.g. the smallest PP Barn HI 
fragment was 
approximately 7.5kbp, whilst the smallest CFA Bam HI fragment 
was approximately 
6kbp. These differences in fragment sizes suggested that the 
PP and CFA genomes 
were arranged differently in the region which is recognised 
by ATT -1. 
The WC11 and C500 profiles on digestion with 
Barn HI, Eco RI and Xho I 
respectively were distinct in that C500 exhibited 
a laddering effect while WC11 did 
not. This suggested that the location of ATT 
-1 differed in the genomes of these two 
AHV -1 isolates. The laddering effect suggests 
that the ATT -1 clone was terminally 
located in C500, since Bam HI, Eco RI and 
Xho I recognition sequences were absent 
from the repeat unit of this isolate. The WC11 
repeat unit did not contain recognition 
sites for any of these three enzymes 
(Bridgen et al 1989), however, a similar 
laddering effect was not observed in 
the WC11 tracks, suggesting that ATT 
-1 was 
located further from the terminal repeats 
in WC11 than in C500. As a result of these 
observations, further mapping studies 
were restricted to the C500 isolate. 
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Figure 4.3 
PP and CFA restriction digests probed with AU-1 
1 2 3 4 5 6 7 
Track 1 - 1kb ladder 
Track 2 - PP digested with Eco Rl 
Track 3 - CFA digested with Eco 
RI 
Track 4 - PP digested with Xho 
I 
Track 5 - CFA digested with Xho 
I 
Track 6 - PP digested with Barn 
HI 
Track 7 - CFA digested with Bam 
HI 
Tracks 2 -7 were probed with DIG 
-labelled KIT-1 
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4.4 HYBRIDISATION OF ATT -1 TO THE C500 CFA DERIVATIVE 
The DIG -labelled ATT -1 insert was used to probe a Hind III digest of CFA DNA, as 
the recognition site for Hind III was also absent from the C500 repeat unit. A 
laddering effect was observed as illustrated in figure 4.4a. When this laddering effect 
was more closely examined each fragment appeared to have another fragment 
directly above it, producing the overall effect of a double ladder. 
The ATT -1 clone contained an internal recognition site for Hind III, as illustrated in 
figure 4.4c. This Hind III site cut the ATT -1 insert into two fragments, one of 
approximately 3.2kbp (fragment A) and the other of approximately 0.6kbp (fragment 
B). The ATT -1 clone was digested with Hind III and fragments A and B were 
subcloned into pBS+ in order to prevent contamination of one fragment with another 
during probe preparation. The inserts of these subclones were labelled with DIG and 
used to probe CFA DNA digested with Hind III. These hybridisations demonstrated 
that a laddering effect was present when each of the probes was used individually to 
probe CFA Hind III digests, as shown in figure 4.4b. These ladders were distinct as 
the smallest fragment observed using fragment A as probe was 4.2kbp, whilst the 
smallest fragment observed using fragment B was 3.9kbp. This difference in the 
individual ladders accounted for the double laddering effect observed when the entire 
ATT -1 insert was used as probe. 
The Hind III recognition sequence was not present in the repeat unit of C500, 
therefore sequence located before the first Hind III site of the unique region would be 
associated with fragments of varying sizes depending on the number of repeat units 
attached to the genomes of the individual virions. This virion variation resulted in 
the laddering effect observed, implying that ATT -1 was terminally 
located and 
suggesting that the internal Hind III site of the ATT -1 clone 
was the first Hind III site 
of the unique region of the CFA genome. On this basis 
either fragment A or 
fragment B was expected to produce a laddering effect dependent 
on the orientation 
of ATT -1 with respect to the terminal repeats. One 
possible explanation for the 
observation that both fragments A and B produced 
a laddering effect when used to 
probe a CFA Hind III digest was that one or 
both of these fragments recognised 
sequence located within the terminal repeat unit. 
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Figure 4.4 
CFA Hind III digests probed with ATT-1 and the Hind III fragments of ATT- 
Figure 4.4a 
2 
Track 1 - 1kb ladder 
Track 2 - CFA digested with 
Hind III and probed 







- 1kb ladder 
- CFA digested with 
Hind III and probed 
with fragment B 
- CFA digested with 
Hind III and probed 
with fragment A 




4.5 CLONING OF THE REPEAT UNIT OF C500 
The repeat unit of C500 was known to be represented by a supermolar fragment of 
1050bp on digestion of the CF C500 derivative with either Hind II, Mbo I or Sac I 
(Bridgen et al 1989). This supermolar fragment was subsequently observed on 
Hind II and Sac I digestion of the three C500 derivatives, PP, CA and CFA, 
employed in this study. Genomic CFA C500 DNA was digested with Sac I and the 
1050bp fragment was recovered from agarose then ligated into the Sac I site of pBS +. 
This clone was designated CR -1. 
A probe of the CR -1 insert was prepared by Sac I digestion of the clone prior to 
labelling with DIG. Two experiments were undertaken to establish whether CR -1 
contained the 1050bp C500 repeat unit. Firstly, the CR -1 clone was compared to the 
WC11 repeat clone, M30 (Bridgen et al 1989), which contained the WC11 Hind II 
950óp repeat unit ligated into pBS +. M30 was digested with Pst I in combination 
with Eco RI to isolate the insert. This was then probed with DIG -labelled CR -1 
insert and homology was observed. Secondly, the CR -1 DIG -labelled insert was used 
to probe PP, CA and CFA Barn HI digests and a laddering effect was observed in all 
tracks (data not shown). These two results indicated that the CR -1 insert was the 
C500 1050bp repeat unit and that the desired DNA fragment had been cloned. 
The CR -1 clone was further characterised and compared to M30 by Sma I digestion 
of the two clones. The two inserts were each isolated by electrophoresis using 1.0% 
agarose, following double digestion with Pst I/Eco RI. The inserts were recovered 
using powdered glass, digested with Sma I then resolved using 7.5% polyacrylamide. 
The M30 insert produced bands of 170, 260, 280 and 320bp, while the CR -1 clone 
produced bands of 180, 290, 300 and 320bp (data not shown). The frequency of 
Sma I sites in both clones suggested that both clones were G +C rich. 
4.6 COMPARISON OF ATT -1 TO CR -1 
A DIG -labelled probe was prepared from the CR -1 insert and used to probe a Pst I 
digest of ATT -1 which had been resolved using 1.0% agarose and transferred to 
nylon. No hybridisation was observed between the CR -1 Sac I 
insert and the ATT -1 
Pst I fragments. This lack of homology indicated that the 
laddering effect observed 
in section 4.4 was not due to ATT -1 sharing homology 
with the C500 repeat region, 
and therefore must be due to ATT -1 being located adjacent 
to the repeats. 
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4.7 POSSIBLE LOCATIONS OF ATT -1 ON THE CFA GENOME 
ATT -1 subclones A and B produced distinct laddering effects when used to probe 
Hind DI CFA digests. This was not due to homology between ATT -1 and the repeat 
unit of C500. Initially, the laddering effect produced on probing Hind IlT CFA 
digests with ATT -1 was interpreted by assuming that either fragment A or fragment 
B represented unique DNA located between the terminal repeats and the first Hind DI 
site of the unique DNA. This interpretation was proved incorrect by the observations 
that fragments A and B independently produced a laddering effect when used to 
probe Hind DI digests of CFA DNA. An alternative explanation for the presence of 
these ladders was that all or part of the ATT -1 clone was repeated such that it was 
present in the same orientation at both ends of the CFA genome. 
The five possible genomic arrangements to explain these ladders are illustrated in 
figure 4.5. The possible arrangements are:- (a) the complete ATT -1 clone is present 
at the left -hand side of the genome and in addition B, or part of B is also present at 
the right -hand side of the genome; (b) the complete ATT -1 clone is present at the 
right -hand side of the genome and in addition A, or part of A is present at the left - 
hand side of the genome; (c) the complete ATT -1 clone is present at both ends of the 
genome in the same orientation; (d) CFA consists of a mixed population whereby 
two genomic arrangements are present, one with the ATT -1 clone at the 5' end and 
one with the ATT -1 clone at the 3' end; (e) either fragment A or fragment B is 
repeated in the genome, once as ATT -1 and once with another fragment, of identical 
size to either A or B respectively. 
The arrangements demonstrated in figures 4.5a and b were eliminated by the fact that 
when ATT -1 was used to probe a CFA Sma I digest (see figure 3.5) only one 
fragment of 3.8kbp was observed, with no hybridisation to fragments of different 
sizes to represent either A or B alone. The arrangement in 4.5d appeared less likely 
than that presented in 4.5c due to the observation that when a CFA Sma I digest was 
probed with DIG -labelled CA DNA a supermolar 3.8kbp fragment was observed (see 
figure 3.4), suggesting that this fragment was present twice. Alternatively this 
supermolar fragment may have been due to the presence of more than one 3.8kbp 
Sma I fragment, particularly since WC11 contains three Sma I fragments of 
approximately this size. The presence of more than one 3.8kbp Sma I fragment 
introduces the possibilities outlined in 4.5e, however the chances of fragment C 
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Figure 4.5 














Fragment A = 3.2kbp 
Fragment B = 0.6kbp 
Fragment C = 3.2kbp # Fragment A 
Fragment D = 0.6kbp # Fragment B 
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being identical in size to fragment A, and likewise fragment D being identical in size 
to fragment B seemed unlikely. 
The simplest working model from the possible genomic arrangements illustrated in 
figure 4.5 was 4.5c, i.e. that the ATT -1 clone is present at either end of the genome 
in the same orientation. In order to determine which of the possible arrangements 
outlined in figure 4.5 was correct additional experiments were undertaken. 
4.8 INVESTIGATION OF THE LOCATION OF ATT -1 IN THE CFA 
GENOME USING THE POLYMERASE CHAIN REACTION 
4.8.1 Introduction 
The polymerase chain reaction (PCR), as described in 2.8.20, was used as an 
alternative to RE data to investigate the location of ATT -1 in the CFA genome. This 
technique was used to attempt to amplify the presumptive junction regions between 
the ends of the ATT -1 clone and the repeats at either terminus of the CFA genome. 
The primers for these reactions were designed from the sequence of the ATT -1 clone 
and the CR -1 clone (see 4.8.2). 
The termini of the CFA genome were designated 5' and 3' arbitrarily, as the 
orientation of the genome relative to the related sequenced y- herpesviruses EBV and 
HVS has not been established with regard to the C500 sequence represented by the 
ATT -1 clone. 
4.8.2 Sequencing and selection of PCR primers from CR -1 
Ends of the CR -1 clone were sequenced in order to generate sufficient data to design 
oligonucleotides for use in PCR. The sequencing was achieved following the method 
described in 2.8.21, involving Taq polymerase and deoxy -7- deaza -dGTP, in an 
attempt to prevent secondary structures caused by the high G +C content of the repeat 
unit (71% G +C as assessed by caesium chloride density centrifugation [Herring et al 
1983]). The limited sequence presented in figure 4.6 was generated from only one 
strand of DNA, due to the presence of secondary structures. Figure 4.6 shows the 
Sac I site in a central location due to orientation and amalgamation of the sequence 
generated from the 5' and the 3' termini of this clone. (This arrangement represents 
the two sequences as contiguous as this is how they would be arranged in vivo). The 
primers selected for PCR are outlined in figure 4.6 and denoted RP1 and RP2. 
84 
Figure 4.6 
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Figure 4.6 also demonstrates the location of the Hind II site which was known to be 
present in the C500 repeats. This site is located 24óp from the Sac I site. 
4.8.3 The use of PCR to determine whether the 5' terminus of the ATT -1 clone 
is adjacent to the C500 terminal repeats 
The oligonucleotides designed for sequencing the ATT -1 clone were used for PCR. 
In the first instance P2, located 725óp from the 5' end of the ATT -1 clone (see 
appendix 3 and figure 4.9) was used in conjunction with primers from the repeat 
region. The orientation of the CR -1 clone relative to its position in the CFA genome 
and with respect to the ATT -1 clone was unknown, therefore PCR reactions were set 
up using P2 in combination with primers taken from CR -1 in opposite orientations 
(RP1 and RP2 as indicated in figure 4.6). The PCR reactions followed the method 
described in 2.8.20 A. 
A fragment of approximately 950bp was observed when P2 was used in conjunction 
with RP 1, while P2 and RP2 did not result in any products. This 950bp product size 
suggested that the ATT -1 clone was located very close to the terminal repeats since 
the product consisted of 752óp of ATT -1 and 48bp of CR -1 leaving only 
approximately 150bp between the two clones. 
The 950bp product was transferred from agarose to two nylon filters in a double - 
sided Southern blot. A probe for the ATT -1 part of the product was prepared by 
digesting the ATT -1 clone with Sph I, while a probe for the CR -1 part was prepared 
by restricting CR -1 with Sac I. The probes were gel purified then labelled with 
DIG. 
Both probes exhibited hybridisation to the 950bp product as demonstrated in figure 
4.7. An identical PCR reaction was carried out using 100ng of CA DNA 
as input. A 
product of 950bp was again observed and when blotted with 
the ATT -1 and CR -1 
probes (as for the CFA product) hybridisation was observed. 
This result is illustrated 
in tracks 2 and 4 in figure 4.7, and is discussed in section 5.9. 
An additional PCR was carried out using a primer 
further from the 5' terminus of the 
ATT -1 clone to verify the location of this clone 
as being adjacent to the terminal 
repeats. The primer selected was located 1564bp 
from the 5' terminus of the clone 
(P1 as illustrated in appendix 3.1). This primer 
was used in conjunction with RP1 
following the conditions described in 2.8.20 B, 
with the target being CFA DNA. The 
predicted size of product was approx 1750bp 
(1564bp from ATT -1, 150bp from the 
sequence between the clones and 48bp 
from CR -1). The PCR products were 
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Figure 4.7 
Probing PCR products from RP1 and P2 
950- 
1 2 3 4 5 
Track 1 - CFA RP1/P2 product. 
Track 2 - CA RP1/P2 product 
Track 3 - lkb ladder 
Track 4 - CA RP1/P2 product 
Track 5 - CFA RP1/P2 product 
Tracks 1 and 2 were probed with an ATT- i fragment labelled with DIG 
Tracks 4 and 5 were probed with CR -1 labelled with DIG 
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resolved through 0.8% agarose and a single fragment of 1700bp was observed (data 
not shown). Similarly a PCR reaction was set up using P3 and RP1 following the 
reaction conditions described in 2.8.20 A. The predicted product size was 
approximately 3kbp. A fragment of 3kbp was observed (see figure 4.8), in addition 
to submolar fragments of varying sizes. These submolar fragments were believed to 
be artefacts of PCR. 
The PCR reactions using primer combinations of RP1 with P1, P2 and P3 
respectively suggested that fragment A in its entirety was located adjacent to the 
repeats at the 5' end of the C500 CFA genome. In order to determine whether 
fragment B was located adjacent to fragment A at the 5' end of the genome a PCR 
reaction was set up using primer 11 and RP1. The reaction conditions were as 
described in 2.8.20 C, with the predicted fragment size being approximately 3.4kbp 
but, when the completed reaction was analysed, no products were observed. The 
reaction was repeated twice, with a second aliquot of primers, dNTPs, reaction buffer 
and Taq polymerise added after 15 cycles to allow for reagent depletion. The 
reaction conditions were as described above, but the initial extension time was raised 
to 4 minutes in one variation, and to 10 minutes (with no extension per cycle) in 
another. No products were observed following either set of conditions. This result 
was inconclusive as no equivalent size control was available. 
The lack of products observed may have been due to size constraints as the desired 
product was larger than any fragments previously amplified in this study. The M13 
universal and reverse primers were used to attempt to amplify the 3.8kbp entire 
ATT -1 insert as a size control, but no 3.8kbp product was observed. Further location 
studies with regard to the orientation of fragment B at the 5' end of the CFA genome 
were restricted to probing Southern blots of genomic digests. 
4.8.4 The use of PCR to determine whether the 3' terminus of the ATT -1 clone 
is adjacent to the C500 terminal repeats. 
The results described in 4.8.3 determined that fragment A 
was adjacent to the 5' 
repeats. The genomic arrangement illustrated by figure 
4.5c suggested that ATT -1 
was located adjacent to the repeats at either end of 
the genome. This was further 
investigated by a PCR reaction carried out using a primer 
orientated towards the 3' 
terminus in combination with RP2 from the repeat 
unit. In the first instance the 
primer selected was P12, located 33bp from the 
3' terminus of ATT -1 (see appendix 
3.1 and figure 4.9). The reaction was carried 
out using 100ng of CFA DNA 
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Figure 4.8 
PCR products from CFA DNA 
3.0- 
1 2 3 4 
-2.7 
44: 4-18 
Track 1- CFA product from P3/RP1 probed with ATT-1 
Track 2- lkb ladder 
Track 3 - lkb ladder 
Track 4 - CFA product from P14 /RP2 probed with ATT-1 fragment B 
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following the conditions described in 2.8.20 A. The product resulting from this 
reaction was approximately 500óp in length (see figure 5.14 ), with 33óp of this from 
ATT -1 and 30óp from CR -1. This result indicated that the ATT -1 clone was located 
very close to the terminal repeats at the 3' end of the genome. This location of 
ATT -1 was further suggested by a PCR reaction involving P14 and RP2. P14 was 
located within fragment A, 1390bp from the end of the ATT -1 clone. The reaction 
conditions were as described in 2.8.20 D. Two products were observed, one of 
1.8kbp and another of 2.7kbp. Both of these fragments exhibited homology to 
ATT -1 (see figure 4.8). The 2.7kbp fragment was believed to represent the region 
between ATT -1 and the terminus of the unique region with one repeat unit also 
present, which would result in a predicted fragment size of 1.8 + 1.05bp. 
The two PCR reactions described above suggested that ATT -1 fragment B was 
adjacent to the 3' terminal repeats, and that fragment A was adjacent to this location 
of fragment B. 
A further PCR reaction was attempted using P4 and RP2 to determine whether all of 
fragment A was adjacent to fragment B at the 3' terminus of the CFA genome. The 
reaction conditions were as described for P11 and RP 1, with a second aliquot of 
reagents added after 15 cycles. The predicted size of the PCR product from this 
reaction was approximately 4.1kbp. Although repeated attempts to generate product 
from this reaction were consistently unsuccessful this result was not conclusive due 
to size constraints in the PCR. 
4.8.5 Conclusions 
The PCR reactions carried out in this section are summarised in figure 4.9. Fragment 
A was established as being adjacent to the 5' terminal repeats, but fragment B was not 
confirmed as being adjacent to this 5' copy of fragment A. Fragment A was 
established as being adjacent to fragment B at the 3' terminus of the molecule, and in 
addition this copy of ATT -1 was demonstrated to be terminally located. 
4.9 INVESTIGATION OF THE LOCATION OF ATT -1 USING RESTRICTION 
ENDONUCLEASES WHICH CUT IN THE REPEAT UNITS OF C500 
4.9.1 Digestion using Sac I and Sac I/Hind III 
CFA DNA was analysed by digestion with Sac I as the recognition 
sequence for this 
enzyme was present in the terminal repeat units of C500, 






































































































































































































































associated with terminally located fragments did not occur. There was no recognition 
site for Sac I in the ATT -1 clone. The result of probing a Sac I CFA digest with 
ATT -1 was that two fragments were observed, one of 4.2kbp and another of 4.9kbp, 
as illustrated in figure 4.10a. 
ATT -1 fragments A and B (see figure 4.4) were labelled with DIG then used 
individually to probe Sac I digests of CFA DNA. Both probes recognised the same 
Sac I fragments, as illustrated in figure 4.10b. This result implied that fragments A 
and B were each present twice in the CFA genome. 
CFA DNA was analysed by Southern blotting after double digestion with Sac I and 
Hind III, and was probed with ATT -1 fragments A and B individually. Fragment B 
hybridised to two CFA Hind IIUSac I fragments, one of 0.9kbp and one of lkbp (see 
figure 4.11, track 4). The observation that fragment B was present twice in a CFA 
Hind III/Sac I digest suggested that fragment B was present twice in the CFA 
genome. One of the fragments would be located between the Hind III site of the 
ATT -1 clone and the Sac I site in the repeat unit at the 3' terminus of the CFA 
genome. The predicted size of this region was approximately 1100bp (635óp from 
fragment B and 500óp between the Sma I site of ATT -1 and the Sac I site of the 
repeats, as predicted by PCR). The two fragments observed were both close to this 
predicted size. The additional fragment recognised by the probe presumably 
represented sequence from the Hind III site of the 5' terminal copy of ATT -1 
downstream to the closest Hind III or Sac I site. 
Fragment A was used to probe a Hind IIUSac I double digest of CFA DNA and 
hybridisation was observed to a single fragment of 3.1kbp (see figure 4.11, track 2). 
This fragment was believed to represent the region of DNA between the Hind III site 
of ATT -1 and the Sac I site of the repeat unit at the 5' end of the genome. The 
predicted size of this fragment was 3347óp (3197 bp of ATT -1 plus 150bp from the 
region between ATT -1 and the repeats). 
The PCR reactions described in section 4.8 had suggested that two copies 
of 
fragment A were present in the CFA genome. The single fragment 
observed in figure 
4.11, track 2, was in contrast to this PCR data, and the two fragments 
exhibited in 
figure 4.10, when fragment A was used to probe a CFA Sac 
I digest. One possible 
explanation for these contradictory observations was that 




CFA digested with Sac I and 




CFA digested with Sac I and probed 
with ATT-1 fragments A and B 
I 2 
Track 1 - lkb ladder Track 1 - CFA digested with Sac I 
Track 2 - CFA digested with Sac I and probed with fragment A 
and probed with A17-1 Track 2 - CFA digested with Sac I 
and probed with fragment B 
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Figure 4.11 





Track 1 - 1kb ladder 
Track 2 - CFA digested with Hind III/Sac I and probed with fragment A 
Track 3 - lkb ladder 
Track 4 - CFA digested with Hind III/Sac I and probed with fragment B 
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figure 4.11 was a doublet, suggesting that a Sac I site is located 150bp 5' to the 3' 
terminal copy of ATT -1. 
When ATT -1 was used to probe a Sac I digest of CFA DNA (see figure 4.10) 
fragments of 4.2 and 4.9kbp were observed. When the Hind M /Sac I fragments 
recognised by fragments A and B individually were added together the total sizes 
were 4.0 and 4.lkbp. This suggests that one of the fragments recognised by fragment 
A or fragment B was a Hind Ell/Hind III fragment rather than a Hind 111/Sac I 
fragment. Further experiments to determine which fragment contained two Hind III 
sites were not undertaken, due to lack of suitable probe. 
In conclusion, the results of probing Sac I CFA digests with ATT -1 and subclones of 
ATT -1 suggested that ATT -1 was present twice in the CFA genome. Analysis of 
Hind III/Sac I digests by hybridisation with the same probes indicated that the region 
directly upstream of the 5' Sma I site of ATT -1 was also repeated, since fragment A 
recognised only one Hind III/Sac I fragment. This implied that the 150bp region 
between ATT -1 and the Sac I site of the repeat units at the 5' end of the genome was 
repeated in addition to ATT -1. 
4.9.2 Digestion using Hind II 
Mapping studies of the ATT -1 clone revealed a recognition site for 
Hind II, the 
presence of which was confirmed by sequencing (see chapter 3). The 
location of this 
Hind II site resulted in ATT -1 insert fragments of 975 and 2857bp. 
Hind II was 
known to recognise a site in the repeat unit of C500, with 
the result that Hind II 
digestion of CFA DNA had been observed to exhibit 
a supermolar fragment of 
approximately 1050bp representing the repeat unit (Bridgen 
et al 1989). 
The ATT -1 insert, labelled with DIG, was used to 
probe a Hind II digest of CFA. A 
laddering effect was observed with a supermolar 
fragment of 2.9kbp evident, as 
illustrated in figure 4.12. This laddering 
effect was at first believed to be due to 
incomplete Hind II digestion of the CFA 
DNA. ATT -1 was hybridised to CFA 
digested with fresh aliquots of Hind II a 
further three times and on each occasion a 
ladder of fragments was observed. The 
consistent presence of Hind II ladders 
suggested that a proportion of the repeat 
units may be degenerate and fail to contain 
recognition sites for Hind II, although 
a proportion must contain Hind II sites to 
allow for the supermolar fragments 
observed on Hind II digestion. Variability 
of the 
repeat units of the AHV -1 isolate 




CFA digested with Hind II and probed with ATT 1 
1 2 
2.94. SO 
Track 1 - lkb ladder 
Track 2 - CFA digested with Hind 
II and probed with ATT-1 
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different sized components contribute to the terminal repeated region of this isolate 
(Bridgen et al 1989), therefore it is possible that C500 also contains repeat unit 
variability. 
CFA DNA was digested with Sac I and Hind II respectively then probed with the 
CR -1 repeat clone. A single fragment of 1050bp, corresponding to the CR -1 clone, 
was observed in the Sac I track. In contrast a ladder of fragments was observed in the 
Hind II track, with the 1050bp fragment being of higher intensity (see figure 4.13). 
This further implied that the repeat units of the C500 genome were degenerate with 
respect to the presence of Hind II sites. 
The ladder produced when ATT -1 was used to probe a Hind II CFA digest was, on 
closer examination, noted to be a double ladder, with one ladder being more intense 
than the other. This double laddering effect was similar to that observed when a 
Hind III digest of CFA was probed with ATT -1 (see figure 4.4a). The Hind II double 
laddering effect was investigated further by probing Hind II CFA digests with ATT -1 
fragments A and B separately (see figure 4.14). An intense fragment of 2.9kbp was 
observed when fragment A was used as probe, in addition to the laddering effect. 
Fragment B hybridised to a fragment of approximately 1.9kbp and a lower intensity 
fragment of 2.4kbp, while additional a effect 
were barely visible. The presence of a laddering effect in Hind II digests probed with 
ATT -1 fragments A and B respectively was consistent with the theory that ATT -1 is 
present twice in the CFA genome, located close to both termini. 
The 5' terminal arrangement implied by PCR (see 4.8.3) resulted in a predicted 
terminal Hind II fragment of approximately 3.1kbp (comprised of 2857bp of ATT -1, 
150bp between ATT -1 and CR1 and 24bp between the Hind II and Sac I sites of CR- 
1). This fragment was believed to be represented by the 2.9kbp supermolar fragment 
observed when fragment A was used to probe CFA DNA digested with Hind II. This 
2.9kbp fragment was 200bp smaller than the predicted fragment, suggesting 
that a 
Hind II site was situated between the Sac I site of CR -1 and the Sma 
I site of ATT -1. 
The presence of a Hind II site was confirmed by Hind II digestion 
of the PCR product 
resulting from primer combination P2/RP1 (see 4.8.3). A 
fragment of less than 75bp 
was observed, corresponding to the 24bp between RP 
1 and the Hind II site in CR -1. 
In addition a fragment of 160bp was observed, 
implying that a Hind II site was 
present immediately upstream of the Sma I site of 
ATT -1. (A fragment of 740bp, 
representing the 5' ATT -1 DNA amplified in the 
PCR reaction was also observed). 
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Figure 4.13 
Hind II and Sac I digests probed with CR -1 
1050bp 
1 2 3 
Track 1 - lkb ladder 
Track 2 - CFA digested with Sac I and probed with CR -1 
Track 3 - CFA digested with Hind II and probed with CR -1 
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Figure 4.14 
CFA digested with Hind II and probed with ATT-1 fragments A and B 
Track 1 - 1kb ladder 
Track 2 - CFA digested with 
Hind II and probed with fragment A 
Track 3 - CFA digested with 
Hind II and probed with fragment B 
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This result implied that the 2.9kbp supermolar fragment observed when fragment A 
was used to probe a Hind II digest of CFA DNA represented the 5' terminus of 
ATT -1. 
The presence of a Hind II site between CR -1 and ATT -1 was difficult to interpret 
with respect to the laddering effect observed when fragment A was used as probe. If 
this Hind II site was the first Hind II site of the unique DNA at the 5' terminus of the 
genome then all ladders would be created by the sequence between this site and the 
repeats. Fragment A would not be expected to produce a laddering effect when used 
to probe a Hind II digest, as the Hind II site contained in fragment A would be the 
second site in the unique DNA rather than the first. The laddering effect observed 
when fragment A was used as probe was originally explained by the degeneracy of 
the repeats. Thus the Hind II site between CR -1 and ATT -1 may be part of the 
repeats hence also have a tendancy to degenerate. If this was the case then the ATT -1 
clone must represent virtually the first base of the unique region of CFA C500 
genome. The unique region may begin with small regions of copies of the repeat unit 
in a similar manner to that observed for HVS (Albrecht et al 1992), whereby a 116bp 
G +C rich region of DNA homologous to H -DNA lies between H -DNA and L -DNA. 
A similar arrangement to HVS would allow for second copies of Hind II and Sac I 
sites. 
The observation that only one supermolar fragment was observed on probing a 
Hind II digest with fragment A was consistent with the single supermolar fragment 
observed on the equivalent Sac I/Hind III filter (see 4.9.1). Once again this could be 
interpreted such that fragment A was present as a single copy, or alternatively that the 
Hind II site immediately before ATT -1 was directly repeated at the 3' terminus 
of the 
genome. 
Fragment B hybridised to fragments of 2.4 and 1.9kbp, once 
again illustrating that 
this fragment was present twice in the CFA genome. 
The 2.4kbp fragment was 
believed to represent the sequence between the Hind 
II site of ATT -1 and the Hind II 
site of the repeats at the 3' terminus of the genome. 
The predicted size of this 
fragment was 975bp from ATT -1, 500óp from 
the sequence between ATT -1 and 
RP2, and 950óp from RP2 to the Hind II 
site of CR -1, resulting in a total of 
approximately 2.4kbp. The submolar nature 
of this fragment was presumably due to 
the fact that the repeat units of CFA virus 
were degenerate, as previously discussed. 
The barely visible larger fragments represented 
the remainder of the 3' terminal 
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fragments containing fragment B. The 1.9kbp fragment was believed to represent the 
DNA downstream of the 5' location of ATT -1, such that a Hind II site was predicted 
lkbp from the 3' Sma I site of ATT -1. 
4.10 DISCUSSION 
This chapter described experiments designed to locate the ATT -1 clone in the CFA 
genome. The ATT -1 clone was isolated from DNA which had undergone one or 
more alterations during passage in tissue culture. CFA virus represented the final in 
vitro arrangement of the C500 genome observed. As this derivative was apparently 
not altered on further serial passage it was possible to propagate larger amounts of 
the CFA derivative than its virulent counterparts. For this reason the location of 
ATT -1 was achieved prior to attempts to locate VIR -1 and VIR -2. The location of 
ATT -1 was intended to assist in the mapping studies of VIR -1 and VIR -2, by virtue 
of the 1923bp sequence it contained which was present in all three clones. 
The location of ATT -1 was initially assessed by attempting to locate it using the 
WC11 map. This was unsuccessful therefore attempts were made to locate ATT -1 in 
the CFA genome. The location appeared to be terminal as when ATT -1 was used to 
probe CFA digested with various REs a laddering effect was observed. Further 
studies using Hind III demonstrated that either end of the ATT -1 clone produced a 
laddering effect, suggesting that the ATT -1 clone, or part of it, was located twice in 
the CFA genome. 
The laddering patterns suggested various hypothetical arrangements of the ATT 
-1 
clone in the CFA genome. The presence of the ATT -1 clone twice, at 
either end of 
the genome appeared the most likely arrangement. PCR was used 
to illustrate that 
ATT -1 was located close to the terminal repeats. The 1050bp 
terminal repeat unit 
was cloned and partially sequenced to generate oligonucleotides 
for use in PCR. The 
results of the PCR reactions described in this chapter 
demonstrated that the ATT -1 
clone was located only 150bp from the Sac I site of the 
repeat unit at the 5' end of the 
unique region. Similarly the ATT -1 clone was located 
only 450óp from the Sac I site 
of the repeat unit at the 3' end of the unique region. 
The use of PCR determined that sequences present 
in ATT -1 were located at either 
end of the genome. Attempts were made, 
using PCR, to prove that the entire ATT -1 
clone was present at either end of the genome. 
Size constraints meant that PCR did 
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not demonstrate unequivocally that ATT -1 was present in its entirety at either end of 
the CFA genome. The PCR results generated did suggest that the entire ATT -1 clone 
was located at the 3' terminus, but did not prove fragment B to be adjacent to 
fragment A at the 5' terminus. 
Further mapping studies used ATT -1 to probe CFA DNA digested with REs which 
recognised sites in the repeat unit of the molecule in order to prevent the laddering 
effect. The enzymes used were Sac I and Hind H. 
The results of analysis of CFA DNA using Sac I and probing with the entire ATT -1 
clone, and with fragments A and B of ATT -1, determined that the ATT -1 clone was 
present twice in the CFA genome. 
Probing Hind II digests of CFA DNA with ATT -1, and subclones of ATT -1 
demonstrated a laddering effect. A laddering effect should not have occurred with 
Hind II, as this enzyme recognised a site in the repeat unit of the C500 genome. The 
laddering effect was believed to be due to the degeneracy of the C500 repeat unit 
whereby not all the repeat units contained the Hind II site. The observation that a 
Hind II site was present between the 5' terminal repeats of the molecule and the Hind 
II site within the ATT -1 clone further complicated this reasoning. The Hind II site 
within this 150bp region was believed to be due to the presence of small regions of 
the repeat unit being present at the junction region between repeat and unique DNA. 
A possible explanation for the resultant laddering effect was that this region was also 
degenerate. 
In conclusion, the experiments described in this chapter determined that the ATT -1 
clone was present in the same orientation at either end of the genome. 
102 
Chapter 5 
Investigations of the locations of 
MR -1 and VIR 2 
5.1 INTRODUCTION 
This chapter describes molecular analysis of the C500 derivatives originally designated PP, CA and CFA. The aim of this analysis was to determine whether particular restriction endonucleases profiles were correlated with virulence and attenuation. The location of the ATT -1 clone in the CFA genome has been described in chapter 4. A similar strategy was employed to attempt to map the two clones 
derived from virulent C500 DNA, designated VIR -1 and VIR -2. The ATT -i clone 
was previously used to probe restriction endonuclease digestions of virulent C500 
DNA in order to compare the profiles with those observed when ATT -1 was used to 
probe equivalent CFA digests. 
The three C500 derivatives were biologically cloned by Dr H.W. Reid. C500 DNA 
was probed with ATT -1, VIR -1 and VIR -2, both in the form of complete inserts and 
as subfragments. This work was limited by the low titre of virus obtained from tissue 
culture, resulting in yields of <514 of viral DNA from harvests of low passage virus. 
In addition, the genomic alterations developing as a result of serial passage appeared 
very quickly during in vitro propagation (see chapter 3). 
The genomic rearrangements occurring during serial passage were represented by 
the VIR -1, VIR -2 and ATT -1 molecular clones. These three clones all differed with 
regard to their 5' termini as illustrated in figure 3.11. This chapter investigates the 
significance of these non -homologous regions with regard to loss of virulence. 
5.2 MOLECULAR ASSESSMENT OF VIRULENCE USING ATT -1 AS A 
PROBE 
The virulence of the C500 populations designated PP, CA and CFA in chapter 3 was 
determined by using tissue culture harvests to inoculate rabbits as described in 2.6.3. 
Assessment of virulence was required at regular intervals during serial passage as the 
virus was known to become attenuated as a result of in vitro propagation. 
The ATT -1 clone was used to probe Sma I digests of PP, CA, CF and CFA DNA 
respectively (see figure 5.1). Briefly, the ATT -1 clone recognised PP Sma I 
fragments of 8.6 and 5kbp, CA and CF Sma I fragments of 5 and 3.8kbp and a CFA 
Sma I fragment of 3.8kbp. The presence of the 5kbp fragment appeared to be related 
to virulence, as the only C500 derivative which failed to exhibit this fragment was 
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Figure 5.1 
Sma I digests of C500 DNA probed with AZT 1 
1 2 3 4 5 
8.8 + 
5.0- 3.84 
Track 1 - 
Track 2 - 
Track 3 - 
Track 4 - 
Track 5 - 
Tracks 2-5 
lkb ladder 
PP digested with Sma I 
CA digested with Sma I 
CF digested with Sma I 
CFA digested with Sma I 
were probed with ATT-1 labelled with DIG 
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CFA, the attenuated derivative. In addition, this 5kbp fragment was also absent from 
the attenuated WC 11 isolate (see figure 3.4). 
5.3 DETERMINATION OF THE STATUS OF THE CA C500 DERIVATIVE 
The CA population displayed fragments of 5 and 3.8kbp when digested with Sma I 
and probed with ATT -1. The presence of these two fragments suggested that the CA 
DNA represented either an intermediate genomic arrangement displaying 
characteristics noted in the PP and CFA derivatives or a mixed populution in which 
a proportion of the virions had retained virulence whilst the remaining virions had 
become attenuated. Closer examination of several preparations which had been 
designated CA revealed that the 5 and 3.8kbp fragments observed on ATT -1 
hybridisation were not equimolar. Figure 5.2 illustrates one such CA derivative 
where the 5kbp fragment was supermolar to the 3.8kbp fragment. This lack of 
equimolarity suggested that the CA derivative was a mixed population containing 
two types of virion, one exhibiting some of the characteristics of the PP derivative, 
and the other exhibiting characteristics of the CFA derivative. 
The nature of the CA derivative was investigated further by biological cloning. A CA 
preparation which exhibited the 5 and 3.8kbp fragments in an approximately 
equimolar ratio was biologically cloned by three serial limiting dilutions (kindly 
prepared by Dr H.W. Reid) to confirm that this variant was a mixed population rather 
than an intermediate genomic arrangement. Four biologically cloned derivatives were 
amplified in bovine turbinate cells to provide sufficient virus to allow genomic 
analysis. The DNA from each derivative was digested with Sma I then probed with 
VIR -1 (see figure 5.3). In three of the four samples fragments of 7 and 5kbp were 
observed. This suggested that the original CA preparation was a mixed population, 
and that the biological cloning resulted in only the virions displaying 
the 5kbp 
fragment (but not the 3.8kbp fragment) being recovered. The 
significance of the 7kbp 
fragment will be discussed in section 5.8. 
Serial passage of the C500 isolate resulted in initially 
virulent cell- associated virus 
becoming attenuated cell -free virus. This 
alteration of the C500 population 
presumably occurred by selection of the derivatives 
most competent at replicating in 
the artificial environment of in vitro culture. 
This suggests that evolutionary pressure 
would select the attenuated virions from a 
mixed population because they are more 
replication competent than virulent virions. 
The biological cloning described in the 
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Figure 5.2 
CA DNA digested with Sma I and probed with ATT-1 
1 2 
5.0-{ 3.8 
Track 1 - 1kb ladder 
Track 2 - CA DNA digested with Sma I 
and probed with ATT-1 
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Figure 5.3 
Biologically cloned CA derivatives probed with VIR -1 
1 2 3 4 
70 .::.. 
5.0i O .,... ... 38 
Track 1 - CA biologically cloned derivative 
1 digested with Sma I 
Track 2 - CA biologically cloned derivative 
2 digested with Sma I 
Track 3 - CA biologically cloned derivative 
3 digested with Sma I 
Track 4 - CA biologically cloned derivative 
4 digested with Sma I 
All tracks were probed with VIR -1 
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previous paragraph may have been expected to result in isolation of virions 
exhibiting CFA characteristics. The observation that three of the four biologically 
cloned CA derivatives did not exhibit the CFA 3.8kbp fragment was attributed to the 
low sample numbers used. 
The fourth biologically cloned CA preparation exhibited fragments of 7, 5 and 
3.8kbp on digestion with Sma I and subsequent probing with VER-1. The presence of 
the 5kbp fragment suggested that, once again, it was the virions exhibiting some of 
the PP characteristics which had been selected by biological cloning. The presence of 
the 3.8kbp fragment was presumably due to a proportion of the virions undergoing 
the transition from virulence to attenuation in the amplification stage of viral 
preparation. 
The CA derivative which was biologically cloned to produce the four DNA 
preparations described above was of a high passage level (37 passages in tissue 
culture). Previously derivatives of this passage level exhibited attenuation. The 
observation that this derivative had not become attenuated at this passage level was 
attributed to the initial biological cloning (to generate the PP derivative) which was 
undertaken immediately after isolation from a MCF affected rabbit, coupled with 
subsequent passage in small culture volumes. CF virus was detected in the 
supernatant of cell culture harvests of the four biologically cloned CA derivatives, 
resulting in recovery of an approximately equivalent quantity of DNA (0.1 -1µg) to 
that recovered from the infected cells (i.e. CA DNA). One of the four derivatives was 
used to inoculate a rabbit and clinical signs of MCF were observed. Viral DNA 
extracted from a cell pellet derived from the lymph nodes of this animal exhibited a 
5kbp fragment only when digested with Sma I and probed with ATT -1 (data not 
shown). 
The experiments described above demonstrated that the CA derivative consisted of a 
mixed population of virions. In cell culture the presence of the PP derivative was 
transient, and the Sma I profile of the CA derivative was observed after very few 
passages. In general viral preparations failing to exhibit the 3.8kbp fragment were 
observed only at very low passage levels after isolation from affected rabbits and 
biological cloning. Limited amounts of DNA were prepared due to the small volume 
of material available from the cultures used to biologically clone the virus. As each 
amplification step required passaging the virus, the PP characteristic was quickly lost 
and the derivatives began to exhibit the 3.8kbp fragment in addition to the 7 and 
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5kbp fragments in the larger cell culture volumes required to prepare DNA in 
quantities of 5 -10µg. 
5.4 DETERMINATION OF THE STATUS OF THE PP DERIVATIVE 
The PP derivative exhibited Sma I fragments of 8.6 and 5kbp when probed with 
ATT -1, as described in 5.2. This result was found to be inconsistent as the Sma I 
profiles of a proportion of biologically cloned PP derivatives exhibited only a 5kbp 
fragment when probed with ATT -1 (data not shown). The derivatives displaying the 
8.6 and 5kbp Sma I fragments on probing with ATT -1 were subsequently referred to 
as PP1 derivatives, whilst those exhibiting the 5kbp fragment alone were referred to 
as PP2 derivatives. These results suggested that the PP2 derivative might represent an 
intermediate genomic arrangement, distinct from the PP1 and CFA derivatives. 
Alternatively, the population referred to as PP1 might be a mixed population, 
comprised of PP2 genomes and a second genomic arrangement. 
The possibility that the PP1 derivative represented a mixed population was 
considered. If PP1 was a mixed population then this would imply that the ATT -1 
clone only recognised sequence contained in a Sma I fragment of 8.6kbp in the 
earliest in vitro C500 population. The additional 5kbp fragment recognised in PP1 
Sma I digests probed with ATT -1 would be due to PP2 virions. The PP1 derivatives 
had all been biologically cloned. This cloning should have isolated the population 
exhibiting the 8.6kbp fragment alone in a proportion of the independently derived 
PP derivatives if the 8.6kbp fragment was representative of an early genomic 
organisation. The 8.6 kbp fragment was never observed without the 5kbp fragment in 
any of the PP1 derivatives digested with Sma I and probed with ATT -l. This implied 
that if the 8.6kbp fragment was representative of an additional genomic organisation 
then the population it characterised must exist extremely transiently such that 
genomic rearrangements occurred almost immediately on extraction of virus from 
affected animals. 
The absence of PP1 derivatives which demonstrated the 8.6kbp Sma I fragment alone 
suggested that PP 1 represented a distinct population rather than a 
mixed population. 
In the PP1 genome ATT -1, or part of ATT -1, appeared to 
be present twice, once in 
the 8.6kbp fragment and again in the 5kbp fragment. 
This duplication of part of 
ATT -1 is consistent with the presence of ATT -1 twice 
in the CFA genome, as 
described in the previous chapter. Three of the 
four biologically cloned CA 
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derivatives described in section 5,3 exhibited fragments %. at Sit, Et wiierr ditmte4i 
with Sma I and probed with VIR=l. This population was diistinIzt tiont tklt 1.M11 
derivatives, which exhibited Sma I fragments of 8,6 ;_, 51* wham vvitth 
VIR-I (see figure 5.4), and therefore this population Was deSitraeliZIM. 
5.5 PROBING SMA I DIGESTS OF THE C500 DERIVATIVES WITII 
VIR-1 AND VIR-2 
The hybridisation profiles described in this section, and the followiin titmett.gatiizim. 
are summarised in figure 5.22. 
The VIR -1 clone was used to probe Sma I digests of PP, CA ..OinjA 12NAL (*gt 
figure 5.4). VIR -1 recognised the same fragments as ATT -1, fat 04;411iii: o,b alaginatt 
of 7kbp was recognised in the CA and CFA derivatives. Simi bit,. wiktit 
clone was used to probe a Sma I digest of PP2 a fragment of lk 
addition to a 5kbp fragment (see figure 5.3). The observation that 
and CFA fragment was present with VIR -1 but not with ATI<I 
fragment was recognised by the region of the VIR -1 clone which waS rtt ;ß:íi iirr 
ATT -1 (i.e. the 5' end of the VIR -1 clone). The significance of mi., II 
fragment will be discussed in section 5.8. The Sma I fragment ies waiiiros 
as probe were found to be consistent for a number of independently deliiiVed 
PP2, CA and CFA derivatives. 
Comparison of the ATT -1 and VIR -1 Sma I C500 hybridisation profiles also 
suggested that the CA population represented both the PP2 and CFA derivatives, The 
PP2 derivative became a mixed population of PP2 and CFA virions very rapidly, 
therefore it was not possible to prepare quantities of PP2 DNA in excess of 2-5µ,g. lin 
the remainder of this study a proportion of the PP2 characteristics were determined 
from CA preparations by eliminating the fragments attributed to CFA virions. 
The VIR -2 clone was used to probe Sma I digests of PP1, CA and CFA derivatives 
(see figure 5.5). These hybridisations demonstrated that the VIR -2 clone produced an 
identical pattern to that observed with the ATT -1 clone (see figure 5,1). The 7kbp 
fragment recognised by VIR -1 was not observed, implying that the 7kbp Sma I 
fragment was recognised by the region of VIR -1 which did not demonstrate 
homology to VIR -2. 
Ilo 
Figure 5.4 
Sma I profiles of AHV 1 digests probed with MR-1 
kb 1 2 3 4 
Track kb -1kb ladder 
Track 1 -WC11 digested with Sma I 
Track 2 -CFA digested with Sma I 
Track 3 -CA digested with Sma I 
Track 4 -PP digested with Sma I 
Tracks 2-4 were probed with VIR 1 
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Figure 5.5 
Sma I digests of C500 DNA probed with VIR -2 
1 2 3 4 
8.6- - 
5.0+ 3.8 
Track 1 - CFA DNA digested with Sma I 
Track 2 - CA DNA digested with Sma I 
Track 3 - lkb ladder 
Track 4 - PP DNA digested with Sma I 
Tracks 1, 2 and 4 were probed with VIR -2 
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5.6 PROBING HIND III DIGESTS OF THE C500 DERIVATIVES WITH 
ATT -1 
When ATT -1 was used to probe Hind III digests of PP1 and PP2 a faint laddering 
effect was observed. In addition supermolar fragments of 3.6kbp were observed in 
both derivatives. The ATT -1 clone had produced a double ladder when used to probe 
a Hind III digest of CFA DNA (see figure 4.4a). ATT -1 fragments A and B also each 
created a laddering effect when used to probe CFA Hind III digests (see figures 4.4b 
and 4.4c). These fragments were used individually to probe Hind III digests of PP1 
DNA in order to compare the Hind III hybridisation profiles of the PP1 and CFA 
genomes. 
When fragment A was used to probe a Hind III digest of PP1 DNA a doublet of 
3.6kbp was observed. This was in contrast to the laddering effect observed when a 
CFA Hind III digest was probed with fragment A (see figure 5.6). This 3.6kbp 
doublet was believed to represent the VIR -1 and VIR -2 clones, which differ by only 
10bp and both contain sequence homologous to ATT -1, suggesting that VIR -1 and 
VIR -2 were both present in the PP1 genome. 
A single fragment of 3.6kbp was observed when fragment A was used to probe a 
Hind III digest of PP2 DNA (data not shown), suggesting that either VIR -1 and 
VIR -2, but not both, were present in this population. 
The absence of a laddering effect in both of the PP derivatives suggested the VIR -1 
and VIR -2 clones were not located as close to the 5' terminal repeats of the PP1 and 
PP2 genomes as fragment A was to the 5' terminal repeats of the CFA genome. 
Hind III digests of PP1 and PP2 were probed with ATT -1 fragment B. This fragment 
was present in ATT -1 but not VIR -1 or VIR -2. A laddering effect was observed in 
both PP derivatives (data not shown), suggesting that fragment B was present and 
was terminally located in both PP1 and PP2. 
The possible terminal location of VIR -1 and/or VIR -2 in 
the PP1 genome was 
investigated further by probing Bam HI and Eco RI PP1 digests 
with VIR -1. The 
VIR -1 and VIR -2 sequences do not contain recognition 
sites for either of these 
enzymes. A laddering effect was observed in both digests, 
as illustrated in figure 5.7. 
This suggested that either VIR -1 or VIR -2 was terminally 
located, or that both clones 
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Figure 5.6 
Hind III C500 digests probed with ATT-1 
Track 1 - PP1 digested with Hind III 
Track 2 - CFA digested with Hind III 
Both tracks were probed with fragment A 
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Figure 5.7 
PP1 DNA digests probed with VIR -1 
1 2 3 
Track 1 - 1kb ladder 
Track 2 - PP1 digested with Barn HI 
Track 3 - PP1 digested with Eco RI 
Tracks 2 and 3 were probed with VIR -1 
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were terminally located at opposite ends of the PP1 genome. The smallest Barn HI 
fragment observed was approximately 7.5kbp, and the smallest Eco RI fragment 
was approximately 8kbp. These fragment sizes suggested that a Bam HI site was 
located a maximum of65kbp from the start of the terminal repeats at one end of the 
genome (assuming that at least one repeat unit of 1050bp was required for each 
virion), and that an Eco RI site was located a maximum of 7kbp from the start of the 
terminal repeats. 
5.7 PROBING HIND III DIGESTS OF THE C500 DERIVATIVES WITH 
VIR -i 
The VIR -1 clone was used to probe PP1, CA and CFA Hind III digests as illustrated 
in figure 5.8. In PP1 DNA a fragment of 3.6kbp was observed, whilst in CA and CFA 
DNA laddering occurred. The smallest fragment evident in the CA and CFA digests 
was 2kbp. The laddering effect in the CA and CFA digests was due to the location of 
fragment A at the 5' terminus of the CFA genome, since the CFA genome was 
present in the CA population. The VIR -1 clone recognised ATT -1 fragment A, as the 
two clones shared homology for the 1923bp of fragment A. This region of homology 
is illustrated in figure 5.9, and will subsequently be referred to as fragment 
C. When 
the VIR -1 clone was used to probe a PP2 digest (see figure 5.10) 
fragments of 3.6 
and 2kbp were observed. 
The 2kbp fragment observed in the PP2, CA and CFA digests 
was not observed when 
ATT -1 was used to probe equivalent C500 digests. The 
CR -1 insert, representing the 
repeat unit of C500, also did not recognise this 2kbp fragment 
(see figure 5.10). This 
implied that the 2kbp Hind III fragment was not the 
smallest fragment of the ladder 
due to the repeats, but was recognised specifically 
by the VIR -1 clone. Hybridisation 
to this 2kbp Hind III fragment was attributed to 
all or part of the 5' 1616bp region of 
the VIR -1 clone, since this is the region of VIR 
-1 which is not homologous to ATT -1 
and VIR -2 (i.e. see figure 5.9). 
The presence of the 2kbp fragment in 
PP2, CA and CFA Hind III digests when 
probed with VIR -1 suggested that the 
5' 1616bp region of VIR -1 may be present 
twice in these C500 derivatives. One 
copy of this sequence would be present in the 
arrangement represented by the VIR -1 
clone, and the second copy would be involved 
in the 2kbp Hind III fragment. Alternatively 
the conformation of VIR -1 might be 
absent in PP2, CA and CFA 
being replaced by the 2kbp fragment. 
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were terminally located at opposite ends of the PP1 genome. The smallest Barn HI 
fragment observed was approximately 7.5kbp, and the smallest Eco RI fragment 
was approximately 8kbp. These fragment sizes suggested that a Barn HI site was 
located a maximum of65kbp from the start of the terminal repeats at one end of the 
genome (assuming that at least one repeat unit of 1050bp was required for each 
virion), and that an Eco RI site was located a maximum of 7kbp from the start of the 
terminal repeats. 
5.7 PROBING HIND III DIGESTS OF THE C500 DERIVATIVES WITH 
VIR -1 
The VIR -1 clone was used to probe PP1, CA and CFA Hind III digests as illustrated 
in figure 5.8. In PP1 DNA a fragment of 3.6kbp was observed, whilst in CA and CFA 
DNA laddering occurred. The smallest fragment evident in the CA and CFA digests 
was 2kbp. The laddering effect in the CA and CFA digests was due to the location of 
fragment A at the 5' terminus of the CFA genome, since the CFA genome was 
present in the CA population. The VER-1 clone recognised ATT -1 fragment A, as the 
two clones shared homology for the 1923óp of fragment A. This region of homology 
is illustrated in figure 5.9, and will subsequently be referred to as fragment C. When 
the VIR -1 clone was used to probe a PP2 digest (see figure 5.10) fragments of 3.6 
and 2kbp were observed. 
The 2kbp fragment observed in the PP2, CA and CFA digests was not observed when 
ATT -1 was used to probe equivalent C500 digests. The CR -1 insert, representing 
the 
repeat unit of C500, also did not recognise this 2kbp fragment (see figure 5.10). 
This 
implied that the 2kbp Hind III fragment was not the smallest fragment 
of the ladder 
due to the repeats, but was recognised specifically by the VER-1 
clone. Hybridisation 
to this 2kbp Hind III fragment was attributed to all or part of the 
5' 1616bp region of 
the VIR -1 clone, since this is the region of VER-1 which is 
not homologous to ATT -1 
and VIR -2 (i.e. see figure 5.9). 
The presence of the 2kbp fragment in PP2, CA 
and CFA Hind III digests when 
probed with VIR -1 suggested that the 5' 1616bp 
region of VER-1 may be present 
twice in these C500 derivatives. One copy of this 
sequence would be present in the 
arrangement represented by the VIR -1 clone, and 
the second copy would be involved 
in the 2kbp Hind III fragment. Alternatively 
the conformation of VIR -1 might be 
absent in PP2, CA and CFA being 
replaced by the 2kbp fragment. 
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Figure 5.8 
C500 Hind III digests probed with VIR -1 
3.6 
2.040i- 
I 2 3 
Track 1 - CFA digested with Hind III 
Track 2 - CA digested with Hind III 
Track 3 - pp1 digested with Hind III 

































































































































































































































































































Hind III digests of C500 DNA probed with CR -1 and VIR -1. 
2.0-110 
I 2 3 4 5 67 
Track 1 - 
Track 2 - 
Track 3 - 
Track 4 - 
Track 5 - 
Track 6 - 
Track 7 - 
Tracks 2 -4 
Tracks 5 -7 
1kb ladder 
PP2 digested with Hind III 
CA digested with Hind III 
CFA digested with Hind HI 
PP2 digested with Hind III 
CA digested with Hind III 
CFA digested with Hind HI 
were probed with CR -1 
were probed with VIR -1 
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Figure 5.11 
C500 RE digests probed with fragment D 
1 2 3 4 5 
Track 1 - 1kb ladder 
Track 2 - PP1 digested with Hind III 
Track 3 - CFA digested with Hind III 
Track 4 - PP1 digested with Sma I 
Track 5 - CFA digested with Sma I 
Tracks 2 -5 were probed with VIR -1 fragment D 
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was recognised specifically by the "unique" region of VIR -1. The observation that ATT -1 and VIR -2 did not recognise this 7kbp fragment implied that fragment C (i.e. the sequence common to all three clones) was not contained within this 7kbp Sma I fragment. The observation that fragment D recognised only one CFA Sma I fragment 
(7kbp) and that this fragment did not contain fragment C, suggested that the CFA 
genome did not contain the VIR -1 clone conformation. Similarly a fragment of 7kbp 
was observed when VIR -1 was used to probe PP2 and CA Sma I digests, but was not 
evident when ATT -1 and VIR -2 were used to probe equivalent digests (compare 
figures 5.1, 5.4 and 5.5). This confirmed the Hind III data that the VIR -1 clone 
conformation was absent from the PP2 and CA genomes. 
An additional VIR -1 "unique" probe, fragment E in figure 5.9, was used to probe 
further aliquots of the PP1 and CFA Hind III and Sma I digests. An identical 
hybridisation profile to that produced using fragment D was observed, suggesting 
that the majority of the 1616óp VIR -1 "unique" sequence was present in the CFA 
genome. 
Analysis of the Sma I hybridisation profiles using the various probes described in this 
chapter resulted in preliminary conclusions regarding the genomic rearrangements 
which occur in the C500 genome as a result of in vitro propagation. The sequence 
common to all three clones (i.e. fragment C in figure 5.9) appeared to be present 
twice in the PP1 genome, contained in both the 8.6 and 5kbp Sma I fragments. Since 
the sequence "unique" to VIR -1 recognised the 8.6kbp Sma I fragment, coupled with 
the assumption that VIR -1 and VIR -2 were both present in PP1 DNA (represented by 
the doublet in track 1, figure 5.6), it was postulated that the sequence of VIR -1 was 
encoded by the Sma I 8.6kbp fragment, and the sequence of VIR -2 was contained 
within the 5kbp fragment. 
Analysis of a Sma I digest of PP1 DNA which had been probed with ATT -1 (track 2, 
figure 5.1) using a Joyce Loebl densitometer on reflectance mode resulted in two 
peaks (see figure 5.12). The ATT -1 clone shared homology with VIR -1 over a region 
of 1923óp (fragment C). In contrast, ATT -1 shared homology with VIR -2 over a 
region of 3134bp. The ratio of the two Sma I peaks when probed with ATT -1 was 
therefore predicted to be 1923:3134, or 1:1.63. The observed results were that the 
5kbp peak was 1.7 times as intense as the 8.6kbp peak. This implied that VIR -2 was 
contained in the 5kbp peak, and that VIR -1 was contained in the 8.6kbp peak. 
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Figure 5.12 
Densitometry plot of PP1 digested with Sma I and probed with ATT-1 
The first peak corresponds to the 5kbp Sma I fragment 
The second peak corresponds to the 8.6kbp Sma I fragment 
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The hybridisation profile of PP2 on Sma I digestion exhibited a 7kbp fragment, but 
no 8.6kbp fragment, when probed with VIR -1. This 7kbp fragment was not observed 
when ATT -1 and VIR -2 respectively were used to probe PP2 DNA digested with 
Sma I, suggesting that the copy of fragment C contained in VIR -1 was lost as PP1 
derivatives developed characteristics of PP2 derivatives following serial passage. 
However, fragment C was present twice in the CFA genome, in the form of the two 
copies of ATT -1 present in this derivative (see chapter 4). The apparent loss, then 
subsequent re- emergence of the "second" copy of fragment C during in vitro 
propagation of C500 virus will be discussed in section 5.12. 
5.9 THE USE OF PCR TO ATTEMPT TO LOCATE VIR -1 AND VIR -2 IN 
THE PP GENOMES 
5.9.1 Introduction 
PCR was used to aid in the location studies described in chapter 4. Similar PCR 
reactions were carried with the PP1 and PP2 genomes as target DNA, using the 
oligonucleotides designed for sequencing VIR -1, VIR -2 and ATT -1 in conjunction 
with the CR -1 repeat clone primers, RP1 and RP2. The primers used and the clones 
from which they were derived are illustrated diagramatically in figure 5.13. The 5' 
and 3' termini of the PP1 and PP2 genome are arbitrarily labelled in the same 
orientation as the CFA genomes. 
5.9.2 The use of PCR to investigate whether VIR -1 or VIR -2 was adjacent to the 
3' terminus of PP1. 
When ATT -1 fragment B was used to probe a PP1 Hind III digest a laddering effect 
was observed. This suggested that the PP1 equivalent to ATT -1 fragment B was 
terminally located in the PP1 genome. The experiments described in 
chapter 4 
illustrated that ATT -1 fragment B was located adjacent to the arbitrarily 
determined 
3' terminus of the CFA genome. PCR was used in order to determine 
whether VIR -i, 
VIR -2, or both were adjacent to fragment B, and whether fragment 
B was terminally 
located, in a similar manner to the arrangement of ATT 
-1 at the 3' end of the CFA 
genome. 
A primer from fragment B, P12, (see appendix 3 
and figure 5.13) was used in 
conjunction with RP2 following conditions described 
in 2.8.20 A, with PP1 DNA as 
target. The resultant product was 500óp in 
length, identical to the CFA product using 
these primers. The PP1 and CFA P12/RP2 
























































































































































































































































































homology was observed (see figure 5.14). This suggested that the PP1 fragment B 
equivalent was terminally located (see figure 5.15). 
The location of VIR -1 and VIR -2 in relation to fragment B was assessed by PCR. 
The primers used were 1311 from fragment B (see appendix 3.1) and P8, from 
fragment C. The target DNA was PP1 DNA, and the reaction conditions were as 
described in 2.8.20 E. For comparison 100ng of CFA DNA was treated identically 
The resultant products were both approximately ikbp in length (illustrated later in 
figure 6.10). This suggested that fragment B was adjacent to either VTR-1 or VIR -2 
or both in the PP1 genome (see figure 5.15). In addition, the observation that the 
products were derived using P11 and P12 (in combination with P8 and RP2 
respectively) suggested that all of fragment B was present in PP 1 DNA. 
PCR was used to determine whether fragment B was adjacent to VIR -1, VIR -2 or 
both in the PP1 derivative. This was achieved by selecting oligonucleotides from 
the regions of VIR -1 and VIR -2 which were not homologous i.e. 5' to fragment C in 
both clones. The primers selected were P7 from VIR -1 and P4 from VIR -2 (see 
figure 5.13). These primers were used in conjunction with P11, following the 
reaction conditions described in 2.8.20 D. The products were a fragment of 3.1kbp 
for primer combination P4/P11, and a fragment of 2.7kbp for P7/P11. 
The predicted product size for P4/P11 was 3.lkbp, therefore the product observed 
was approximately the correct size. Homology was observed between this product 
and both VIR -2 and fragment B, and this established that VIR -2 was adjacent to 
fragment B. Similarly the predicted P7/P11 product was 2.7kbp, therefore the 
product 
observed was approximately the correct size. Homology was observed 
between this 
product and both VIR -1 and fragment B, and this established that 
VIR -1 was also 
located adjacent to fragment B. Figure 5.16 illustrates these 
two PCR products 
probed with VIR -2 and VIR -1 respectively. 
When fragment B was used to probe a Sma I digest of 
PP1 DNA fragments of 8.6 
and 5kbp were observed (see figure 5.17), illustrating 
that fragment B was present 
twice in the PP 1 genome. The 8.6kbp fragment 
was believed to contain the VIR -1 
clone as described in section 5.8. The observation 
that fragment B recognised this 
8.6kbp fragment, coupled with the PCR product 
from primer combination P7/P11, 
suggested that fragment B was located adjacent 
to VIR -1 as part of this 8.6kbp 
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Figure 5.14 
Comparison of 3' terminal PP1 and CFA PCR reactions 
1 2 3 
Track 1 - lkb ladder 
Track 2 - PCR product of PP1 amplified with primer combination P12 /RP2 
Track 3 - PCR product of CFA amplified with primer combination P12/RP2 






Possible 3' termini locations of PP1 
Sma I 8.6kbp 
VIR 1 
Sma I 
N =Po- .. .. is.. 
P7 P8 P11 P12 RP2 
PP1 




P4 P8 P11 P12 
Sma I 
B 
This figure illustrates the possible 3' termini of the PP1 genome in (a) and 






PP1 PCR products 
2 3 
1.4y ONO .sts. 
Track 1 - lkb ladder 
Track 2 - PCR product of PP1 amplified using primer combination P4/P11 
Track 3 - PCR product of PP1 amplified using primer combination P7/Pi i 
Track 1 was probed with VIR -2 
Track 2 was probed with VIR -1 
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Figure 5.17 




Track 1 - 1kb ladder 
Track 2 - PP1 digested with Sma 
I and probed with fragment B 
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fragment. Similarly, the 5kbp fragment apparently contained the VIR -2 clone, located adjacent to fragment B. 
The PCR reaction involving P12 and RP2 suggested that fragment B was terminally 
located. Figure 5.15 illustrates the two possible 3' genomic arrangements of the PP1 
derivative from the data described in this section, compared to the CFA 3' terminus 
which was established in chapter 4. PCR reactions were carried out using RP2 with a 
primer common to VIR -1 and VIR -2, P8 (see figure 5.13), with PP1 DNA as target. 
The reaction conditions were as described in 2.8.20 F, and a product of 
approximately 2kbp was observed. This product was homologous to ATT -1 fragment 
B (data not shown), further suggesting that either VIR -1 or VIR -2 was located close 
to the 3' terminal repeats of the PP1 genome. 
5.9.3 The use of PCR to investigate whether part of VIR -1 or VIR -2 was 
adjacent to the 3' terminus of PP2 
The VW-1 clone conformation was apparently absent from the PP2 genome, but part 
or all of the 5' 1616óp of the sequence "unique" to VIR -1 was present. If PP2 was a 
direct descendant of PP1, and if the genomic arrangement illustrated in figure 5.15a 
was correct then at least 1923óp (fragment C) were absent from the 3' terminal 
location in PP2 compared to PP1. If this loss was a straight deletion then gene 
amplification using P7 in combination with Pi i would result in a product of <2.7kbp 
(with 2.7kbp being the PP1 product). A PCR reaction involving P7/P11 was carried 
out following the conditions described in 2.8.20 A, with 100ng of PP2 DNA as the 
target sequence, and a product of 500bp was observed. Hybridisation was not 
observed between this product and fragment D, suggesting that the 500bp fragment 
may be an artefact of PCR. In order to investigate this further P7 and P11 were used 
alone in two separate PCR reactions, following the conditions described for P7 in 
conjunction with P11. The results of these reactions were that a 500bp fragment was 
observed in the sample using Pll alone, implying further that the P7/P11 product 
was an artefact. 
The lack of products observed using primer combination P7/P11 with PP2 DNA 
suggested that fragment B may not be adjacent to the region of VIR -1 which was 
included in the PP2 genome (i.e. the 2kbp Hind III fragment). The PP1 derivative 
contained two copies of fragment B, as illustrated in figure 5.17. In contrast the PP2 
derivative appeared to contain only one copy of fragment B, since ATT -1 (which 
contains fragment B) recognised only the Sma I 5kbp fragment in PP2 DNA. This 
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suggested that it was not only a copy of fragment C that was absent from PP2, when 
compared to PP1, but also a copy of fragment B. This possibility was investigated 
further by using P7 in combination with RP2 in a PCR reaction with 100ng of PP2 as 
target DNA, following the reaction conditions described in section 2.7.20 D. A 
500óp product was observed, but this product did not exhibit homology to either 
CR -1 or VIR -1, therefore was assumed to be an artefact of PCR. 
A PCR reaction involving P12 and RP2, following the reaction conditions described 
for CFA P 12/RP2 in 2.8.20 A, was used to amplify 100ng PP2 DNA. The product 
observed was identical in size to the fragments illustrated in figure 5.14, and 
exhibited homology to CR -1 (data not shown). In addition, a PCR reaction involving 
P8 and RP2, following the reaction conditions described in 2.8.20 F, was used to 
amplify PP2 DNA. A product homologous to ATT -1 fragment B, and of 
approximately 2kbp in length, was observed (data not shown). This implied that 
VIR -2 was located directly upstream to the 5' terminal location of fragment B, since 
the region of VIR -1 encoding P8 was absent from the PP2 genome. 
A PCR reaction involving primer combination P4/P11 following the conditions 
described in 2.8.20 D with PP2 DNA as target resulted in a product of 3.1kbp. This 
product was identical in size to the PP1 equivalent product (see figure 5.16), and 
exhibited homology to VIR -2 (data not shown). This was predicted because the 
VIR -2 clone and fragment B were located within the PP2 5kbp fragment, and this 
fragment was apparently unchanged between the PP1 and PP2 derivatives. 
5.9.4 The use of PCR to investigate whether VIR -2 was adjacent to the 5' 
termini of PP1 and PP2 
The VIR -2 and ATT -1 clones differed in the sequence located at their 5' termini such 
that the VER-2 clone contained a 386bp region of DNA which was not present 
in 
ATT -1. When ATT -1 and VIR -2 were aligned (see figure 5.9) this 386bp 
fragment 
was located to the 5' side of ATT -1. If the VIR -2 clone was located 
adjacent to the 5' 
terminus of PP1 and PP2 this 386bp region, together with the 
Sma I data, implied 
that VER-2 could not be located as close to the 5' termini 
of the PP1 and PP2 
genomes as ATT -1 was to the 5' terminus of the CFA genome. 
The PCR reaction which had confirmed that ATT 
-1 fragment A was terminally 
located at the 5' end of the CFA genome involved 
primers P2 and RP 1. The PP1 and 
PP2 derivatives respectively were amplified 
using these oligonucleotides, following 
132 
the reaction conditions described in section 2.8.20 A. No products were observed in 
either reaction, suggesting that VIR -2 was located further from the 5' termini of both 
PP derivatives than ATT -1 was from the CFA 5' terminus. 
The lack of product using P2 and RP1 to amplify PP1 DNA contrasted with an earlier 
result when P2 and RP1 were used in an identical reaction with virulent CA DNA 
(see figure 4.7). This PCR using 100ng CA DNA as input generated a 950óp product 
which was identical in size to the equivalent CFA product. This product was thought 
to be due to the presence of CFA virions in the CA population, as described in 
section 5.3. 
A primer closer to the 5' terminus of VIR -2, P16 (see appendix and figure 5.13), was 
used in combination with RP1, as P16 was closer to the 5' terminus of VIR -2, 
although not present in ATT -1. The reaction conditions were as described in 
2.8.20 A, using 100ng of PP1 and PP2 respectively as target DNA. A 400óp product 
was observed, but this product did not exhibit homology to either VIR -2 or CR -1, 
therefore was apparently an artefact of PCR. 
5.9.5 The use of PCR to investigate whether VIR -1 (or the 5' region of VIR -1 
present in PP2) was adjacent to the 5' termini of PP1 and PP2 
The VIR -1 clone did not contain the sequence for P2, nor did its 2kbp Hind III PP2 
equivalent, therefore an alternative 5' VIR -1 primer, P6 (see figure 5.13) was used in 
conjunction with RP1 in an identical reaction cycle to that described for RP1 and P2. 
No products were observed, suggesting that VIR -1 and its PP2 equivalent were 
located further from the 5' terminus of both PP derivatives than ATT -1 was from the 
CFA 5' terminus. 
5.9.6 The use of PCR to investigate whether VIR -1 or VIR -2 was adjacent to 
the 5' termini of PP1 and PP2 in an inverted orientation 
The possibility that the VIR -1 or the VIR -2 clone might be adjacent to the 5' terminal 
repeats of PP1 and PP2 in an inverted orientation to that of ATT -1 at the 5' terminus 
of the CFA genome was considered. An inverted orientation would explain the lack 
of product observed in sections 5.9.4 and 5.9.5. A potential theory for the 
rearrangement involving a "flipping" mechanism would be possible if VIR -1 or 
VIR -2 was orientated in this manner. When P14 was combined with 
RP1, using PP1 
DNA as target, and following the reaction conditions described 
in 2.8.20 A, no 
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products were observed. This result was inconclusive as the fragments may have 
been larger than the size constraints. 
5.9.7 Conclusions 
PCR was used to assess whether the locations of VIR -1 and VIR -2 in the PP1 and 
PP2 genomes paralleled the location of ATT -1 in the CFA genome. The conclusions 
from these PCRs were that ATT -1 fragment B was present twice in the PP1 genome, 
adjacent to both VIR -1 and VIR -2, and was present at least once in the PP2 genome, 
adjacent to VIR -2. In addition fragment B was shown to be adjacent to the 3' termini 
of both virulent genomes. In the PP1 genome either VIR -1 or VIR -2 was located 5' to 
the 3' terminal location of fragment B, and in the PP2 genome, VIR -2 was located 5' 
to the 3' terminal location of fragment B. 
The PCR reactions to determine whether VIR -1 or VIR -2 were located at the 5' 
termini of both PP derivatives, in the orientation presented in figure 5.13, or in the 
opposite orientation, did not result in products. The lack of products did not 
demonstrate conclusively that VIR -1 and VIR -2 were not located close to the 5' 
terminal repeats of PP1 and PP2, but did illustrate that neither clone was located as 
close to the 5' repeats of either PP derivative as ATT -1 was to the 5' terminus of the 
CFA genome. 
5.10 SAC I ANALYSIS OF PP1 
PP1 was digested with Sac I and probed with VIR -1 and VIR -2 respectively, as 
illustrated in figure 5.18. VIR -1 recognised fragments of 7.5 and 3kbp, while VIR -2 
recognised a single fragment of 7.5kbp. These results were difficult to interpret as 
VIR -1 was predicted to hybridise to three fragments, one corresponding to VIR -2 and 
two corresponding to VIR -1 since VIR -1 has internal Sac I sites (the central 167óp 
VIR -1 Sac I fragment was not observed). Similarly VIR -2 was predicted to hybridise 
to two Sac I fragments, one corresponding to itself, and one corresponding 
to the 
homologous region of VIR -1 (fragment C in figure 5.9). The 
observed result 
suggested that VIR -1 and VIR -2 must be located very close to 
each other. 
The observation that VIR -2 recognised only one fragment 
(of 7.5kbp) in a PP1 Sac I 
digest suggested that either the VIR -1 and VIR -2 
copies of fragment C were 
contained in identically sized Sac I fragments, or that 
both copies were contained in 
the one Sac I fragment. The data described in the previous 
section suggested that both 
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Figure 5.18 
PP1 DNA digested with Sac I and probed with VIR -1 and VIR -2 
1 2 3 
Track 1 - lkb ladder 
Track 2 - PP1 digested with Sac I and probed with VIR -1 
Track 3 - PP1 digested with Sac I and probed with VIR -2 
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VIR -1 and VIR -2 were located adjacent to fragment B in PP1. In addition, the 
Sma I hybridisation profiles suggested that VIR -2 was included in a Sma I 5kbp 
fragment, and that VTR -1 was included in a Sma I 8.6kbp fragment. One possible 
organisation of the above data is presented in figure 5.19. The PP1 Hind III, Sac I and 
Sma I data is combined to generate the sizes of each individual fragment. The Sma I 
5 and 8.6kbp fragments are illustrated below this map, and the Sac I fragments are 
illustrated above it. The observed Sac I fragment recognised by both VIR -1 and 
VIR -2 was 7.5kbp, however, inaccuracies do occur when sizing fragments from the 
results of Southern blots, therefore this fragment may be closer to the 8.Ikbp 
fragment calculated. 
The PP1 genomic organisation proposed in figure 5.19 was investigated further using 
PCR with various primers 5' and 3' to the 800bp fragment located between VIR -2 and 
the copy of fragment B adjacent to VIR -1. Although extensive PCR analysis 
involving the VIR -2 primers P16 and P2, in combination with the fragment B primer 
12, and VIR -1 primer 14 was undertaken, product was not generated. One possible 
explanation for this failure was that the genome is not arranged in the manner 
'described in figure 5.19. An alternative explanation is that the nature of the sequence 
encoded by this 800bp region somehow inhibits the PCR, possibly by its secondary 
structure as has been observed previously (Green and Sargan 1991). This region of 
the C500 genome also proved impossible to clone (see section 3.6). 
5.11 PROBING C500 DIGESTS WITH THE REGION OF VIR -2 ABSENT 
FROM VIR -1 AND ATT -1 
The 5' 386bp of the VIR -2 clone did not share homology with the ATT -1 or VIR -1 
clones. This fragment is referred to as the sequence "unique" to VIR -2 in the 
remainder of this section. 
The VIR -2 sequence was believed to be present in the 5kbp Sma I fragment observed 
in PP1 and PP2 DNA (see section 5.8). Earlier results had suggested that this 
fragment was correlated with virulence (see section 5.2). The 5kbp Sma I fragment 
was absent from the CFA genome, and was apparently replaced by a 3.8kbp Sma I 
fragment. No other fragment was observed in the CFA digest when VIR -2 or ATT -1 
were used as probe, suggesting that at least 1.2kbp of DNA which 
was present in the 








































































































































The proposed arrangement of the DNA in the 5kbp Sma I fragment was as illustrated 
in figure 5.19. This implied that if l.2kbp was "lost" then the VIR -2 "unique" DNA 
would be part of this. Pst I digestion of VIR -2 produced a 5' fragment of 496óp 
(fragment F in figure 5.9), which contained the 386óp of sequence "unique" to VIR -2 
in addition to 110bp of sequence present in both VIR -2 and ATT -1. Fragment F was 
labelled with DIG and used to probe Sma I digests of CA and CFA DNA. A 5kbp 
fragment was recognised in the CA DNA, with a faint 3.8kbp fragment (see figure 
5.20a). A faint 3.8kbp fragment was all that was observed in the CFA track. In both 
digests the 3.8kbp fragment should be recognised by the 110bp of the probe which 
was common to ATT -1 and VIR -2. 
A probe specific for the 5' end of the VIR -2 clone was prepared using P16 and the 
pBS SK+ M13 reverse sequencing primer to generate a DIG labelled probe using 
PCR (see 2.8.21). The reaction conditions were as described in 2.8.20 G. The PCR 
product was used to probe CA and CFA Sma I digests respectively (see figure 5.20b). 
A fragment of 5kbp was observed in the CA digest, while no fragments were 
observed in the CFA digest. This showed that the 5' region of the VIR -2 clone was 
absent from the CFA genome. 
The VIR -2 clone lost homology with the ATT -1 clone 55bp before the 5' Sma I site 
of the ATT -1 clone. The possibility that the Sma I site and the 55bp 3' to it, might be 
conserved as the 5' Sma I site of the 5kbp fragment was investigated. A primer was 
designed from the 5' teiminns of ATT -1 (P15) and used in conjunction with P16 (see 
figure 5.21). This combination was used to amplify 100ng of PP1 DNA. The reaction 
cycle was as described in 2.8.10 H. Two products were observed from the PP1 
reaction, one of 800bp (the predicted product size) and one of 200óp. CFA DNA was 
also amplified using P15 and P16, as a negative control, since the CFA genome did 
not contain the sequence for P16, as illustrated above. However, a product of 800bp 
was also observed from the CFA reaction. This result was initially thought to be due 
to contamination of the CFA reaction with PP1 DNA, therefore both reactions were 
repeated, but the same products were observed. The observed products from 
the PP1 
and CFA PCR reactions did not exhibit homology to a VIR -2 specific 
probe (as 
described in the previous paragraph), suggesting that this product 
was an artefact of 
PCR. In conclusion, the sequence immediately 3' to the 
5' Sma I site of the CFA 
3.8kbp fragment was not believed to be the same as the sequence 
3' to the 5' Sma I 
site of the PP1 and PP2 5kbp fragment. 
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Figure 5 
Sma I C500 digests probed with 5' 
Figure 5.20a 
Probing CA and CFA Sma I 
digests with fragment F 
1 2 3 
Track 1- lkb ladder 
Track 2 - Sma I digested CFA 
Track 3 - Sma I digested CA 
Tracks 2 and 3 were probed 
with fragment F 
.20 
VIR -2 sequence 
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Figure 5.20b 
Probing CA and CFA Sma I 




Track 1 - Sma I digested CFA 
Track 2 - Sma I digested CA 
Tracks 1 and 2 were probed 
with VIR -2 P16 5' terminal fragment 
Figure 5.21 
Diagramatic representation of the potentially conserved region 3' to the 5' 







3.8kbp CFA Sma I fragment (AIT-1) 
Hind III Sma I 
B 
5kbp PP1 and PP2 Sma I fragment 
VIR-2 
- Potentially conserved region 
- Homologous region 
A - ATT-1 fragment A 
B - ATT-1 fragment B 
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Hind III Sma I 
B 
5.12 DISCUSSION 
This chapter described attempts to establish the location of the VIR -1 and VIR -2 
clones in virulent C500 viral genomes. In chapter three the virulent derivatives of 
C500 were described as PP, CA and CF (see figure 3.2). Closer investigation of the 
population designated PP illustrated that two separate genomic arrangements were 
present, therefore the PP derivative was divided into PP1 and PP2 genomes. 
Similarly, closer examination of the CA population showed it to consist of PP2 and 
CFA genomes. The CF population was not discussed specifically in this chapter, 
although the limited data presented suggested that this population was similar to the 
CA population (see figure 5.1, where the CA and CF profiles are identical). 
Restriction digests, using Hind III and Sma I respectively, resulted in consistent, but 
distinct restriction profiles for the three C500 derivatives, PP1, PP2 and CFA, when 
probed with the three C500 clones, VER-1, VIR -2 and ATT -1, as summarised in 
figure 5.22. Molecular analysis of tissue culture harvests was based on these 
differences in restriction profiles. Comparison of the Sma I restriction profiles 
suggested that the 5kbp fragment was associated with virulence, since the only 
derivative not exhibiting this fragment was CFA. In contrast, the loss of the 8.6kbp 
fragment did not appear to lead directly to loss of virulence. 
The location of VIR -1 and VIR -2 in the PP1 and PP2 genomes was investigated both 
by Southern blotting experiments and by PCR. The Hind III PP1 and PP2 profiles, 
when probed with VIR -1 or VIR -2, did not result in a laddering effect (see figure 
5.22). This suggested that both VIR -1 and VIR -2 were not located as close to the 
terminal repeats at both ends of either the PP 1 or the PP2 genomes as ATT -1 was to 
both terminal repeats in the CFA genome. 
The use of PCR to investigate the location of VIR -1 and VIR -2 established a 3' 
terminal location for either VIR -1 or VIR -2, adjacent to fragment 
B in the PP1 
genome, and a 3' location for VIR -2 adjacent to fragment B in the 
PP2 genome. The 
PCR reactions to locate either VIR -1 or VTR-2 at the 5' end of 
the PP1 and PP2 
genomes were inconclusive. However, amalgamation of PCR 
and Southern blotting 
data determined that neither VIR -1 nor VIR -2 was located 
as close to the 5' terminal 
repeats of the PP1 and PP2 genomes as ATT -1 was 




Summary of restriction profiles of the C500 derivatives 
PROBE DERIVATIVE Sma I Hind III 
VTR-1 PP1 8.6 and 5kbp 3.6kbp 
VIR -2 PP1 8.6 and 5kbp 3.6kbp 
ATT -1 PP1 8.6 and 5kbp 3.6kbp + laddering 
VIR -1 PP2 7 and 5kbp 3.6 and 2kbp 
VIR -2 PP2 5kbp 3.6kbp 
ATT -1 PP2 5kbp 3.6kbp + laddering 
VIR -1 CFA 7 and 3.8kbp 2kbp + laddering 
VIR -2 CFA 3.8kbp laddering 
ATT -1 CFA 3.8kbp laddering 
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The hybridisation profiles observed when VIR -1 and VIR -2 were used to probe a 
Sac I digest of PP1 DNA presented the possibility that, rather than being located at 
opposite ends of the genome, VIR -1 and VIR -2 were located almost adjacent to each 
other (see figure 5.19). 
The PP2 genome was shown to differ from the PP1 genome in that PP2 DNA 
appeared to contain only one copy of the 1923óp sequence common to all three 
clones (i.e. fragment C), while PP1 contained two copies of this sequence, as VIR -1 
and VIR -2. In addition, PP2 appeared to contain only one copy of the 3' 635óp 
Hind M/Sma I ATT -1 fragment (i.e. fragment B). This suggested that a minimum of 
approximately 2.6kb present in PP1 was absent from PP2. Comparison of the PP1 
and PP2 Sma I profiles, when probed with VIR -1, suggested a loss of 1.6kbp, as the 
PP1 Sma I 8.6kbp fragment was replaced by a 7kbp Sma I fragment. Similarly the 
VIR -1 3.6kbp Hind III PP1 fragment appeared to be replaced by a 2kbp PP2 
fragment. Although these Sma I and Hind III fragments represent a rearranged region 
of the C500 genome recognised by the 5' sequence of VIR -1, direct comparison of 
fragment sizes does not necessarily reflect loss of sequence. 
The proposed 3' terminal organisation of the PP1 genome was used to create a 
potential organisation for the 3' terminal sequence of the PP2 genome (see figure 
5.23), taking into consideration the PP2 Sma I 7kbp and the Hind III 2kbp fragments 
observed. This organisation was not assessed by PCR due to lack of PP2 DNA. The 
arrangement presented is only one of several possiblities. 
Comparison of the PP2 and CFA Sma I profiles illustrated that a 5kbp PP2 fragment 
became a 3.8kbp CFA fragment, suggesting a region of >1.2kbp was absent from the 
CFA genome. The VIR -2 clone was shown to contain 386bp (at the 5' end) which 
was present in PP2, but absent in CFA DNA. This suggested that a deletion of 
>386bp had occurred. The PCR reaction to determine whether the ATT -1 5' Sma I 
site was conserved as the 5' Sma I site of the PP2 5kbp fragment suggested that it was 
not, therefore the sequence deleted was probably >1.2kbp. One possible arrangement 
of the 3' terminus of the CFA genome is presented in figure 5.23. 
While substantial work will be required to confirm the suggested 
genomic 
organisations presented in figure 5.23, they do present 
a possible model of two 
sequential deletion events occurring in the transition from 
virulence to attenuation of 
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The CFA genome contains a second copy of the ATT-1 clone at the 5' end of the 
genome. Neither this copy of ATT -1, nor an equivalent, appear to be located at the 5' 
end of the PP1 or PP2 genomes. The total DNA lost sequentially from the PP1 to the 
CFA genomic arrangement is >3.8kbp (i.e.2.6kbp from PP1 to PP2, and 1.2kbp from 
PP2 to CFA). This is equivalent to the sequence contained in the 5' copy of ATT -1. 
One possible reason for a second copy of ATT -1 in the CFA genome is conservation 
of size of the C500 molecule, and this will be discussed further in chapter seven. 
In conclusion, the work described in this chapter led to a proposed map of the 3' 
terminal region of the PP1 genome. Comparison of restriction endonuclease profiles, 
in addition to PCR reactions, resulted in preparation of a model of sequential 





The three C500 clones, ATT -1, VIR -1 and VIR -2 were all sequenced (see chapter 
3), and the complete sequences are presented in appendix 3. Sequence analysis 
was performed using several of the computer programmes which form part of the 
University of Wisconsin genetics computer group (GCG) sequence analysis package. 
This chapter describes the various programmes which were used to analyse the C500 
sequence. The sequence generated was compared to the sequences of other 
herpesviruses, particularly the gammaherpesviruses Herpesvirus saimiri (HVS) and 
Epstein -Barr virus (EBV), both of which have been completely sequenced 
(Albrecht et al 1992, Baer et al 1984). Comparison to other related rhadinoviruses, 
such as OHV -2, was not possible as the OHV -2 genome has not yet been sequenced. 
However, OHV -2 was demonstrated to contain one open reading frame (ORF) which 
was homologous to AHV -1. 
6.2 SEQUENCE COMPOSITION AND ANALYSIS 
The G +C content of each of the three clones was analysed using the GCG 
programme COMPOSITION. The three clones, ATT -1, VIR -1 and VIR -2 had G +C 
compositions of 44 %, 47% and 45% respectively. These percentages were 
compared to the G +C contents of other rhadinoviruses as demonstrated in figure 
6.1. The limited sequence data generated suggests that AHV -1 unique 
DNA is 
slightly deficient in G +C. The dinucleotide frequencies showed a markedly 
lower 
CpG frequency than would be expected from the mononucleotide 
compositions as 
illustrated in figure 6.2a. (The predicted CpG frequency 
was calculated by 
multiplying the probability of a C by the probability of 
a G). The difference 
between the actual CpG frequencies and the predicted 
CpG frequencies is 
approximately three -fold for all three clones. This 
CpG depletion has been 
observed in the gammaherpesviruses EBV, HVS 
and murid herpesvirus 4 (Honess 
et al 1989, Efstathiou et al 1990a). Honess et al 
(1989) observed a corresponding 
increase in TpG and proposed that this could 
be the result of the mutagenic 
effects of DNA methylation during latency in 
a dividing cell. A slight increase in the 
frequency of TpG is observed in the C500 




G +C content of rhadinoviruses 
rhadinovirus 
* Ateline herpesvirus 2 
(herpesvirus ateles) 
* Saimirine herpesvirus 2 
(herpesvirus saimiri) 
** Murid herpesvirus 4 
Alcelaphine herpesvirus 1 
G +C content G +C content 
(complete genome) (unique L DNA) 
References 
* Fleckenstein and Mulder 1980 
** Efstathiou et al 1990b 
* ** Bridgen et al 1989 
47.1% 
45.4% 





ATT 1 44% 
VIR 1 47% 
VIR 2 45% 
Figure 6.2 
Deviations from expected dinucleotide frequencies 
Figure 6.2a 
Comparison of predicted and actual CpG frequency of the C500 clones 
Clone Actual CpG frequency Predicted CpG frequency 
ATT 1 63 185 
61 186 
VIR1 
VIR 2 61 170 
Figure 6.2b 
Comparison of predicted and actual TpG frequency of the C500 clones 
Clone Actual TpG frequency 









6.3 DNA DATABASE SEARCHING 
Extensive database searching was carried out using the software and databases 
available on the SEQNET molecular biology facility. ATT -1, VIR -1 and VIR -2 
were compared to sequences in the EMBL database using the GCG FASTA DNA 
and protein database searching programme (Lipman and Pearson 1985). No 
significant homology was observed between the cloned DNA and sequences stored 
in the database. 
6.4 IDENTIFICATION OF PROBABLE CODING REGIONS IN ATT -1, 
VIR -1 AND VIR -2 
Potential coding regions of the three clones were predicted using TESTCODE. 
This programme identifies protein coding sequences by plotting a measure of the 
composition at every third base, based on Fickett's testcode statistic (Fickett 1982). 
Significant predictions are made for window sizes of 200bp or more, therefore in 
all cases the window size selected was 200bp. TESTCODE outputs were prepared 
for all three clones, as exemplified in figure 6.3. TESTCODE identifies codons for 
methionines, stop codons and predicts with a 95% confidence limit that any 
sequence above the line at 9.5 is coding DNA, and conversely a confidence limit of 
95% that any sequence below 7.5 is non -coding. A prediction is not made for the 
region of DNA between these two parameters. Hypothetical peptides were identified 
from the regions of ATT -1, VIR -1 and VIR -2 above the 7.5 TESTCODE non - 
coding 95% confidence limit. The minimum size of the hypothetical peptides 
was 80 amino acids, and the sequences were not required to 
begin with a 
methionine to allow for the presence of introns. Nine hypothetical peptides 
were 
coded for by one strand of sequence (see figure 6.4), with only one 
being encoded 
by the opposite strand. The sequence in appendix 3 is 
presented with the strand 
which encodes the nine hypothetical petides beginning with 
base 1, although this is 
the opposite orientation from the previous descriptions 
of the clones in chapters 3, 
4 and 5. The single ORF in the "non- coding" strand 
did not exhibit homology to 
any protein sequences in the database and will 




































































































































































































Figure 6.4a HYPOTHETICAL PEPTIDES COMMON TO ALL THREE 
PEPTIDE ONE: ATT-1 bases 845-1747, frame B 
1 SHLDTVSAVC TKERCPNKTV FSQYGARQRy 
51 PDISSLLRDS SSTQENTDEE SGPCCSKTLS 
101 DTESCDSQVR PESTDSDTHA EDDDVPEAPQ 
151 NPATTQTGFY YNQQSSDNFA SRIDASATST 
201 TVPTTATGSS SCIKICMGVV SRRPHTAAMW 















PEPTIDE TWO: ATT -1 bases 1017 -1361, frame C 
1 EIHLQLKKIQ TKNLARAAAR LSAQVCHSLN LNMTPARPLH LIRTLSHVIA 
51 RFVQKVLTPT PMQKTMMFLK HPKQQAKLSQ QLPKRHRVAA VSTIQLPLRR 
101 DSTITSSQVI ILPLV 
PEPTIDE THREE: ATT-1 bases 1414-1932, frame A 
1 SRLFNFCLFP YSTHNGHWQQ QLHQNMYGGG QQTTTYGSYV GGYSDANGQS 
51 VGASTSYYTS KPATSRSSTA LQWTTLFPPA SSSASSSQVS DYFSPFPYFP 
101 GSSTVPQAFE PLAPSTPSLL DELLDRDSGL VSQQQAPAPP QNDQGGPPQY 
151 VPVAQEQQQS STDPLSDEMR RIF 
Figure 6.4b HYPOTHETICAL PEPTIDES COMMON TO ATT -1 AND VIR -2 
PEPTIDE FOUR: ATT-1 bases 2281-2925, frame A 
1 KHLWGLMHKH SATADMLPIS AFSPLKFLGG VVATPQGPVL 
51 QAFPCPPAIT PINQFVNYQP APAMDKIWRP AFEDYRGVTM 
101 SLRPALQELP EPSSPQSQSS VDDDTDSKED VTETLECAQA 
151 PSEKTSQLLL ALQAARPAFA EGKGTAIRAY RLIEAKDLGK 





Figure 6.4c HYPOTHETICAL PEPTIDE PRESENT IN VIR -2 ONLY 
PEPTIDE FIVE: VIR-2 bases 2988-3458, frame C 
1 LWLGSEMLAE MLWPAVNMLL PRKALLVDIF FILAATNLMI AAFALGCLAF 
51 YKQLVYITIG NLTFPHQSGD EVIRAMYIPP VNDSVDFNPG FRLSWLNTLS 
101 PLSDGPYDSW SQCEICPGRF VSKRPVIMSP QRPIAFKTAS LPVRIFLNVF 
151 IFILHRI 
Figure 6.4d HYPOTHETICAL PEPTIDES PRESENT IN VIR -1 ONLY 
PEPTIDE SIX: VIR -1 bases 1646 -1963, frame B 
1 KHLWGLMHKH SATADMLPIS AFSPLKFLGG VVATPQGPVL WDATTTPVPF 
51 QAFPCPPAIT PINQFVNYQP APAMDKIWRP AFEDYRGVTM RPAKTHYSCS 
101 PRVPYN 
PEPTIDE SEVEN: VIR -1 bases 2001 -2264, frame A 
1 NLDGPDSMST PGGGGASGRS PNGLGARPKD KGPKGKSPPK 
51 DLGARPKEKG PKGKSPPKDG PAARTHQKTQ ELVQKKFL 
PEPTIDE EIGHT: VIR -1 bases 2204 -2482, frame B 
1 RRACSKNPPK DPGARPEKVP LAFPGPGPVD TNPSRHDVIE 
51 KMWLPPGTKP PCPTPLWTPV RSCYLVVQTP HGTEGKEYIE 
PEPTIDE NINE: VIR -1 bases 2341 -2779, frame A 
1 ESVQKNVAAS RNEATMPYTL MDPCAVLLSS GSNAPWDRRK 
51 IGTPVTPVYL TISDDDLDDA KVLQEVVLKS LLFQAEILQV 







6.5 PROGRAMMES USED FOR PROTEIN DATABASE SEARCHING AND 
PEPTIDE ANALYSIS 
6.51 Protein database searching 
Homologous protein sequences are more likely to be conserved than the genes 
which encode them since selection acting at the protein level may conserve the 
sequence, whilst silent mutations, or mutations resulting in conservative substitutions 
may result in more substantial changes in the DNA sequence. Differences in the 
G +C composition and codon usage between different species may cause substantial 
divergence at the DNA level while similarity at the protein level is maintained. 
Protein database searching using the nine hypothetical peptides was achieved 
using the PROSRCH protein sequence database searching programme (Coulson et al 
1987), which uses the "best local similarity" algorithm of Smith and Waterman 
(1981). When these searches were undertaken 42,215 polypeptides comprising 
some 12,368,860 amino acids were present in the database. The search programme 
collects alignments between the input sequence and the database sequences and 
produces a score based on the system of Dayhoff et al (1978), which looks at 
accepted point mutations (PAMs). PAM is a measure of divergent evolution 
whereby one PAM = 1 substitution per 100 aligned residues. The PAM value used 
when searching the database for similarities to the C500 hypothetical peptides was 
250, to allow for distant matches. 
The SWEEP matrix optimal alignment programme was also used to compare the 
hypothetical peptides to sequences in the database. The SWEEP program uses the 
algorithm of Lipman and Pearson (1985) and scans each probe sequence twice. 
Optimal alignment is achieved following a modification of the Needleman and 
Wunsch (1970) algorithm. The default matrix is 250 PAM. 
6.5.2 Statistical analysis of the degree of homology between two peptides 
PROSRCH and SWEEP were used to compare the hypothetical peptides to other 
database entries. Statistical analysis of homology was assessed using 
GCG BES'l'N'1T, 
which uses the "best local similarity" algorithm of Smith and 
Waterman (1981), 
combined with the score system of Dayhoff et al (1978), 
in a similar manner to 
PROSRCH. Statistical analysis was achieved by rearranging 
one of the sequences 
randomly one hundred times, whilst maintaining 
length and composition, then 
realigning it to the first sequence. The results were 
expressed as quality (of the 
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match) +/- the standard deviation calculated by BES l'FIT. Any homology above 
the 95% confidence limit (i.e. the average match plus two standard deviations) was 
regarded as being significant. 
6.5.3 Comparison of peptides according to their secondary structure 
GCG PEPTIDESTRUCTURE was used to predict the secondary structure of the 
hypothetical peptides by assessing hydrophobicity according to the method of Kyte 
and Doolittle (1981) and secondary structure according to Chou and Fasman 
(1978), with the results being displayed graphically using PLOTSTRUCTURE. 
The output form of PLOTSTRUCTURE selected was a two -dimensional, or 
"squiggly ", plot. The predicted structural features of peptides were demonstrated 
by sine waves for a- helices, sharp saw tooth waves for 13- sheets, 1800 turns for 
13 -turns and dull, saw tooth waves for coils. The PLOTSTRUCTURE outputs 
described in this chapter were overlaid with symbols demonstrating local 
hydrophobic and hydrophilic regions within the peptides. In addition, peptide 5 
was also overlaid with symbols demonstrating antigenicity. The antigen index was 
calculated by summing several weighted measures of secondary structure as 
described by Jameson and Wolf (1988). 
The GCG programme MOTIFS was also employed when looking at secondary 
structure; this programme looks for consensus sequences which are consistent 
features of functional domains. 
6.6 RESULTS OF ANALYSIS OF THE C500 HYPOTHETICAL PEPTIDES 
6.6.1 Introduction 
The nine hypothetical peptides were each compared to sequenced peptides using 
PROSRCH and SWEEP. Two -dimensional plots were also prepared for each of 
these peptides, and are included in the remainder of this section where appropriate. 
Peptides 2, 3, 6, and 7 all demonstrated no statistically 
or structurally 
significant homologies to the proteins in the database. The 
remaining 5 peptides 
demonstrated degrees of homology to previously sequenced 
proteins as discussed 
in the remainder of this section, with emphasis on homology 
to other 7- herpesviruses. 
6.6.2 Analysis of peptide 1 
The SWEEP output for peptide 1 demonstrated 
limited homology between this 
peptide and a protein sequence from the 
'y- herpesvirus Bovine herpesvirus -4 
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(BHV -4). The BHV -4 protein exhibited 39% similarity and 18% identity to peptide 
1 over 319 residues (i.e. encompassing the entire length of peptide 1). The quality 
of the match was 108.7, average 100.8 +/ -3.0. 
The BHV -4 protein exhibited homology to EBV BRLF1 ORF (van Santen 1993). 
This EBV ORF encodes an immediate early protein involved in transcription 
regulation as an activator. The BRLF1 ORF is encoded between nucleotides 103,369 
and 105,183 in the EBV genome. The HVS homologue of EBV BRLF1, HVS ORF 
50, is located between bases 70,798 and 72,402 in the HVS genome (Albrecht et al 
1992). The HVS ORF 50 and EBV BRLF1 proteins exhibit highly significant 
homology to each other, as the quality of the match was 230, average 164 +/- 5.3. 
The SWEEP output for peptide 1 did not list matches to either EBV BRLF1 or HVS 
ORF 50, however, peptide 1 was compared with each of these peptides using 
BESTFIT. Peptide 1 demonstrated 40% similarity and 24% identity to BRLF1, 
with the quality being 107.2, average 102.0 +/- 3.3, while 35% similarity and 18% 
identity was observed between peptide 1 and ORF 50, with the quality being 96.1, 
average 97.7 +/- 3.8. The regions of EBV BRLF1 and HVS ORF 50 which were 
matched to peptide 1 by BES "l'F1'l' were compared to each other. This match 
exhibited 42% similarity but only 9% identity and was not statistically significant as 
the quality was 99.8, average 95.1 +/- 3.0. This region of these two peptides, in 
common with peptide 1, demonstrated no consensus sequences for structural motifs 
as listed in the MOTIFS package. 
The ORFs which encoded the BHV -4 peptide, EBV BRLF1 and HVS ORF 50 
consisted of 552, 605 and 535 amino acids respectively, compared to the 301 
residues of peptide 1. These larger peptides were all encoded from a single ORF, 
suggesting that if the homology to peptide 1 was significant, peptide 1 should be 
part of a larger ORF. The location of EBV BRLF1 and HVS ORF 50 is more 
central in their respective genomes than is the terminal location of peptide 
1. 
Co- linearity has recently been established between HVS 
and AHV -1 by 
sequencing small regions interspersed throughout 
the AHV -1 genome (A. 
Ensser, personal communication). The AHV -1 equivalent 
of HVS ORF 50 has 
not yet been sequenced. Regions 5' and 3' to the aligned 
position of HVS ORF 50 in 
the AHV -1 genome have been sequenced. These 
sequences suggest that an AHV -1 
equivalent to HVS ORF 50 is more likely to 
be situated in a similar location to 
that of HVS ORF 50 than the terminal location 
of peptide 1. 
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In conclusion, the statistical significance of the match between peptide 1 and the 
BHV -4 peptide was only just above the 95% confidence limit (i.e 108.7 compared to 
106.8), and when searching 42,215 peptides a random match of this quality is 
possible. 
6.6.3 Analysis of peptide 4 
The PROSRCH output from peptide 4 demonstrated a degree of homology to an 
EBV tegument protein, and to the EBV EBNA1 protein, which is involved in the 
EBV latent cycle (Baer et al 1984, Klein 1989), but neither match was significant. No 
structural features were common to peptide 4 and either EBV protein, therefore the 
matches were regarded as random occurrences. 
6.6.4 Analysis of peptide 5 
The PROSRCH output from peptide 5 demonstrated homology to an EBV 
probable membrane antigen of 140kD which functions as a tegument protein. 
BESTFTI' analysis demonstrated 45% similarity and 19% identity between these 
peptides with the quality being 56.1, average 59.1 +1- 1.9. This match was not 
statistically significant, nor was the match to the HVS 140kD membrane antigen 
equivalent. The structures of the PROSRCH "matched" regions of peptide 5 and 
the EBV protein were compared (figures 6.5a and 6.5b). Both peptides demonstrated 
a hydrophobic region of 15 -20 amino acids at the carboxy terminus of the 
"homologous region ", preceded by approximately 40 residues structured as 13- 
turns. The overall structural similarity of the two peptides was lost upstream of 
this point. The functional significance of the region was assessed using MOTIFS, 
but no known functional motifs were present in this region of either peptide. 
The 140kD EBV tegument protein comprises 1318 amino acids, compared to the 
157 amino acids of peptide 5. Peptide 5 may be an exon of a larger protein, as it is 
encoded close to the terminus of the VIR -2 clone, hence further exons may be 
encoded downstream. 
The limited structural similarity of these two peptides may suggest a 
common 



































































































































































































































6.6.5 Analysis of peptide 8 
Peptide 8 demonstrated homology to a herpes simplex virus 1 (HSV -1) protein ÚL36 (McGeoch et al 1988) by PROSRCH. This HSV -1 protein was related to an EBV tegument protein, HVS ORF 64, an equine herpesvirus 1 protein and a varicella zoster virus protein. BESTF1l' demonstrated 42% homology and 32% identity between peptide 8 and HSV -1 UL36, with the quality being 43.9, average 
39.1 +/- 1.6, but the homology between peptide 8 and the EBV and HVS proteins 
was not statistically significant. No structural homology or functional motifs were 
observed between peptide 8 and the relevant regions of HVS -1 ÚL36, the EBV 
protein, and HVS ORF 64. 
The statistically significant homology between peptide 8 and HSV UL36 was 
possibly due to the proline rich nature of peptide 8, as 18 of the 93 residues are 
proline and 13 of these were involved in the 32% identity observed. 
6.6.6 Analysis of peptide 9 
Peptide 9 demonstrated statistically significant homology to the hypothetical 
peptide encoded by HVS ORF 64, located between bases 89,200 and 96,606 in the 
HVS genome (Albrecht et al 1992). The quality of this match was 49.8, average 
45.2 +/- 1.5, with 38% similarity and 24% identity exhibited. Peptide 9 
displayed little structural similarity to this region of HVS ORF 64, and no known 
functional motifs were observed. When the two peptides were analysed using GCG 
COMPARE then DOTPLOT (see figure 6.6) homology was clearly observed 
between residues 40 -100 of peptide 9 and 305 -365 of ORF 64. This match was 
highly significant as the quality was 32.4, average 20.2 +/- 2.1. 
Peptide 9 comprises 113 amino acids compared to the 2,469 amino acids of HVS 
ORF 64 and the 3,149 amino acids of its EBV homologue, BPLF1, which is located 
centrally in the EBV genome (Baer et al 1984). ORF 64 and BPLF1 are both 
encoded by single ORFs, however, if peptide 9 is part of a larger equivalent protein 
it would have to be comprised of exons. The consensus sequence for a 3' exon 
splice site (discussed in section 6.7), however, was not observed in peptide 9. The 
homology between peptide 9 and ORF 64 nevertheless does appear to be genuine, 
and perhaps the peptides share a common ancestor and function. 
Peptide 9 was encoded by the region of VIR -1 present in all C500 derivatives. 
This ORF was not altered during in vitro propagation of the C500 isolate, but the 
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Figure 6.6 DOTPLOT of peptide 
9 compared with HVS ORF 64 
ORF 64, residues 254 to 372 
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sequence upstream was rearranged in the PP2 and CFA genomes, compared to PP1 DNA, possibly affecting expression. Expression of peptide 9 alone could not be entirely responsible for virulence as the rearrangements which surround this peptide occur in the PP2 derivative, a C500 derivative known to be virulent. 
6.6.7 Comparison of peptide 4 and peptide 6 
The ORFs which encode hypothetical peptides 4 and 6 share common sequence in 
their first 93 amino acids, as both ORFs are located over the region of homology 
loss between VIR -1 and the other two clones. No significant homology was 
observed between these two peptides and other known sequences. 
The peptides both contained potential initiator methionines as their seventh and 
sixteenth amino acid residues. A TATA box promoter of sequence TATAAAA 
was observed 5bp 5' to the first codon of both ORFs. TATA boxes are typically 
located 25 -30bp upstream of the mRNA cap site (Alberts et al 1983), therefore 
this TATA box could act as a promoter for transcription of these peptides from the 
methionine at residue 16. This data suggests that peptides 4 and 6 may be expressed 
at some point during the viral cycle. 
The PP1 genome contained the sequence of both the VIR -1 and VIR -2 clones, 
therefore both peptide 4 and peptide 6 could be transcribed in this C500 derivative. 
The loss of ability to encode peptide 6 occurred as PP1 derivatives were serially 
passaged and subsequently demonstrated the characteristics of the PP2 
population. The PP2 derivative of C500 had retained the ability to infect 
susceptible animals, therefore the loss of the ORF which encodes peptide 6 was 
not directly attributed to loss of virulence of the C500 isolate. 
6.6.8 Comparison of peptide 5 and a small ATT -1 peptide (peptide 10) 
The ORF which encoded peptide 5 was located in VIR -2, over the region where 
homology is lost between VIR -2 and ATT -1. The equivalent ORF in ATT -1 was 
located between nucleotides 3632 and 3832, and encoded 70 amino acid residues. No 
stop signal was observed before the end of the sequenced DNA. The sequence 
of peptide 10 is: 
1 LWLGSEMLAE MLWPAVNMLL PRKALLVDIF FILAATNLMI 
40 AAFALGLLAF YNAEISDLSA DATPLSPGPP 
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The first 51 residues of this peptide were common to peptide 5. No significant 
homology was observed when peptide 10 was compared to other protein sequences 
in the database. 
The seventh, eleventh and eighteenth residues of peptides 5 and 10 are 
methionines. A sequence of TATTTA, an almost exact copy of the SV40 early 
promoter TATTTAT (Laimins et al 1982), was observed 7bp 5' to both ORFs, 
suggesting that either of the methionines at positions 11 and 18 may be initiator 
codons. Figure 6.5a shows a 15 -20 amino acid hydrophobic sequence at the 
carboxy -terminus of peptide 5, representing a possible membrane spanning region. 
The antigenicity plot of peptide 5 (figure 6.7), predicts residues 100 -130 to be 
strongly antigenic. The DNA sequences which encode the hydrophobic and 
antigenic domains of peptide 5 are absent from the CFA genome. These sequences 
are lost as C500 virions adapt from resembling the PP2 population to resembling 
the CFA population, suggesting that peptide 5 may be important in the virulence 
mechanism of the C500 isolate. 
6.7 FURTHER ANALYSIS OF PEPTIDE 1 
Peptide 1 was encoded by the largest C500 ORF sequenced, and was common to all 
three clones. The structure of peptide 1 exhibited a marked polarity in that the 
amino terminus of the peptide was found to be highly hydrophilic, while the carboxy 
terminus was highly hydrophobic. Peptide 1 was located close to the terminal repeats 
of C500, therefore was compared to similarly located peptides in the rhadinovirus 
prototype, HVS (Albrecht et al 1992). 
The ORF closest to the 5' terminus of the HVS subgroup A, strain 
11 encodes a 
HVS transformation- associated protein, STP -A11 (Murthy 
et al 1989). An 
equivalent protein was found in HVS subgroup C, 
strain 488, STP -C488 
(Biesinger et al 1990, Jung et al 1991). Both STP 
-A11 and STP -C488 have 
tumour -inducing activities independent of the rest of 
the genome. The DNA and 
amino acid sequences of these HVS peptides 
demonstrate no identity to other 
known transforming genes and it has been suggested 
that they may represent a new 
class of proteins involved in lymphocyte transformation 
(Jung et al 1991, 



















































































STP -A 11 and STP -C488 exhibit limited amino acid sequence homology to each other, but are structurally similar, as both have acidic amino termini and hydrophobic carboxy termini. STP -C488 codes for 18 directly repeated collagen -like motifs of Gly -X -Y (where either X or Y is proline) located centrally in the peptide (Jung et al 1991). STP -A11 codes for only 9 of these motifs, and these are dispersed throughout the amino terminal portion of the protein (Murthy et al 1989). 
Comparison of figures 6.8a, b and c demonstrates a greater degree of structural 
similarity between peptide 1 and STP -A1 1 than between STP -A11 and STP -C488. 
The isoelectric point for the 32 amino terminal residues of STP -A11 is 3.5, 
compared to a pI of 4.4 for the 17 amino terminal residues of STP -C488. The 
comparable region of peptide 1, from residues 50 -180, has an isoelectric point of 
3.5. The hydrophobic carboxy terminus of peptide 1 is significantly longer than the 
carboxy terminus of either of the HVS proteins, comprising of 100 residues 
compared to 26 and 28 residues in STP -A11 and STP -C488 respectively. Peptide 
1 contains 6 of the collagen -like repeats, interspersed throughout the peptide. 
The three peptides are compared in bar chart form in figure 6.9 (adapted from Jung 
et al 1991). 
STP -All and STP -C488 both begin with a methionine. In contrast, peptide 1 neither 
begins with a methionine, nor does it code for a methionine close to the amino 
terminus. In addition, a TATA box promoter was not observed upstream of this 
reading frame. Lack of these transcription initiation features suggest that this 
sequence may be an exon. 
A consensus sequence for 3' exon splice sites is conserved throughout eukaryotes. 
The sequence consists of a pyrimidine rich region of variable length (but always 
more than 10 nucleotides) followed by a short consensus sequence extending 
only 3 residues upstream and 1 residue downstream of the splice point. This 
sequence is (Py)nNPyAGG, with Py representing pyrimidines and the final G being 
the first nucleotide of the exon. The AGG of this sequence is almost invariant 
(Watson et al 1987). The closest match to this consensus sequence was located 
between nucleotides 862 -882 of ATT -1 (TCTCTGCTGTTTGCACCAAGG) 
which encode residues 6 -13 of peptide 1. The first coding base of 
the exon would 
be 882, corresponding to amino acid 13 (see figure 6.4). The 
region encodes the 
criteria for a 3' splice site with the exception of base 



















































































































































































































































































































































































































































































































































































































































pyrimidine but is an adenine (reviewed in Watson et al 1987, Jackson 1991). In 
conclusion, amino acid 13 of peptide 1, glutamine, may be the first amino acid of this 
exon. 
6.8 AN 01IV -2 HOMOLOGUE OF PEPTIDE 1 
The ORF which encoded peptide 1 was observed in the PP1, PP2 and CFA 
derivatives of C500. OHV -2 is closely related to AHV -1, therefore a peptide 1 
homologue was looked for in the OHV -2 genome. The OHV -2 DNA has not yet 
been isolated as an intact genome, therefore OHV -2 DNA was isolated from 
immortalised T- lymphocytes derived from cattle affected with OHV -2 induced MCF 
(Reid et al 1989). 
A PCR using oligonucleotides from the DNA sequence located to the 5' and 3' ends 
of the ORF which encodes peptide 1 (P8 and Pl1 in appendix 3) was carried out 
using 500ng of DNA from each of two immortalised cell -lines (kindly prepared by 
Miss I Pow). The reaction conditions were as described in 2.8.20 F. Identical 
reactions were carried out with inputs of 100ng of PP1, CFA and WC11 DNA 
respectively. The WC11 DNA was included to ascertain whether peptide 1 was 
present in this AHV -1 isolate. 
A product of 1050bp was observed in all five PCR reactions. These products 
were probed with fragment B in figure 3.12, which is located internal to the PCR 
primers used, and homology was observed (see figure 6.10), demonstrating that the 
region of the C500 genome which encodes peptide 1 is also present in WC11 and 
in OHV -2. The region which encodes peptide 1 appears to be highly conserved 
between the two AHV -1 isolates and between AHV -1 and OHV -2. An additional 
PCR using P3 and P14 was used to amplify a 400bp fragment internal to P8 and 
Pi i (see appendix 3). A product of 400bp was observed when the DNA from the 
OHV -2 immortalised cell -lines was used as target (data not shown). 
6.9 SEARCHING THE C500 SEQUENCE FOR THE PRESENCE OF U RNAS 
Cells of all vertebrate species contain 6 different small nuclear RNAs (U1-U6), 
ranging in size from 100 -215 nucleotides, which are complexed with proteins to 
form small nuclear ribonucleoproteins (snRNPs). snRNPs are involved in pre - 
mRNA splicing and processing (reviewed in Maniatis and Reed 1987). Marmoset 
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Figure 6.10 








1 2 3 4 5 6 
lkb ladder 
01W -2 cell-line 1 PCR 
01W -2 cell-line 2 PCR 
PP C500 PCR 
CFA C500 PCR 
WC11 PCR 
Tracks 2 -6 were probed with fragment B from Figure 3.12 
169 
T lymphocytes transformed with HVS contain the first virally encoded U RNAs 
(known as HSURs) to be identified. Their sequences are related to each other but 
are distinct from any previously characterised cellular U RNA (Lee et al 1988), and 
are encoded adjacent to STP -A11 in HVS strain 11 (Albrecht et al 1992). These 
HSURs contained three consensus sequences (Albrecht and Fleckenstein 1992): 
sm -site AUUUUUG 
stem GGCNCTGG 
stem CCAGNGCC 
C500 homologues of these sequences were searched for using BES lFI'T to analyse 
each consensus sequence individually. Near -perfect matches were observed to each 
of these sequences, but the matches were too distant from each other to be coding 
for HSUR equivalents, since HSURs range in size from 75 to 140 nucleotides 
(Murthy et al 1986). 
6.10 DISCUSSION 
The sequence of the C500 genome represented by the three clones, ATT -1, VIR -1 
and VIR -2, was compared to all other DNA sequences entered in the EMBL DNA 
database. No significant homology was observed. 
The G +C content of the cloned DNA was consistent with other rhadinoviruses, 
and the CpG ratio was consistent with y- herpesviruses as a whole. The short 
repeated regions observed were also a common feature of y- herpesviruses. 
Exhaustive analysis of hypothetical peptides both via amino acid sequence and 
structural similarity revealed very little homology to sequences in the database. The 
most statistically significant homology observed was between a short region of 
peptide 9 and HVS ORF 64, however the biological significance of this homology is 
not known. The best structural homology observed was between peptide 1 and the 
HVS transforming protein STP-A1 1. It is not known at present whether peptide 1 
is expressed in active Ally-1 or OHV -2 infection, nor if this hypothetical peptide 
has transforming ability. The pathogenesis of MCF is not yet fully understood, 
however, AHV -1 and OHV -2 both have the ability to immortalise T- lymphocytes 
(Wilkinson et al 1992, Reid et al 1989a). Peptide 1 may function in a similar 
manner to STP -All and STP -C488 and may have the potential to transform 
lymphocytes. However, the presence of two copies of peptide 1 in the attenuated 
C500 genome (see chapter 4) suggests that peptide 1 may not be the AHV -1 
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equivalent of the HVS STPs, or that additional factors are required in order for 
peptide 1 to be functional. 
The sequence encoding peptide 6 was known to be genomically altered during in 
vitro propagation of C500 virus, such that the ORF encoding peptide 6 was 
present in the PP1 derivative but absent from the PP2 and CFA derivatives. 
However, the first 76 residues from the initiator methionine were included in 
peptide 4, which was present in all three C500 derivatives. The loss of peptide 6 
did not appear to be directly related to loss of virulence of the C500 molecule. 
The sequence analysis described in this chapter identified a potential coding region 
which may be involved with virulence, i.e. the ORF for peptide 5. The final 106 
amino acids of this sequence encodes the potential antigenic and membrane 
spanning regions of the peptide, and is absent from the CFA genome. This sequence 
is lost from the C500 genome, implying that peptide 5 may be a factor required for 
virulence. 
In conclusion, the region of the C500 genome sequenced showed little homology 
to other sequences in the DNA or protein databases. The ORF which encodes 






The C500 isolate of AHV -1 is altered on serial passage in cell culture, resulting in a 
loss of virulence. The aim of this project was to identify and characterise the region 
of the C500 genome correlated with virulence. This chapter discusses the combined 
results described in chapters 3, 4, 5 and 6. 
7.2 THE BIOLOGICAL SIGNIFICANCE OF THE GENOMIC 
ALTERATIONS OBSERVED 
Following isolation and for the first few passages in vitro the C500 isolate of AHV -1 
was cell- associated and capable of producing MCF on inoculation into susceptible 
hosts. On additional passage, the virus became cell -free, retaining virulence, until 
finally it became attenuated (and cell- free). Molecular comparison of viral DNA 
using the restriction endonuclease Sma I demonstrated consistent profiles defining 
stages in this attenuation process. The initial population observed during in vitro 
propagation was PP1. The PP1 derivative represented virulent cell- associated 
C500 virions. The PP1 derivative characteristics were lost on further passage, 
and the virions observed exhibited characteristics of the PP2 population. 
Although the PP2 derivative was described as cell- associated in chapter 5, PP2 DNA 
was also recovered from cell -free virions in the supernatants of PP2 infected cultures. 
The PP1 and PP2 genomes were not observed together in any of the C500 viral 
preparations studied, suggesting that the rearrangement of the PP1 genome which 
results in the PP2 organisation must be extremely advantageous in the artificial 
environment of in vitro culture, as the PP2 arrangement quickly becomes prevalent. 
One advantage that PP2 virions may have over PP1 virions is that PP2 virions 
may exist in a cell -free form. The PP1 infectivity in vitro is largely cell- associated 
and infection appears to pass by cell contact, as illustrated by the syncytia in figure 
3.1a. The production of a cell -free virus would allow a more rapid spread of 
infection in the monolayer, and therefore would present a large replicative 
advantage. 
The genomic reorganisation whereby PP2 virions were replaced by virions 
exhibiting the characteristics of the CFA genome was a more gradual transition, 
as mixed populations of PP2 and CFA virions (originally defined as CA virus) 
were observed over several passages (4 -10), before the CFA organisation became 
dominant. The CFA virions were presumably more replication competent in vitro 
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than their PP1 and PP2 predecessors. The 3.8kbp Sma I fragment observed in C500 
attenuated virus hybridised to a fragment of similar size in the standard isolate of 
AHV -1 (WC11), which had also become attenuated as a result of in vitro passage 
(Plowright et al 1965). This suggested that the two attenuated derivatives from 
different isolates were rearranged in a similar manner as a result of serial passage in 
tissue culture. This strengthens the suggestion that the genomic alterations identified 
in this study during the process of attenuation are related to loss of virulence. 
The proposed sequential rearrangements of the C500 genome (see figure 5.23) 
illustrate the in vitro alterations of the 3' terminal unique region sequence. A 
second copy of ATT -1 was observed at the 5' end of the CFA unique region, yet 
VIR -1 and VIR -2 equivalents were not found as close to the 5' termini of PP1 and 
PP2. The total DNA lost in the two transitions from PP1 to CFA was >3.8kbp, while 
the size of the ATT -1 clone was 3.8kbp, therefore the length of the unique region is 
approximately the same for both the PP1 and CFA genomes. Conservation of 
genome size has been observed in several 7- herpesviruses. The unique region of 
BHV -4 has been shown to differ by as little as lkbp (in a 112kbp sequence) in four 
different strains, suggesting that size constraints are important (Bublot et al 1990). 
The EBV genome length also appears to be strictly conserved as the B95 -8 strain has 
a 12kbp deletion, compared to other strains, but this is apparently compensated for by 
an increase in the number of copies of the internal repeat unit (Bornkamm et al 
1980, Hayward et al 1980). It has been suggested that a genome length is maintained 
which is optimal for encapsidation (Miller 1984). In HVS the replication 
mechanism is believed to be by concatameric replication, with the enzyme 
responsible for cleaving and packaging individual molecules cutting at random 
in one of the repeat units. The second cleavage site is then restricted such that 
overall genome size is conserved (Stamminger et al 1987). One HVS strain, SMHI, 
lost oncogenicity as a result of serial passage in vero cells, generating SMHI- 
VERO. Genomic analysis revealed that the SMHI -VERO derivative differed 
from SMHI by a deletion of approximately 6.6kbp at the 5' terminus of the 
unique sequence. In addition, a fragment of L -DNA was inserted into the H -DNA 
of SMHI -VERO. This inserted DNA was an inverted repetition of a 5.6kbp region of 
the 3' end of L -DNA (Daniel et al 1980). The effect of this duplication was that 
genome length was approximately conserved between the SMHI strain and its 
attenuated derivative. The second copy of the ATT -1 clone in the C500 genome 
may be present to conserve genome size to allow efficient replication and packaging. 
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The second copy of the ATT -1 clone observed in the CFA genome may have arisen 
from a random duplication to conserve genome length. This seems unlikely 
because, if the duplication was a random event, the different derivatives would be 
expected to yield different duplicated fragments. The results described in chapter 
4 were produced using different preparations of C500 virus, yet the same 
sequence was always present twice (i.e. ATT -1). This suggests that duplication of 
the ATT -1 sequence presents a replicative advantage. The attenuated AHV -1 
isolate, WC11, also contains a Sma I fragment of 3.8kbp, which is homologous to 
ATT -1. It has not been determined whether WC11 contains one or two copies of this 
sequence. 
The mechanism which results in duplication of the ATT -1 clone in the CFA genome 
is not understood. In addition, it has not been established whether the PP2 
genome undergoes two sequential rearrangements, with deletion of the 1.2kbp 
fragment being the first event, and duplication of ATT -1 being the second. 
Alternatively, the deletion and duplication events may occur simultaneously. 
7.3 ALTERED READING FRAMES AS A RESULT OF ATTENUATION 
The proposed genomic locations of VER-1, VW-2 and ATT -1 in the PP1, PP2 and 
CFA derivatives were compared to assess which ORFs were altered as a result of 
serial passage, as demonstrated in figure 7.1. The PP2 genome differs from the PP1 
genome by a deletion of fragment B and the region of VIR -1 encoding peptides 1, 2, 
3 and 6. The CFA genome differs from the PP2 genome by deletion of the 800óp 
sequence and peptide 5. In addition, the ability of the C500 virus to cause MCF in 
rabbits is lost in the transition from PP2 to CFA. 
The biological properties of the three C500 derivatives have bearing on the 
interpretation of the ORFs which are altered as a result of serial passage. The PP1 
derivative is cell- associated and represents the first C500 genomic arrangement 
observed on isolation in cell -culture of virus from experimentally infected rabbits. 
The PP2 genomic arrangement is found in both cell- associated and cell -free 
forms, and inoculation of a rabbit with PP2 virus resulted in MCF. CFA virus is 
largely cell -free, and is avirulent for rabbits. 
C500 virus was isolated in tissue culture from a naturally occurring case of MCF in a 



























































































































































unspecified number of passages as frozen infected rabbit lymph nodes and spleen. 
This isolate has been maintained as stocks of frozen suspensions of lymph node and 
spleen cells in 10% DMSO in liquid nitrogen and periodically passaged in rabbits. 
When isolated from infected rabbits and propagated in tissue culture PP1 viral 
infectivity was largely cell -associated, although infectious cell -free AHV -1 virus is 
found in the ocular and nasal secretions of young wildebeest calves (Mushi and 
Rurangirwa 1981). The PP2 derivative was isolated from infected tissue culture 
supernatants in a cell -free form, and therefore the possibility that this derivative was 
more closely related to the wildebeest form was considered. However, the MCF 
affected animal acts as a dead end host and apparently does not produce cell -free 
virus on natural infection from the wildebeest (Mushi and Rurangirwa 1981), nor on 
infection by inoculation. The PP1 genomic arrangement was therefore considered as 
being the most closely related C500 derivative to the wildebeest virus. 
The rearrangement of the C500 genome in the transition from PP1 to PP2 virions 
results in the loss of peptide 6 and relocation of peptides 7, 8 and 9. Peptide 6 is 
closely related to peptide 4. The two peptides are identical in their first 93 amino 
acids, with their overall sizes being 106 and 215 amino acids respectively. Peptide 6 
may have arisen from a duplication of peptides 1, 2 and 3 in the evolution of the 
virus, and therefore may be non -functional. Alternatively peptide 6 may act to inhibit 
the formation of cell -free virions. 
The rearrangement of peptides 7, 8 and 9 in the transition from PP1 to PP2 may 
result in these peptides being located closer to promoters or enhancers, thus 
expression of one or all of peptides 7, 8 and 9 may be related to the cell -free 
properties of the PP2 derivative. 
Comparison of the PP2 and CFA genomes demonstrated a deletion of the 800bp 
unsequenced region and the ORF for peptide 5, suggesting that the 800bp region 
and/or peptide 5 were necessary for virulence. Attempts to clone this 800óp region, 
and to amplify the region by PCR were unsuccessful. Preliminary attempts to assess 
whether peptide 5 is expressed during PP1 infection of bovine thyroid cells by 
Northern blot analysis of mRNA have been unsuccessful, however it is possible that 
peptide 5 may not be expressed in vitro, but may be expressed in MCF affected 
animals. In addition, the expression of peptide 5 may be extremely short- lived, and 
may be transcribed in a low copy number. 
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The significance of two copies of the ATT -1 clone in the CFA genome with regard 
to the ORFs duplicated has not been elucidated. Perhaps peptides 1 -4 are important 
for in vitro propagation of the virus, and second copies result in up- regulations of 
1 or all of peptides 1 -4. The observation that peptides 1, 2 and 3 are present 
twice in the PP1 genome, once in the PP2 genome and twice in the CFA genome is 
difficult to interpret with regard to the differences between the three C500 
derivatives. Perhaps peptide 4, which is present once in PP1 and PP2, but twice in 
CFA, is involved in increasing the replication competence of CFA virions. 
Peptide 1 exhibited structural similarities to the HVS transforming genes STP -All 
and STP -C488 as described in chapter 6. However, the transforming genes were 
deleted from two HVS strains which exhibited attenuation as a result of in vitro 
propagation. (Daniel et al 1980, Koomey et al 1984). The presence of two copies of 
peptide 1 in the CFA derivative, with one of these copies in an identical location to 
that observed in PP2, was in direct contrast to the absence of the STPs in HVS 
attenuated derivatives, and suggested that peptide 1 was not functionally similar to 
the STPs. Peptide 5, although not exhibiting structural homology to the HVS STPs, 
may be the AHV -1 equivalent. The pathogenesis of MCF is not fully understood (see 
section 1.7), however, the development of a T cell -line from lymph node cells of a 
rabbit infected with AHV -1 (Wilkinson et al 1992) suggests a transformation- related 
mechanism, analagous to the development of a lymphoid cell -line from infection 
with HVS (Schirm et al 1984). 
Peptides 7, 8 and 9 may be involved in the virulence of the C500 isolate, as the 
sequence upstream of these peptides is altered between PP2 and CFA genomes, 
possibly affecting expression. 
7.4 POSSIBLE RECOMBINATION FEATURES OF THE C500 SEQUENCE 
The genomic rearrangements documented in the previous chapters, and the 
sequence data generated, were analysed in an attempt to discover recombination 
mechanisms. Throughout the course of this work various possible recombination 
mechanisms have been considered. The presence of large, internal, inverted 
duplications of terminal sequences, correlating with high frequency inversion of the 
unique sequence elements enclosed in these duplications, has been reported in 
herpesviruses, and results in either two or four isomeric forms (summarised by 
Honess 1984). However, the rhadinovirus prototype, HVS, exists in only one 
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isomeric form (Roizman 1990). The mapping of the AHV -1 isolate WC11 
suggested that the genomic arrangement was similar to that of HVS ( Bridgen et 
al 1989, Bridgen 1991). The presence of two isomers of C500 would account for the 
two copies of ATT -1 at either end of the genome, if the entire unique region of the 
C500 genome was inverted. The observation that the two copies of ATT -1 are 
present in the same orientation suggests that inversion is not the method of 
recombination. The mechanism by which the ATT -1 clone is duplicated is not 
known, but may be linked to its proximity to the terminal repeat units of the 
genome. 
The limited sequence data generated from the three molecular clones exhibited 
two short regions of repeated DNA, both located within the VIR -1 clone (see 
section 3.13.3). Second copies of these repeat regions were not observed in the 
remainder of the region sequenced. The two copies of the 85bp repeat are situated 
in the region of the breakpoint of the VIR -1 clone which occurs in the transition 
from PP1 to PP2 genomes, presenting the possibility that this region is somehow 
involved in the rearrangements observed. 
A consensus sequence was observed before the two points of homology loss (see 
section 3.15). In the transition from PP1 to PP2 (see figure 5.23) the consensus 
sequence in occurs upstream of the breakpoint in 
homology with the other two clones (i.e. base 1923). The deleted sequence includes 
residues 1 to 1923 of the VIR -1 clone. The exact size of fragment lost from the PP1 
genome has not been determined, but the Southern blotting analysis suggests that the 
deletion ends close to the breakpoint at base 1923. Thus the consensus sequence is 
encoded within the region which becomes deleted, and possibly marks the end of 
the deletion. In contrast, the location of the consensus sequence in the VIR -2 clone, 
in the PP2 genome, is before the fragment deleted in the transition from PP2 to 
CFA, and therefore probably marks the start of the deletion. 
One possible explanation for the consensus sequence being present before the start 
of one deletion, and before the end of another is that the sequence is recognised 
by a cleaving enzyme. This enzyme is presumably influenced by other factors to 
determine which recognition sites should be cleaved in different environments, as 
the VIR -2 clone contains a second consensus sequence (upstream of base 1923), 
which is not cleaved in either rearrangement. In order to facilitate the two 
sequential deletions in the transition from PP1 to CFA a further copy of the 
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consensus sequence may be present within the unsequenced 800óp region, to 
mark the start of the PP1 -PP2 deletion, and to be deleted itself in the PP2 -CFA 
deletion. 
The presence of internal copies of the repeat unit was also considered as a 
mechanism by which the C500 genome may recombine. The ladders observed, using 
the various clones as probe (see chapters 4 and 5), all produced large sized 
fragments, suggesting that if internal copies of the repeat units existed, there must 
be multiple copies present. In addition the WC11 mapping studies did not suggest 
the presence of internal repeats ( Bridgen 1991). 
In conclusion, the recombination mechanism which results in the C500 
derivatives observed was not resolved in the course of this study, but a consensus 
sequence located close to the breakpoints was identified as a possible cleavage 
signal. 
7.5 COMPARISON TO OTHER GAMMAHERPESVIRUSES 
Infection of susceptible hosts with AHV -1 or OHV -2 results in MCF. The clinical 
features of the disease caused by these two agents are similar and the viruses are 
thought to be closely related (see chapter 1). The amplification of an OHV -2 
sequence, identical in size and homologous to the equivalent AHV -1 fragment (see 
section 6.9), demonstrated further the similarities between the two viruses. In 
addition, this amplification also demonstrated that the ORF for peptide 1 is 
conserved between AHV -1 and OHV -2. 
The most closely related completely sequenced gammaherpesvirus to AHV -1 is 
HVS. The two genomes share the common features of multiple copies of 
tandemly arrayed, terminally located repeat units flanking an internal unique 
sequence (Bornkamm et al 1976, Bridgen 1991). The 5' terminus of the HVS 
genome encodes the genes responsible for the transforming ability of HVS (Beisinger 
et al 1990, Jung et al 1991, Jung and Desrosiers 1991). The region of the C500 
genome containing the DNA sequence which is rearranged as a result of in vitro 
propagation was arbitrarily labelled as being adjacent to the 3' end of the unique 
region in chapters 4 and 5. Preliminary observations from sequencing short regions 
throughout the C500 genome have indicated that, in general, collinearity exists 
between C500 and HVS (A Ensser, personal communication). If the rearranged 
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C500 region contains ORFs with a similar function to the 5' HVS sequences then 
the unique region of the C500 genome represented by VIR -1, VIR -2 and ATT -1 
should be re- orientated such that sequence formerly discussed as being 3' terminal 
would become 5' terminal. In the remainder of this chapter the region originally 
described as 3' in the C500 genome will be referred to as 5' to facilitate easier 
comparisons to other 7- herpesviruses. 
HVS strains have been shown to vary greatly in the 5' terminal 7kbp region 
(Medveczky et al 1984). A contiguous 4.5kbp sequence of this region was found 
to be unnecessary for viral replication in cultured cells, but essential for the 
oncogenic potential of the strain (Desrosiers et al 1984 and 1985). The genomic 
alterations occurring in the 5' region of C500 result in loss of virulence, but 
replication in cell culture is enhanced. Two attenuated strains derived from 
adjustments to culturing conditions, strain 11 att and SMH1 -VERO, both exhibited 
spontaneous deletions in the 7kbp 5' unique region. In strain llatt a terminal 
fragment of 2.3kbp was deleted, and in SMH1 -VERO a deletion of approximately 
6.6kbp occurred (Koomey et al 1984, Daniel et al 1980). The attenuated derivative 
of C500, in comparison, differed from the virulent parental virus by loss of >3.8kbp. 
The Herpesvirus ateles (HVA) genome exhibits general collinearity to HVS, with the 
exception of the 5' 4kbp unique region. Infection of susceptible hosts with HVA 
results in similar characteristics to those observed in HVS- induced malignancy 
(Falk 1980), but none of the ORFs in the HVA terminal region demonstrate 
homology to the HVS transforming proteins. However, HVA does encode two U 
RNAs in this region, which share homology with the HSURs (DeGrand and Mulder 
1992). The C500 DNA sequenced did not encode any U RNAs, however, the 
general loss of collinearity exhibited between HVS and HVA was reflected in the 5' 
unique region of C500. 
The lymphocryptovirus EBV has also been completely sequenced. The organisation 
of the EBV genome is generally collinear to the HVS genome, however, the genes 
responsible for the transforming ability of EBV are not arranged collinearly to the 
STPs of HVS. In addition no nucleic acid or amino acid sequence homology exists 
between the transforming genes of HVS or EBV (Albrecht et al 1992). The ORFs 
identified in this study of AHV -1 did not demonstrate significant homology to the 
genes responsible for the transforming ability of HVS or EBV, despite the general 
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collinearity between HVS, (and by implication EBV), (A. Ensser, personal 
communication). 
The genes involved in the transforming ability of EBV are also involved in latent 
expression of the EBV genome. The three best characterised latent EBV transcripts 
are: EBV nuclear antigen (EBNA) 1, which is involved in activating transcription of 
the latent genome; EBNA 2, which is required for the initiation of lymphocyte 
transformation, and latent membrane protein (LMP), which has oncogenic effects 
(reviewed by Miller 1990). AHV -1 may be expressed in a similar manner to EBV, 
thus the lymphoproliferative effects of AHV -1 observed in susceptible hosts may be 
the result of expression of products of latent rather than lytic expression. In the 
natural host initial infection with AHV -1 is associated with at least some productive 
replication and release of cell -free virus (Mushi and Rurangirwa 1981) which readily 
spreads by contagion. Persistance of AHV -1 infection in this host is then in a latent 
form. The course of infection in MCF susceptible hosts is obscure, but no contagious 
spread is observed and very limited virus transcription appears to occur, although 
cell- associated infectivity can be demonstrated. In affected tissues very little if any 
viral antigen or DNA can be demonstrated (see section 1.8) and it may be that virus 
transcription is limited to that associated with latency in the natural host, however, in 
the inappropriate host these products lead to the immune deregulation recognised as 
MCF. Alternatively expression of specific latent products may vary depending on 
the host. Studies of EBV- associated disease in immunocompromised 
individuals showed differential expression of latent products. In Burkitt's lymphoma 
tissue samples demonstrated EBNA 1 alone, while nasopharyngeal carcinoma 
tissues contained EBNA 1 and a proportion (40 %) of tissues also demonstrated 
LMP. In contrast, tissues from lymphoproliferative disease associated with EBV 
contained EBNA 1, EBNA 2 and LMP (Cohen 1991). 
In vitro propagation of AHV -1 resulted in attenuation, both of the C500 isolate and 
the WC11 isolate. In this artificial environment the result of AHV -1 infection of 
bovine monolayers is target cell lysis, suggesting that the virus is acting in a 
replicative rather than latent manner. Thus the genes encoding the peptides 
necessary for the establishment of latency would not be required in vitro. Perhaps 
these genes are deleted in the CFA genome, hence CFA virus would subsequently be 
unable to establish latency, and therefore virulence would be lost. 
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The gene encoding the latently expressed EBNA -2 protein is essential for the 
lymphocyte transformation associated with EBV (Hammershmidt and Sugden 1989). 
A laboratory derived strain, P3HR -1, which lacks a DNA segment that includes the 
EBNA -2 gene and part of the EBNA leader protein gene will not transform 
lymphocytes (King et al 1982, Rabson et al 1982). Recombinant transformation - 
competent EBV was produced by transfecting P3HR -1- infected cells with a cosmid 
vector containing EBNA -2 (Cohen et al 1989). Further studies suggested that 
EBNA -2 plays an important dual role in the process of B cell activation to the 
lymphoblastoid phenotype; the protein can have a direct role upon cellular gene 
expression and is also involved in activating the expression of a second virus 
encoded effector protein, LMP (Abbot et al 1990). The ORF for peptide 5, and the 
800óp region, were deleted in the attenuated C500 genome, thus peptide 5 may have 
a similar role to that of EBNA -2 in the pathogenesis of MCF. 
The switch between latency and replication of EBV is controlled by expression of a 
single polypeptide, designated ZEBRA (Bam HI fragment Z, EBV replication 
activator), (Grogan et al 1987). The possible AHV -1 equivalent(s) to this ZEBRA 
protein would be peptides 7, 8 and 9, as the sequence 5' to these ORFs is altered as 
the virus becomes more replication competent. This rearrangement may result in 
these peptides being located close to promoter sequences. 
Certain defective EBVs with deleted and rearranged genomes do not establish latency 
(Miller et al 1984). The P3HR -1 strain of EBV was found to contain a proportion of 
defective genomes, termed het DNA. This het DNA was extensively deleted and 
rearranged, and the gene for ZEBRA was under positive regulation (reviewed by 
Miller 1990). The het DNA genome is an example of defective interfering particles 
(DIP). DIP are described as subgenomic deletion mutants, generated from infectious 
particles, which are capable of modulating infections. DIP frequently play an 
important part in viral persistance in vitro, and may, in some instances, modify viral 
infections in vivo, causing attenuation or persistance of an infection. Successive 
passages in vitro, using a high multiplicity of infection, frequently give rise to 
DIP (summarised by Roux et al 1990). However, DIP are not believed to be 
involved in the attenuation of AHV -1 observed as a result of in vitro propagation, 
due to the biological cloning of the virus preparations carried out at various time 
points during cell culture. 
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7.7 CONCLUSIONS 
The aim of this project was to investigate the genomic arrangements occuring in 
vitro which result in loss of virulence of the C500 isolate of AHV -1. The variable 
regions observed initially from Sma I digests of the C500 derivatives were 
representative of two sequential genomic alterations which resulted in 
attenuation. The significance of these rearrangements was investigated by 
sequencing the three molecular clones derived from the C500 derivatives, and by 
assessing their location with regard to the terminal repeats of the molecule. The 3' 
region of the ORF which encodes peptide 5 was lost when the virus became 
attenuated, and therefore peptide 5 appeared to be the most likely candidate for 
involvement in the latency /transformation mechanism of the virus. In addition, the 
800bp region adjacent to this ORF was also deleted in the transition from 
virulence to attenuation, therefore may encode peptide(s) involved in virulent 
infection of susceptible hosts. The failure to clone this region, and the inability 
to amplify the region using PCR suggested that the DNA encoded in this region 
contains obstructive structural features. 
7.8 FUTURE WORK 
The work carried out in this project offers many possibilities for future studies to 
extend the data presented. The 800bp uncloned and unsequenced deleted region 
requires to be cloned, using an enzyme other than Sma I. The previous attempts to 
clone and amlify this region suggest that sequencing of the region may be 
problematic, however, once cloned, this should be attempted. 
The proposed genomic rearrangements of the C500 isolate during in vitro 
propagation need to be confirmed. One method to achieve this would be to carry out 
double digests of PP1 and PP2 DNA using various combinations of the restriction 
endonucleases Hind II, Hind III, Sac I and Sma I, as all fragment sizes could be 
predicted. This work was not undertaken in the present study due to difficulties in 
generating sufficient viral DNA. 
The aim of this work was to determine the factors important for the virulence of 
the C500 isolate of AHV -1. The ORF for peptide 5 appears to be important in 
maintaining virulence, as loss of this ORF correlates with attenuation. Extensive 
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expression studies should be undertaken to establish whether this peptide is 
expressed in vivo and in vitro. Preliminary expression studies have consisted of 
Northern blot analysis of PP1 tissue culture mRNA products. No hybridisation to 
peptide 5 was observed, however, if peptide 5 is important for latency then it may not 
be expressed in tissue culture. Further studies to assess whether peptide 5 is 
expressed may require in situ hybridisation analysis of samples from affected 
animals. As the virus has only been detected in 1 in 104 cells in affected animals 
(Bridgen et al 1992), very little viral messsage may be present. The lymphoblastoid 
cell -lines developed from AHV -1 and OHV -2 affected animals (Wilkinson et al 
1992, Reid et al 1983 and 1989a) may express peptide 5, therefore Northern blot 
analysis of mRNA produced by these cell -lines should be undertaken. 
Studies to determine which of the nine hypothetical peptides identified in this study 
are expressed during in vitro propagation should also be undertaken. The proposed 
genomic rearrangements of the three C500 derivatives, coupled with the 
interpretation of the significance of the ORFs altered as described in this chapter 
suggest that one or all of peptides 7, 8 and 9 might be expressed in PP2 and CFA but 
not PP1 infection of cells of bovine lineage. In addition, expression of peptides 1 -4 
may be upregulated on infection with CFA virus. 
Peptide 5 may be the AHV -1 analogue the HVS transforming peptides (STPs), or 
to EBNA -2, and experiments to assess whether co- transfection of peptide 5 with the 
CFA genome may result in recombination events and virulent infection should be 
undertaken. Preliminary attempts to transfect bovine thyroid cells with the intact 
CFA genome have proved unsuccessful, however, to date the only method attempted 
has been by calcium chloride. Future studies should involve alternative methods of 
transfection such as electroporation. If peptide 5 is an analogue to the HVS STP 
peptides then it may be responsible for the generation of T lymphocytes 
immmortalised by AHV -1. HVS has been used to transform human CD4+ and CD8+ 
cells in vitro (Beisinger et al 1992). This immortalisation overcomes the problems of 
the necessity of periodic restimulation involved in the maintenance of human T cells. 
The immortalised cells can be used as a model to study signal transduction in 
activated human T lymphocytes (Broker et al 1993). Future work should include 
investigations into the possible use of AHV -1 to immortalise bovine T lymphocytes 
to facilitate immunological studies. 
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The sequence generated from the three C500 clones could be used to develop a 
diagnostic PCR. The observation that peptide 1 was also amplified from OHV -2 
DNA with the C500 primers suggests that a PCR developed from this region of the 
clones would not be AHV -1 specific. PCR to determine whether peptide 5 is present 
in OHV -2 should also be undertaken, because if peptide 5 is vital to the pathogenic 
effects of MCF then a peptide 5 homologue would be anticipated in the OHV -2 
genome. 
The comparison of virulent and non -virulent AHV -1 derivatives described in this 
thesis has led to the identification of a variable region of the AHV -1 genome which is 
correlated with the ability of the virus to induce MCF when used to inoculate rabbits. 
The future applications of the data described may not only increase our understanding 
of the pathogenesis of MCF, but may also be used to explore the possibility of 
immunisation of susceptible animals with specific deletion mutants, and, more 
generally, as a tool in the study of bovine immunity. 
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Appendices 
Appendix 1 Suppliers 
AMERSHAM - Amersham, Buckinghamshire, U.K. 
BDH - Poole, Dorset, U.K. 
BECKMAN - High Wickham, Buckinghamshire, U.K. 
BIORAD - Hemel Hempstead, Hertfordshire, U.K. 
BOEHRINGER MANNHEIM - Lewes, East Sussex U.K. 
CAMBIO LIMITED - Cambridge, U.K. 
DIFCO - East Molesey, Surrey, U.K. 
FUNGAZONE - E.R. Squibb, Hounslow, Middlesex, U.K. 
FISONS (SCOTLAB) - Coatbridge, U.K. 
GENETIC RESEARCH INSTRUMENTATION LIMITED - Dunmow, Essex, U.K. 
GIBCO BRL - Uxbridge, Middlesex, U.K. 
HYBAID - Teddington, Middlesex, U.K. 
NOVABIOCHEM - Nottingham, U.K. 
OSWELL DNA - Edinburgh, U.K. 
PERKIN ELMER CETUS - Norwalk, Connecticut, U.S.A. 
PHARMACIA - Milton Keynes, U.K. 
PROMEGA - Southampton, U.K. 
SIGMA - Poole, Dorset, U.K. 
STRATAGENE - Cambridge, U.K. 
STRATECH SCIENTIFIC LIMITED - London, U.K. 
201 
Appendix 2 Description of the experiments carried out to map the ATT -1, 
VIR -1 and VIR -2 clones 
A2.1 The mapping of ATT -1 
The ATT -1 clone was initially mapped with the restriction endonucleases (REs) 
which have sites in the polylinker of pBS+ (see figure 2.2). The REs which had 
sites in the insert are listed in figure A2.1a, with the relevant sizes calculated 
accurately following the complete sequencing of the clone as described in chapter 3. 
The location of each RE site in the insert relative to its location in the polylinker 
allowed mapping if a site was present only once in the insert, as only two fragments 
would be produced on digestion of ATT -1, and a process of simple deduction located 
some RE sites. Thus the insert was mapped for Hind II, Hind HE and Sph I on RE 
data alone. In addition the insert fragments ligated to pBS+ were also mapped for 
Kpn I and Pst I. This initial mapping data is shown in figure A2.lb. 
The clone was mapped for Kpn I by using the 2572 and 339bp fragments 
respectively to probe Hind II and Hind III digests of ATT -1. The 2572bp fragment 
hybridised to both Hind II and both Hind III fragments, while the 339bp fragment 
hybridised to the Hind II 2857bp and the Hind III 3197bp fragments respectively. 
This meant that the 2572bp Kpn I fragment was located adjacent to the 5' end of the 
ATT -1 clone. 
The clone was mapped for Pst I by probing Hind II, Hind III, Sph I and Kpn I 
digests with the Pst I 165, 216, 342 and 2039bp fragments respectively. The 
165bp fragment hybridised to the Sph I 792óp fragment, the Kpn I 92 lbp fragment, 
the Hind II 2857bp fragment and the Hind III 3197bp fragment, implying that this 
fragment was located close to the 5' -end of the insert. The Pst I 216 and 342óp 
fragments both hybridised to the Sph I 6244óp fragment, the Kpn I 2572bp 
fragment, the Hind II 2851óp fragment and the Hind III 3197bp fragment, which 
meant that neither fragment was adjacent to the 5' -end of the clone. Size 
constraints meant that the 165bp fragment must be adjacent to the 5' -end of the 
clone, with the 2039bp fragment next. This was reinforced by the fact that the 
2039bp Pst I fragment hybridised to both Sph I fragments, all three Kpn I fragments 
and the smaller Hind II and Hind III fragments. The orientation of the 216 and the 
342 fragments was resolved by analysis of partial digests of the ATT -1 clone. The 
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Figure A2.1 
Initial mapping data for ATT 1 








Fragment sizes (in bp) 
4179, 2857 
3839, 3197 
4125, 2572, 339 
4274, 2039, 342, 216, 165 
2793, 1761, 1638, 844 
6244, 792 
(total insert size 3832óp, plasmid size 3204óp) 
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Key 
H -HindID 
I - Hind 1 
K - Kpn I 
L - Sph I 
P - PstI 
S - Sma I 
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clone was linearised with Hind III, then Pst I was added at a final dilution of 0.2 units 
per 1,tg of DNA. Aliquots of this digest were removed at 5, 10, 20 and 40 
minute intervals, and the enzyme was inactivated immediately by incubation at 
600C. The resultant digests were then resolved by electrophoresis using 0.6% 
agarose, transferred to nylon filters and probed with DIG -labelled pBS +. The 
differences in the size of the bands and their order represented the size of the 
Pst I fragments and the order of these in the plasmid. 
The Pvu II sites in the ATT -1 clone were mapped by using the 844, 1638 and 
176 lbp fragments respectively to probe Pst I digests. Pvu II does not have a site in 
the polylinker of pBS +, however it does have sites to either side of the polylinker 
hence the fragments to the 5' and 3' ends of the insert include pBS DNA. The 
844bp fragment recognised Pst I fragments of 2039 and 342óp, suggesting a 
central location, while the 1638bp fragment recognised the Pst I 4274, 342 and 
216óp fragments, locating this Pvu II fragment at the 3' end of the clone. Finally 
the 176 lbp fragment recognised the 2039 and 165bp Pst I fragments implying a 5' 
location for this fragment. 
The completed map of ATT -1 is presented in figure 3.6. 
A2.2 The mapping of VIR -i 
The VTR-1 clone was initially mapped following the method described for the ATT - 
1 clone. The REs which had sites in the insert and the relevant fragment sizes are 
exhibited in figure A2.2a, with a map of this data in figure A2.2b. 
The Pst I map of the VIR -1 clone was completed first as the large number of Pst I 
fragments would facilitate accurate mapping of the remaining REs. The Pst I 
mapping was achieved in an identical manner to that described for ATT -1, 
however the plasmid was first linearised with Eco RI in place of Hind III. 
The Sac I sites were located by using the 167 and the 2078bp fragments to probe Pst I 
digests. The 167óp fragment recognised Pst I fragments of 1139, 345 and 94óp, 
therefore this fragment was judged to be adjacent to the 5' Sac I fragment, with the 
1139bp fragment located at the 3' -end of the insert. This was reinforced by the Pst 
I fragments that the 1139bp Sac I fragment hybridised to. Similarly the Hind II 
340 and 1686bp fragments were used to probe Pst I digests, with the 340óp 
fragment hybridising to the Pst I 3' terminal 435óp fragment, thus suggesting 
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Figure A2.2 








VIR 1 RE fragment sizes 
Fragment sizes (in bp) 
4717, 1686, 340 
4137, 1139, 435, 345, 
2793, 2061, 1036, 844 
4498, 2078, 167 
3411, 3332 
342, 216, 84, 45 
(total insert size 3539bp, plasmid size 3204óp) 
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I - HindII 
P - Sph I 
L -PstI 
205 
terminal location, and the 1686bp Hind II fragment was shown to be the centrally 
located Hind II fragment. 
The Pvu II sites were mapped by using the 844, 1036 and 206 lbp fragments to probe 
Pst I digests. The 844bp fragment hybridised to Pst I fragments of 1139 and 342bp, 
and therefore was the centrally located Pvu II fragment. The 1036óp fragment 
hybridised to the Pst I 435, 342 and 216bp fragments, thus was located at the 3' -end 
of the clone, whilst the 2016bp fragment was found to be located at the 5' -end by 
hybridisation. 
The completed map of VIR -1 is presented in figure 3.7. 
A2.3 The mapping of VIR -2 
The VIR -2 clone was initially mapped following the method described for ATT -1, 
using the REs in the polylinker of pBS SK +. REs which had sites in the insert and the 
relevant fragment sizes are exhibited in figure A2.3a, with a map of this data in 
figure A2.3b. Sph I was included in the mapping of VIR -2 although it does not 
have a site in the polylinker of pBS SK +. 
The clone was mapped for Pst I by analysis of partial digests as described for 
ATT -1, with the plasmid first linearised with Eco RI instead of Hind III. 
The insert was mapped for Kpn I using the 339 and 1937bp fragments to probe Pst 
I digests. The 339bp fragment hybridised to the Pst I fragment of 2039bp only, 
while the 1937bp fragment hybridised to Pst I fragments of 2039, 435, 342 and 
216bp. This data meant that the 339bp Kpn I fragment was located centrally, and 
the 1937bp fragment was located at the 3' -end of the insert. 
The insert was mapped for Sph I by double -digesting VIR -2 with Sph I and and Eco 
RI (a polylinker enzyme with no sites in the insert). This enabled location of the 
Sph I at 1123bp from the 5' -end of the clone. 
The plasmid was mapped for Pvu II by using the 844, 998 and 213 lbp fragments 
to probe Pst I digests of VIR -2. The 844bp fragment recognised Pst I fragments of 
2039 and 342bp, suggesting a central location. The Pvu II 998óp fragment 
recognised Pst I fragments of 435, 342 and 216bp, implying a 3' location, while 
the 213 lbp fragment recognised Pst I fragments of 2039 and 496óp, thus was 
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Figure A2.3 








VIR 2 RE fragment sizes 
Fragment sizes (in bp) 
3298, 3188 
4895, 1252, 339 
3393, 2039, 496, 342, 
2513, 2131, 998, 844 
6486 
216 
(total insert size 3528óp, plasmid size 2958bp) 
Figure A2.1b Map of AU-1 based on the restriction data in figure A2.1a 
H K P I H 
I I I 
Key 
H - HindIIl 
I - Hind II 
K - KpnI 
P - PstI 
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Appendix 3.1 The complete sequence of ATT -1 
GGGAAACAGTAAACCACATGTGTTGGACTTAAAGTTTGCTTGATCTAATTACTTGATTAT 
1 + + + + + + 60 
CCCTTTGTCATTTGGTGTACACAACCTGAATTTCAAACGAACTAGATTAATGAACTAATA 
PRIMER 12 3'GGTGTACACAACCTGAATTT5' Tm-56°C 
GTAACAGCCTTTTATACTAACATATTTATTTTTAGGATGATTAATAATAAACAATGACTA 
61 + + + + + + 120 
CATTGTCGGAAAATATGATTGTATAAATAAAAATCCTACTAATTATTATTTGTTACTGAT 
TCCTAAAAATGTTTTTGCATACTTTAAGGTTTAAAAATCTAAATTATATTTTTTAAATCA 
121 + + + + + + 180 
AGGATTTTTACAAAAACGTATGAAATTCCAAATTTTTAGATTTAATATAAAAAATTTAGT 
TTTTACAGAGGAGACTATCAAGACCAATATGCATAGATGACTTCATAGACATCACTGCTG 
181 + + + + + + 240 
AAAATGTCTCCTCTGATAGTTCTGGTTATACGTATCTACTGAAGTATCTGTAGTGACGAC 
ATCTTGGTGATACAATAGGGGCTGCTTTAAAGTCCTTCCAGCAAAATAATGCTTGCACTC 
241 + + + + + + 300 
TAGAACCACTATGTTATCCCCGACGAAATTTCAGGAAGGTCGTTTTATTACGAACGTGAG 
AAGAACAGAGTGAGCAGTTTACCAGGGAGTATATGATGTCTGCAAAATATTCTCCAGGAG 
301 + + + + + + 360 
TTCTTGTCTCACTCGTCAAATGGTCCCTCATATACTACAGACGTTTTATAAGAGGTCCTC 
AACAAATTTAGAAATGAAATGTTTGGATTTGTTGCTGATATGAACCTGCTAAATCTATTT 
361 + + + + + + 420 
TTGTTTAAATCTTTACTTTACAAACCTAAACAACGACTATACTTGGACGATTTAGATAAA 
GCCCTGTTCAGAAGCTATAAGCAGAGAGTTAGGACCACTTTGGAAAACAGCTTCTATGTG 
421 + + + + + + 480 
CGGGACAAGTCTTCGATATTCGTCTCTCAATCCTGGTGAAACCTTTTGTCGAAGATACAC 
CCACTGCCTCATCTCAAATATTAGATTCTTTTTAGAAAGAGTTATAAGGCTCTCTGACAA 
481 + + + + + + 540 
GGTGACGGAGTAGAGTTTATAATCTAAGAAAAATCTTTCTCAATATTCCGAGAGACTGTT 








601 + + + + + + 660 
CATACAAGAGGACAGGCTTCGGTCCCCCTTTCGATTCGAAACTTGGTTCCCTCTTACAAA 
AGCGGAGGGAGACAAAACATGATGAATGCCGCCAAGAAGGTTTTGACAGTGTACTCTAGC 




721 + + + + + + 780 
GAGTCTCTGCTACCTCTTTAGTCAGGTCTTCATTTCCGAATGTACCGAATGTAAAAGGTC 
TGCCTGACATTGAGCAGGTATTCCAACCACTGTTTAAGTTGGAGCAAGAAATCAGAAAAG 
781 + + + + + + 840 
ACGGACTGTAACTCGTCCATAAGGTTGGTGACAAATTCAACCTCGTTCTTTAGTCTTTTC 
GTAAAGCCACCTTGACACAGTCTCTGCTGTTTGCACCAAGGAAAGATGTCCCAATAAGAC 
841 + + + + + ' + 900 
CATTTCGGTGGAACTGTGTCAGAGACGACAAACGTGGTTCCTTTCTACAGGGTTATTCTG 
TGTGTTCTCACAGTATGGGGCCAGGCAGAGGTATGTGTTACCAGAAGTTTTACTGGAAGC 




961 + + + + + + 1020 
TTCACTTGGTGTCAGTTGGGATCGAATGCCCTCGGGACTGTAAAGTAGAGAAAACTCTCT 
PRIMER 3 5'CTCAAGAAAATACAGACGAA3' T =54 °C Pst I 
m 
TTCATCTTCAACTCAAGAAAATACAGACGAAGAATCTGGCCCGTGCTGCAGCAAGACTCT 
1021 + + + + + + 1080 
AAGTAGAAGTTGAGTTCTTTTATGTCTGCTTCTTAGACCGGGCACGACGTCGTTCTGAGA 
CAGCCCAGGTGTGCCACAGCCTCAATCTGAATATGACCCCAGCCCGACCTCTCCACCTGA 
1081 + + + + + + 1140 
GTCGGGTCCACACGGTGTCGGAGTTAGACTTATACTGGGGTCGGGCTGGAGAGGTGGACT 
TTCGGACACTGAGTCATGTGATAGCCAGGTTCGTCCAGAAAGTACTGACTCCGACACCCA 
1141 + + + + + + 1200 
AAGCCTGTGACTCAGTACACTATCGGTCCAAGCAGGTCTTTCATGACTGAGGCTGTGGGT 
TGCAGAAGACGATGATGTTCCTGAAGCACCCCAAGCAGCAAGCCAAACTCAGCCAACAAC 




1261 + + + + + + 1320 
ATGGGTTCTCTGTGTCTCAACGACGTCACAGATGTTAGGTCGATGGTGAGTCTGCCCTAA 
CTACTATAACCAGCAGTCAAGTGATAATTTTGCCTCTCGTATAGATGCATCTGCCACATC 
1321 + + + + + + 1380 
GATGATATTGGTCGTCAGTTCACTATTAAAACGGAGAGCATATCTACGTAGACGGTGTAG 
PRIMER 14 T =58 °C 3'TATCTACGTAGACGGTGTAGS' 
m 
AACCAGTTATGGGTATCCAGGCCCAGTCACTAATCACGGCTTTTCAACTTCTGTCTTTTC 





1441 + + + + + + 1500' 
GGTATGTCATGGGTGTTGCCGGTGACCGTCGTCGTCGACGTAGTTTTATACATACCCCCA 
GGTCAGCAGACGACCACATACGGCAGCTATGTGGGGGGTTACTCAGATGCTAATGGCCAG 
1501 + + + + + + 1560 
CCAGTCGTCTGCTGGTGTATGCCGTCGATACACCCCCCAATGAGTCTACGATTACCGGTC 
TCTGTTGGTGCAAGTACCAGTTACTACACCAGTAAGCCTGCGACCAGCCGCAGCAGCACC 




1621 + + + + + + 1680 
CGAGACGTCACCTGGTGAAACAAAGGTGGCCGGTCGAGTAGACGAAGGTCGTCGGTTCAA 
PRIMER 8 3'TTCAA 
TCTGATTATTTCAGCCCCTTCCCTTATTTTCCTGGCAGTTCTACAGTTCCTCAGGCCTTC 






1741 + + + + + + 1800 
CTCGGAAATCGCGGTAGATGGGGATCGAACGACCTACTTGACGAACTATCTCTGTCACCT 
CTTGTAAGCCAGCAGCAGGCACCTGCACCTCCCCAAAATGACCAGGGGGGGCCTCCTCAG 
1801 + + + + + + 1860 
GAACATTCGGTCGTCGTCCGTGGACGTGGAGGGGTTTTACTGGTCCCCCCCGGAGGAGTC 
TATGTGCCCGTTGCTCAAGAGCAACAGCAGTCCAGTACAGACCCGCTGTCTGATGAGATG 
1861 + + + + + + 1920 
ATACACGGGCAACGAGTTCTCGTTGTCGTCAGGTCATGTCTGGGCGACAGACTACTCTAC 
AGGAGAATTTTTTGAGTTTTTGACAGTGTGAACCCCGTTTGAACCAGACCATAGCCATAT 
1921 + + + + + + 1980 
TCCTCTTAAAAAACTCAAAAACTGTCACACTTGGGGCAAACTTGGTCTGGTATCGGTATA 
TTTGGGAGTGTAAACAGAATCCTCTGTAAACTGCCTTTTTTATGTGAAATGCGTCTCTCG 
1981 + + + + + + 2040 
AAACCCTCACATTTGTCTTAGGAGACATTTGACGGAAAAAATACACTTTACGCAGAGAGC 
CCAAAACTATCTGCTCTTGTTTTGACAAAAAGTGGAAGTGTGTGTTTATATGATTCACAA 
2041 + + + + + + 2100 
GGTTTTGATAGACGAGAACAAAACTGTTTTTCACCTTCACACACAAATATACTAAGTGTT 
AACTGTAGTTTAACAGTAAAAGTTAATTGTGGTTTGTGGTATGACACACAGTTCTGGAAA 
2101 + + + + + + 2160 
TTGACATCAAATTGTCATTTTCAATTAACACCAAACACCATACTGTGTGTCAAGACCTTT 
CTGACCAAACAGTGTGTTCTTATGTGCACTTATTTTGTATTTCCCTTATGCCTGCCAGAG 
2161 + + + + + + 2220 
GACTGGTTTGTCACACAAGAATACACGTGAATAAAACATAAAGGGAATACGGACGGTCTC 
211 
PRIMER 1 5'TCAACACTATAA 
TGCTCAATAAAAGTTACACTCAAGTGCCACTGAGAGTTTTTTCTTTTTTCAACACTATAA 




-52°C Pvu II 
I 
AAGCATCTTTGGGGACTCATGCATAAGCACTCTGCTACAGCTGACATGCTACCCATTTCA 
2281 + + + + + ' + 2340 
TTCGTAGAAACCCCTGAGTACGTATTCGTGAGACGATGTCGACTGTACGATGGGTAAAGT 
GCATTTAGCCCTCTGAAATTCTTGGGTGGAGTGGTGGCTACACCCCAGGGGCCAGTATTG 
2341 + + + + + + 2400 
CGTAAATCGGGAGACTTTAAGAACCCACCTCACCACCGATGTGGGGTCCCCGGTCATAAC 
TGGGATGCCACTACTACTCCTGTCCCTTTCCAGGCTTTCCCCTGCCCTCCGGCAATAACT 
2401 + + + + + + 2460 
ACCCTACGGTGATGATGAGGACAGGGAAAGGTCCGAAAGGGGACGGGAGGCCGTTATTGA 
CCTATAAATCAGTTTGTTAATTATCAGCCTGCGCCTGCGATGGATAAGATATGGAGACCT 




2521 + + + + + + 2580 
CGGAAACTCCTGATGGCACCCCATTGATACTCTGGCCGGAATGGCCTCCATGGACTTTGT 
AGTTTGAGACCAGCTTTACAGGAGCTACCCGAGCCATCATCTCCTCAAAGTCAGAGTTCT 
2581 + + + + + + 2640 
TCAAACTCTGGTCGAAATGTCCTCGATGGGCTCGGTAGTAGAGGAGTTTCAGTCTCAAGA 
GTGGATGATGACACAGATTCTAAAGAAGATGTTACAGAGACCTTAGAATGTGCTCAGGCT 
2641 + + + + + + 2700 
CACCTACTACTGTGTCTAAGATTTCTTCTACAATGTCTCTGGAATCTTACACGAGTCCGA 
CTGACAGATCTGAAGTGGGGTACAGTGGACCCTTCCGAGAAGACATCTCAGTTACTGCTT 
2701 + + + + + + 2760 
GACTGTCTAGACTTCACCCCATGTCACCTGGGAAGGCTCTTCTGTAGAGTCAATGACGAA 
GCACTTCAAGCGGCGAGACCAGCATTTGCAGAAGGCAAAGGAACAGCTATACGCGCCTAC 
2761 + + + + + + 2820 
CGTGAAGTTCGCCGCTCTGGTCGTAAACGTCTTCCGTTTCCTTGTCGATATGCGCGGATG 
AGACTTATTGAAGCTAAAGACTTGGGCAAGCTAGTAGTGAGAGGACCCAAAAAAGACAAG 












3001 + + + + + + 3060 
TGTTTCCGTCTCCACGCGTCTACCTCATGTTCTAACGTACGATTTGAGAAATCTCTTTTA 
PRIMER 2 5 ' AGATGATGAAGGTAAAGGAC3 ' T =56°C 
m 
TACCACAAACGAATACTTCAGATGATGAAGGTAAAGGACTTCCCCGTATAAATATACCCC 
3061 + + + + + + 3120 
ATGGTGTTTGCTTATGAAGTCTACTACTTCCATTTCCTGAAGGGGCATATTTATATGGGG 
CCGTGCCCTTTGGGAAAAGAGTACCTAAACACTTAATACTCTTTTTTACACTCCAGGAGC 
3121 + + + + + + 3180 
GGCACGGGAAACCCTTTTCTCATGGATTTGTGAATTATGAGAAAAAATGTGAGGTCCTCG 
TGGAAGATAAAACAAAAGAACTGAAATTTTTACAGGAGAGTACCTTGCGGCTTTTAAAAC 
3181 + + + + + + 3240 
ACCTTCTATTTTGTTTTCTTGACTTTAAAAATGTCCTCTCATGGAACGCCGAAAATTTTG 
AGAATGAGAAACTAAGGGCACGGCTGGCTTCCCTGCATGTAAAAACATCAGCTACGAACT 
3241 + + + + + + 3300 
TCTTACTCTTTGATTCCCGTGCCGACCGAAGGGACGTACATTTTTGTAGTCGATGCTTGA 
AAACCCCCGCCCCATTCTACCCTCAATCTATAAATAAAGTTTTGTTTGCACCCATTTTTA 
3301 + + + + + + 3360 
TTTGGGGGCGGGGTAAGATGGGAGTTAGATATTTATTTCAAAACAAACGTGGGTAAAAAT 
TGTGTTTGTGTGTATGTTTAGGGGTGGGTATTGGTTTtAAAAAGTAAAAGATTAGTATTG 
3361 + + + + + + 3420 
ACACAAACACACATACAAATCCCCACCCATAACCAAAATTTTTCATTTTCTAATCATAAC 
TGACATCTGGGACAAAGAAACTATTTTTAACCTTTTCAGGTATAGACTTTACCCTATTGA 
3421 + + + + + + 3480 
ACTGTAGACCCTGTTTCTTTGATAAAAATTGGAAAAGTCCATATCTGAAATGGGATAACT 
CACACTCTTAAGTAACTATTTAAGATATTAATGTTTTGTAAGCCTTGCCTACGTACCGGG 
3481 + + + + + + 3540 
GTGTGAGAATTCATTGATAAATTCTATAATTACAAAACATTCGGAACGGATGCATGGCCC 
AGTGTAAATAACTTTAAGAGCTTCCCCCGTAACTCGTATGTATTCTGTTTATTTAGTGTG 
3541 + + + + + + 3600 
TCACATTTATTGAAATTCTCGAAGGGGGCATTGAGCATACATAAGACAAATAAATCACAC 
ACTGTATTTTAAAAATATTTAACTGTGGCTGGGCTCTGAGATGTTGGCAGAAATGTTGTG 
3601 + + + + + + 3660 
TGACATAAAATTTTTATAAATTGACACCGACCCGAGACTCTACAACCGTCTTTACAACAC 
Pst I PRIMER 4 3'GACACCGACCCGAGACTCTAS' Tm-54°C 
I 
GCCTGCAGTGAACATGCTGCTTCCCCGTAAAGCACTTTTGGTAGACATTTTTTTTATTTT 




3721 + + + + + + 3780 
CCGTCGGTGTTTAAATTACTATCGACGGAAACGGGACCCGACGAACCGAAAGATATTACG 
CGAGATCTCGGACCTCTCTGCGGACGCCACGCCCCTTTCCCCGGGTCCGCCC 
3781 + + + + +-- 3832 
GCTCTAGAGCCTGGAGAGACGCCTGCGGTGCGGGGAAAGGGGCCCAGGCGGG 
PRIMER 15 3 ' CTGCGGTGCGGGGAAAGGGG5 ' Tin-70°C 
214 
Appendix 3.2 The complete sequence of VIR -1 
AGCTTTGAACCAAGGGAGAATGTTTAGCGGAGGGAGACAAAACATGATGAATGCCGCCAA 
1 + + + + + + 6 
TCGAAACTTGGTTCCCTCTTACAAATCGCCTCCCTCTGTTTTGTACTACTTACGGCGGTT 
GAAGGTTTTGACAGTGTACTCTAGCCTCAGAGACGATGGAGAAATCAGTCCAGAAGTAAA 
61 + + + + + + 120 
CTTCCAAAACTGTCACATGAGATCGGAGTCTCTGCTACCTCTTTAGTCAGGTCTTCATTT 
GGCTTACATGGCTTACATTTTCCAGTGCCTGACATTGAGCAGGTATTCCAACCACTGTTT 
121 + + + + + + 180 
CCGAATGTACCGAATGTAAAAGGTCACGGACTGTAACTCGTCCATAAGGTTGGTGACAAA 
AAGTTGGAGCAAGAAATCAGAAAAGGTAAAGCCACCTTGACACAGTCTCTGCTGTTTGCA 
181 + + + + + + 240 
TTCAACCTCGTTCTTTAGTCTTTTCCATTTCGGTGGAACTGTGTCAGAGACGACAAACGT 
CCAAGGAAAGATGTCCCAATAAGACTGTGTTCTCACAGTATGGGGCCAGGCAGAGGTATG 




301 + + + + - - -.- + + 360 
ACAATGGTCTTCAAAATGACCTTCGTTCACTTGGTGTCAGTTGGGATCGAATGCCCTCGG 
PRIMER 3 T 
m 
=54 °C 5'CTCAAGAAAATACAGACGAA3' 
CTGACATTTCATCTCTTTTGAGAGATTCATCTTCAACTCAAGAAAATACAGACGAAGAAT 




421 + + + + + + 480 
GACCGGGCACGACGTCGTTCTGAGAGTCGGGTCCACACGGTGTCGGAGTTAGACTTATAC 
ACCCCAGCCCGACCTCTCCACCTGATTCGGACACTGAGTCATGTGATAGCCAGGTTCGTC 
481 + + + + + + 540 
TGGGGTCGGGCTGGAGAGGTGGACTAAGCCTGTGACTCAGTACACTATCGGTCCAAGCAG 
CAGAAAGTACTGACTCCGACACCCATGCAGAAGACGATGATGTTCCTGAAGCACCCCAAG 




601 + + + + + + 660 
GTCGTTCGGTTTGAGTCGGTTGTTGATGGGTTCTCTGTGTCTCAACGACGTCACAGATGT 
ATCCAGCTACCACTCAGACGGGATTCTACTATAACCAGCAGTCAAGTGATAATTTTGCCT 




721 + + + + + + 780 
GAGCATATCTACGTAGACGGTGTAGTTGGTCAATACCCATAGGTCCGGGTCAGTGATTAG 
3 ' TATCTACGTAGACGGTGTAG5 ' PRIMER 14 T =58 C 
m o 
ACGGCTTTTCAACTTCTGTCTTTTCCCATACAGTACCCACAACGGCCACTGGCAGCAGCA 





841 + + + + + + 900 
CGACGTAGTTTTATACATACCCCCACCAGTCGTCTGCTGGTGTATGCCGTCGATACACCC 
GGGTTACTCAGATGCTAATGGCCAGTCTGTTGGTGCAAGTACCAGTTACTACACCAGTAA 
901 + + + + + + 960 
CC CAATGAGT C TACGATTACCGGTCAGACAAC CACGTTCATGGTCAATGATGTGGTCATT 
Pst I 
GC CTGCGAC CAGC CGCAGCAGCAC CGCTCTGCAGTGGAC CACTTTGTTTC CAC CGGCCAG 
961 + + + + + + 1020 
CGGACGCTGGTCGGCGTCGTCGTGGCGAGACGTCAC CTGGTGAAACAAAGGTGGC CGGTC 
CTCATCTGCTTCCAGCAGCCAAGTTTCTGATTATTTCAGC CC CTTC CCTTATTTT C CTGG 
1021 + + + + + + 1080 
GAGTAGACGAAGGTCGTCGGTTCAAAGACTAATAAAGTCGGGGAAGGGAATAAAAGGACC 
PRIMER 8 3'TTCAAAGACTAATAAACTCG5' T =52 C 
m o 
CAGTTCTACAGTTCCTCAGGCCTTCGAGCCTTTAGCGCCATCTACCCCTAGCTTGCTGGA 
1081 + + + + + + 1140 
GTCAAGATGTCAAGGAGTCCGGAAGCTCGGAAATCGCGGTAGATGGGGATCGAACGACCT 
TGAACTGCTTGATAGAGACAGTGGACTTGTAAGCCAGCAGCAGGCACCTGCACCTCCCCA 
1141 + + + + + + 1200 
ACTTGACGAACTATCTCTGTCAC CTGAACATTCGGTCGTCGTC CGTGGACGTGGAGGGGT 
AAATGACCAGGGGGGGCCTCCTCAGTATGTGCCCGTTGCTCAAGAGCAACAGCAGTCCAG 
1201 + + + + + + 1260 
TTTACTGGTCCCCCCCGGAGGAGTCATACACGGGCAACGAGTTCTCGTTGTCGTCAGGTC 
TACAGACCCGCTGTCTGATGAGATGAGGAGAATTTTTTGAGTTTTTGACAGTGTGAACCC 
1261 + + + + + + 1320 
ATGTCTGGGCGACAGACTACTCTACTCCTCTTAAAAAACTCAAAAACTGTCACACTTGGG 
CGTTTGAACCAGACCATAGCCATATTTTGGGAGTGTAAACAGAATCCTCTGTAAACTGCC 
1321 + + + + + + 1380 
GCAAACTTGGTCTGGTATCGGTATAAAACCCTCACATTTGTCTTAGGAGACATTTGACGG 
TTTTTTATGTGAAATGCGTCTCTCGCCAAAACTATCTGCTCTTGTTTTGACAAAAAGTGG 
1381 + + + + + + 1440 
AAAAAATACACTTTACGCAGAGAGCGGTTTTGATAGACGAGAACAAAACTGTTTTTCACC 
AAGTGTGTGTTTATATGATTCACAAAACTGTAGTTTAACAGTAAAAGTTAATTGTGGTTT 




1501 + + + + + + 1560 
CACCATACTGTGTGTCAAGACCTTTGACTGGTTTGTCACACAAGAATACACGTGAATAAA 
TGTATTTCCCTTATGCCTGCCAGAGTGCTCAATAAAAGTTACACTCAAGTGCCACTGAGA 
1561 + + + + + + 1620 
ACATAAAGGGAATACGGACGGTCTCACGAGTTATTTTCAATGTGAGTTCACGGTGACTCT 
PRIMER 1 5'TCAACACTATAAAAGCATCT3' Tm-52°C 
GTTTTTTCTTTTTTCAACACTATAAAAGCATCTTTGGGGACTCATGCATAAGCACTCTGC 




1681 + + + + + + 1740 
ATGTCGACTGTACGATGGGTAAAGTCGTAAATCGGGAGACTTTAAGAACCCACCTCACCA 
GGCTACACCCCAGGGGCCAGTATTGTGGGATGCCACTACTACTCCTGTCCCTTTCCAGGC 
1741 + + + + + + 1800 
CCGATGTGGGGTCCCCGGTCATAACACCCTACGGTGATGATGAGGACAGGGAAAGGTCCG 
TTTCCCCTGCCCTCCGGCAATAACTCCTATAAATCAGTTTGTTAATTATCAGCCTGCGCC 
1801 + + + + + + 1860 
AAAGGGGACGGGAGGCCGTTATTGAGGATATTTAGTCAAACAATTAATAGTCGGACGCGG 
TGCGATGGATAAGATATGGAGACCTGCCTTTGAGGACTACCGTGGGGTAACTATGAGACC 
1861 + + + + + + 1920 
ACGCTACCTATTCTATACCTCTGGACGGAAACTCCTGATGGCACCCCATTGATACTCTGG 
GGCAAAGACCCACTACTCTTGCTCTCCCCGTGTGCCTTACAACTGAAGTGCTGGTTGATG 









PRIMER 5 5'CCTAGGAGCTCGGCCTAAAG3' Tm-64°C 
GAGGTGCAAGTGGGAGAAGTCCAAATGGCCTAGGAGCTCGGCCTAAAGATAAGGGGCCCA 










CTCGGC CTAAGGAGAAGGGGC C CAAAGG CAAGT C C C CAC CTAAAGACGGGC CTG CAGCAA 




GAAC C CAC CAAAAGAC C CAGGAG CT CGTC CAGAAAAAGTT C CTTTAG CATTTC CAGGG C C 
2221 + + + + + + 2280 
CTTGGGTGGTTTTCTGGGTCCTC GAG CAGGTCTTTTTCAAGGAAATCGTAAAGGTCCCGG 
TGGTCCGGTGGATACCAACCCAAGTAGGCATGATGTCATTGAAGCTGCTCCTGGTGATGA 
2281 + + + + + + 2340 
ACCAGGCCACCTATGGTTGGGTTCATCCGTACTACAGTAACTTCGACGAGGACCACTACT 
GAATC CGTACAAAAAAATGTGG CTGC CT C CAGGAACGAAGC CAC CATGC C CTACAC C CTT 
2341 + + + + + + 2400 
CTTAGGCATGTTTTTTTACACCGACGGAGGTCCTTGCTTCGGTGGTACGGGATGTGGGAA 
ATGGACCCCTGTGCGGTCTTGCTATCTAGTGGTTCAAACGCCCCATGGGACCGAAGGAAA 
2401 + + + + + + 2460 
TACCTGGGGACACGCCAGAACGATAGATCACCAAGTTTGCGGGGTACCCTGGCTTCCTTT 
GGAATACAT CGAAATAC TAAAGTGAAAAC GATTGGAAC TC C TGTAAC TC CTGTATAC CTA 




2521 + + + + + + 2580 
TGATATAGTCTACTACTGGACCTACTGCGTTTCCACGACGTCCTCCACCAGGATTTTTCG 
Pst I 
CTC CTCTTC CAAGCAGAGATC CTGCAGGTAGAGGCAGGCAAGAACCTC CTC CTTTAC CAC 
2581 + + + + + + 2640 
GAGGAGAAGGTTCGTCTCTAGGACGTCCATCTCCGTCCGTTCTTGGAGGAGGAAATGGTG 
CTAGGGACTACGAACCCAGCAAGCCCGGAGCTTTGCGCCTAGAACTACGGGATATAGTAC 
2641 + + + + + + 2700 
GATCCCTGATGCTTGGGTCGTTCGGGCCTCGAAACGCGGATCTTGATGCCCTATATCATG 
3'TGATGCTTGGGTCGTTCGGGS' PRIMER 7 T 
m 
=64 °C 
AGAAAGTAAGGTATATTGGTGGTG C CTATAATGAACTGGAGG CTATATTTAGAGATAACT 
2701 + + + + + + 2760 
TC TTTCATTC CATATAAC CAC CACGGATATTAC TTGAC CTCCGATATAAATCTC TATTGA 
AACGAAAGACAACGAGAACGAGAAAGAAGAATGGACTATGCCTTAATAGCACTAATTATC 
2761 + + + + + + 2820 
TTGCTTTCTGTTGCTCTTGCTCTTTCTTCTTACCTGATACGGAATTATCGTGATTAATAG 
CTCCTCATTATCATCGTGCTGCTTCTAATTGTACTGTAAGTACAATTTTTTATCGACCTG 
2821 + + + + + + 2880 
GAGGAGTAATAGTAG CAC GAC GAAGATTAACATGACATTCATGTTAAAAAATAGCTGGAC 
218 
5'TAACCTTGTTTTACCTATGT3' PRIMER 6 Tm-52°C 
TAACAATAACCTTGTTTTACCTATGTAACCTTAATTGTATTTTATATTAACATCTCATTA 
2881 + + + + + + 2940 
ATTGTTATTGGAACAAAATGGATACATTGGAATTAACATAAAATATAATTGTAGAGTAAT 
TTTCTTTACAGGATAGCACTGATGGTTAAACAGGGCTTCTTCAGCAATGCAACAAACTCA 
2941 + + + + + + 3000 
AAAGAAATGTCCTATCGTGACTACCAATTTGTCCCGAAGA9GTCGTTACGTTGTTTGAGT 
ACAGCTTCCCATTAATGGACATGACCAGTTATCGCGCCTAGACTCCTAAATACAGGTGAT 
3001 + + + + + + 3060 
TGTCGAAGGGTAATTACCTGTACTGGTCAATAGCGCGGATCTGAGGATTTATGTCCACTA 
GTTGGCACAAGTTTAGGCCTACTGCCTGATTTTGCTAGACACTTTGCCTCAATTTTACTT 
3061 + + + + + + 3120 
CAACCGTGTTCAAATCCGGATGACGGACTAAAACGATCTGTGAAACGGAGTTAAAATGAA 
TTGCTGCACTTTAAACTGTTTCAGGGCTAGAGACTTTGCTGAGATGGACTGTTGCTGCAC 
3121 + + + + + + 3180 
AACGACGTGAAATTTGACAAAGTCCCGATCTCTGAAACGACTCTACCTGACAACGACGTG 
TTTAAACTGTTTCAGGGCTAGAGACTTTGTCTGAGATGGACTGTTGCTGCACTTTAAACT 
3181 + + + + + + 3240 
AAATTTGACAAAGTCCCGATCTCTGAAACAGACTCTACCTGACAACGACGTGAAATTTGA 
GTTTCAGGGCTAGAGACTTTGTCTGAGATGGACTGTTGCTGCACTTTAAACTGTTTCAGG 
3241 + + + + + + 3300 
CAAAGTCCCGATCTCTGAAACAGACTCTACCTGACAACGACGTGAAATTTGACAAAGTCC 
GCTAGAGACTTTGTCTGAGATGGACTGTTGCTGCACTTTAAACTTTTTCAGGGCTAGAGA 




3361 + + + + + + 3420 
GAAATGGACTCTACCTGACAACGACGTGAAATTTGAAAACGTCCGTCGTACGACGAATGA 
TTTGTCATGTTATTCACCAAAGAAAATGTATGTATATGTCTTTTTTATACAAATATCCAC 
3421 + + + + + + 3480 
AAACAGTACAATAAGTGGTTTCTTTTACATACATATACAGAAAAAATATGTTTATAGGTG 
3'AAAACAGTACAATAAGTGGT5' PRIMER 9 Tm-52°C 
ACATTTTTAAATTACATACTTGTTTCTGTAACATGTGCCTGTAAACTCTGATATAAGCT 
3481 + + + + + 3539 
TGTAAAAATTTAATGTATGAACAAAGACATTGTACACGGACATTTGAGACTATATTCGA 
219 
Appendix 3.3 The complete sequence of VIR -2 
AGCTTTGAACCAAGGGAGAATGTTTAGCGGAGGGAGACAAAACATGATGAATGCCGCCAA 
1 + + + + + + 60 
TCGAAACTTGGTTCCCTCTTACAAATCGCCTCCCTCTGTTTTGTACTACTTACGGCGGTT 
GAAGGTTTTGACAGTGTACTCTAGCCTCAGAGACGATGGAGAAATCAGTCCAGAAGTAAA 
61 + + + + + + 120 
CTTCCAAAACTGTCACATGAGATCGGAGTCTCTGCTACCTCTTTAGTCAGGTCTTCATTT 
GGCTTACATGGCTTACATTTTCCAGTGCCTGACATTGAGCAGGTATTCCAACCACTGTTT 
121 + + + + + + 180 
CCGAATGTACCGAATGTAAAAGGTCACGGACTGTAACTCGTCCATAAGGTTGGTGACAAA 
AAGTTGGAGCAAGAAATCAGAAAAGGTAAAGCCACCTTGACACAGTCTCTGCTGTTTGCA 
181 + + + + + + 240 
TTCAACCTCGTTCTTTAGTCTTTTCCATTTCGGTGGAACTGTGTCAGAGACGACAAACGT 
CCAAGGAAAGATGTCCCAATAAGACTGTGTTCTCACAGTATGGGGCCAGGCAGAGGTATG 




301 + + + + + + 360 
ACAATGGTCTTCAAAATGACCTTCGTTCACTTGGTGTCAGTTGGGATCGAATGCCCTCGG 
PRIMER 3 Tm-54°C 5'CTCAAGAAAATACAGACGAA3' 
CTGACATTTCATCTCTTTTGAGAGATTCATCTTCAACTCAAGAAAATACAGACGAAGAAT 




421 + + + + + + 480 
GACCGGGCACGACGTCGTTCTGAGAGTCGGGTCCACACGGTGTCGGAGTTAGACTTATAC 
ACCCCAGCCCGACCTCTCCACCTGATTCGGACACTGAGTCATGTGATAGCCAGGTTCGTC 
481 + + + + + + 540 
TGGGGTCGGGCTGGAGAGGTGGACTAAGCCTGTGACTCAGTACACTATCGGTCCAAGCAG 
CAGAAAGTACTGACTCCGACACCCATGCAGAAGACGATGATGTTCCTGAAGCACCCCAAG 




601 + + + + + + 660 
GTCGTTCGGTTTGAGTCGGTTGTTGATGGGTTCTCTGTGTCTCAACGACGTCACAGATGT 
ATCCAGCTACCACTCAGACGGGATTCTACTATAACCAGCAGTCAAGTGATAATTTTGCCT 
661 + + + + + + 720 
TAGGTCGATGGTGAGTCTGCCCTAAGATGATATTGGTCGTCAGTTCACTATTAAAACGGA 
220 
CT CGTATAGATGCATCTGCCACATCAACCAGTTATGGGTATCCAGGC CCAGT CACTAATC 
721 + + + + + + 780 
GAGCATATCTACGTAGACGGTGTAGTTGGTCAATACCCATAGGTCCGGGTCAGTGATTAG 








841 + + + + + + 900 
CGACGTAGTTTTATACATACC CC CACCAGT CGT CTGCTGGTGTATGCCGT CGATACACC C 
GGGTTACTCAGATGCTAATGGCCAGTCTGTTGGTGCAAGTACCAGTTACTACACCAGTAA 
901 + + + + + + 960 
CC CAATGAGT CTACGATTAC CGGTCAGACAACCACGTT CATGGT CAATGATGTGGTCATT 
Pst I 
GC CTGCGAC CAGC CGCAGCAGCAC CGCTCTGCAGTGGAC CACTTTGTTTCCAC CGGC CAG 
961 + + + + + + 1020 
CGGACGCTGGTCGGCGTCGTCGTGGCGAGACGTCACCTGGTGAAACAAAGGTGGCCGGTC 
CTCATCTGCTTC CAGCAGC CAAGTTTCTGATTATTTCAGC C CCTTCC CTTATTTTC CTGG 
1021 + + + + + + 1080 
GAGTAGACGAAGGTCGTCGGTTCAAAGACTAATAAAGTCGGGGAAGGGAATAAAAGGACC 
PRIMER 8 3 ' TTCAAAGACTAATAAAGTCG5 ' T 
m 
=52 °C 
CAGTTCTACAGTTCCTCAGGC CTTCGAGC CTTTAGCGC CATCTAC C C CTAGCTTGCTGGA 
1081 + + + + + + 1140 
GTCAAGATGTCAAGGAGTCCGGAAGCTCGGAAATCGCGGTAGATGGGGATCGAACGACCT 
TGAACTGCTTGATAGAGACAGTGGACTTGTAAGCCAGCAGCAGGCACCTGCACCTCCCCA 
1141 + + + + + + 1200 
ACTTGACGAACTATCTCTGTCACCTGAACATTCGGTCGTCGTCCGTGGACGTGGAGGGGT 
AAATGACCAGGGGGGGCCTCCTCAGTATGTGCCCGTTGCTCAAGAGCAACAGCAGTCCAG 
1201 + + + + + + 1260 
TTTACTGGTCCCCCCCGGAGGAGTCATACACGGGCAACGAGTTCTCGTTGTCGTCAGGTC 
TACAGACCCGCTGTCTGATGAGATGAGGAGAATTTTTTGAGTTTTTGACAGTGTGAACCC 
1261 + + + + + + 1320 
ATGTCTGGGCGACAGACTACTCTACTCCTCTTAAAAAACTCAAAAACTGTCACACTTGGG 
CGTTTGAAC CAGAC CATAGC CATATTTTGGGAGTGTAAACAGAATC C T CTGTAAACTGC C 
1321 + + + + + + 1380 
GCAAACTTGGT C TGGTAT CGGTATAAAAC C CT CACATTTGT CTTAGGAGACATTTGACGG 
TTTTTTATGTGAAATGCGTCTCTCGCCAAAACTATCTGCTCTTGTTTTGACAAAAAGTGG 
1381 + + + + + + 1440 
AAAAAATACACTTTACGCAGAGAGCGGTTTTGATAGACGAGAACAAAACTGTTTTTCACC 
AAGTGTGTGTTTATATGATTCACAAAACTGTAGTTTAACAGTAAAAGTTAATTGTGGTTT 
1441 + + + + + + 1500 
TT CACACACAAATATACTAAGTGTTTTGACAT CAAATTGT CATTTT CAATTAACAC CAAA 
221 
GTGGTATGACACACAGTTCTGGAAACTGACCAAACAGTGTGTTCTTATGTGCACTTATTT 
1501 + + + + + + 1560 
CACCATACTGTGTGTCAAGACCTTTGACTGGTTTGTCACACAAGAATACACGTGAATAAA 
TGTATTTCCCTTATGCCTGCCAGAGTGCTCAATAAAAGTTACACTCAAGTGCCACTGAGA 
1561 + + + + + + 1620 
ACATAAAGGGAATACGGACGGTCTCACGAGTTATTTTCAATGTGAGTTCACGGTGACTCT 
PRIMER 1 5'TCAACACTATAAAAGCATCT3' Tin-52°C 
GTTTTTTCTTTTTTCAACACTATAAAAGCATCTTTGGGGACTCATGCATAAGCACTCTGC 




1681 + + + + + + 1740 
ATGTCGACTGTACGATGGGTAAAGTCGTAAATCGGGAGACTTTAAGAACCCACCTCAACCA 
GGCTACACCCCAGGGGCCAGTATTGTGGGATGCCACTACTACTCCTGTCCCTTTCCAGGC 
1741 + + + + + + 1800 
CCGATGTGGGGTCCCCGGTCATAACACCCTACGGTGATGATGAGGACAGGGAAAGGTCCG 
TTTCCCCTGCCCTCCGGCAATAACTCCTATAAATCAGTTTGTTAATTATCAGCCTGCGCC 
1801 + + + + + + 1860 
AAAGGGGACGGGAGGCCGTTATTGAGGATATTTAGTCAAACAATTAATAGTCGGACGCGG 
TGCGATGGATAAGATATGGAGACCTGCCTTTGAGGACTACCGTGGGGTAACTATGAGACC 




1921 + + + + + + 1980 
CCGGAATGGCCTCCATGGACTTTGTTCAAACTCTGGTCGAAATGTCCTCGATGGGCTCGG 
ATCATCTCCTCAAAGTCAGAGTTCTGTGGATGATGACACAGATTCTAAAGAAGATGTTAC 
1981 + + + + + + 2040 
TAGTAGAGGAGTTTCAGTCTCAAGACACCTACTACTGTGTCTAAGATTTCTTCTACAATG 
AGAGACCTTAGAATGTGCTCAGGCTCTGACAGATCTGAAGTGGGGTACAGTGGACCCTTC 
2041 + + + + + + 2100 
TCTCTGGAATCTTACACGAGTCCGAGACTGTCTAGACTTCACCCCATGTCACCTGGGAAG 
CGAGAAGACATCTCAGTTACTGCTTGCACTTCAAGCGGCGAGACCAGCATTTGCAGAAGG 
2101 + + + + + + 2160 
GCTCTTCTGTAGAGTCAATGACGAACGTGAAGTTCGCCGCTCTGGTCGTAAACGTCTTCC 
CAAAGGAACAGCTATACGGGGCTACAGACTTATTGAAGCTAAAGACTTGGGCAAGCTAGT 








2281 + + + + + + 2340 
TGTAAAAAGAATTTTAATTTTCATTGAAAAATCCAACGTACTTCGATTGTGAAAAAAAGA 
CTTTTTATAGATACAGCAGAGTACCACAAAGGCAGAGGTGCGCAGATGGAGTACAAGATT 
2341 + + + + + + 2400 
GAAAAATATCTATGTCGTCTCATGGTGTTTCCGTCTCCACGCGTCTACCTCATGTTCTAA 





2401 + + + + + + 2460 
CGTACGATTTGAGAAATCTCTTTTAATGGTGTTTGCTTATGAAGTCTACTACTTCCATTT 
GGACTTCCCCGTATAAATATACCCCCCGTGCCCTTTGGGAAAAGAGTACCTAAACACTTA 
2461 + + + + + + 2520 
CCTGAAGGGGCATATTTATATGGGGGGCACGGGAAACCCTTTTCTCATGGATTTGTGAAT 
ATACTCTTTTTTACACTCCAGGAGCTGGAAGATAAAACAAAAGAACTGAAATTTTTACAG 
2521 + + + + + + 2580 
TATGAGAAAAAATGTGAGGTCCTCGACCTTCTATTTTGTTTTCTTGACTTTAAAAATGTC 
GAGAGTACCTTGCGGCTTTTAAAACAGAATGAGAAACTAAGGGCACGGCTGGCTTCCCTG 
2581 + + + + + + 2640 
CTCTCATGGAACGCCGAAAATTTTGTCTTACTCTTTGATTCCCGTGCCGACCGAAGGGAC 
CATGTAAAAACATCAGCTACGAACTAAACCCCCGCCCCATTCTACCCTCAATCTATAAAT 
2641 + + + + + + 2700 
GTACATTTTTGTAGTCGATGCTTGATTTGGGGGCGGGGTAAGATGGGAGTTAGATATTTA 
AAAGTTTTGTTTGCACCCATTTTTATGTGTTTGTGTGTATGTTTAGGGGTGGGTATTGGT 
2701 + + + + + + 2760 
TTTCAAAACAAACGTGGGTAAAAATACACAAACACACATACAAATCCCCACCCATAACCA 
TTTAAAAAGTAAAAGATTAGTATTGTGACATCTGGGACAAAGAAACTATTTTTAACCTTT 
2761 + + + + + + 2820 
AAATTTTTCATTTTCTAATCATAACACTGTAGACCCTGTTTCTTTGATAAAAATTGGAAA 
TCAGGTATAGACTTTACCCTATTGACACACTCTTAAGTAACTATTTAAGATATTAATGTT 
2821 + + + + + + 2880 
AGTCCATATCTGAAATGGGATAACTGTGTGAGAATTCATTGATAAATTCTATAATTACAA 
TTGTAAGCCTTGCCTACGTACCGGGAGTGTAAATAACTTTAAGAGCTTCCCCCGTAACTC 
2881 + + + + + + 2940 
AACATTCGGAACGGATGCATGGCCCTCACATTTATTGAAATTCTCGAAGGGGGCATTGAG 
GTATGTATTCTGTTTATTTAGTGTGACTGTATTTTAAAAATATTTAACTGTGGCTGGGCT 
2941 + + + + + + 3000 
CATACATAAGACAAATAAATCACACTGACATAAAATTTTTATAAATTGACACCGACCCGA 
PRIMER 4 3'GACACCGACCCGA 
Pst I 
CTGAGATGTTGGCAGAAATGTTGTGGCCTGCAGTGAACATGCTGCTTCCCCGTAAAGCAC 





3061 + + + + + + 3120 
AAAACCATCTGTAAAAAAAATAAAACCGTCGGTGTTTAAATTACTATCGACGGAAACGGG 
TGGGCTGCTTGGCTTTCTATAAGCAATTGGTTTATATAACAATTGGCAACCTAACCTTTC 
3121 + + + + + + 3180 
ACCCGACGAACCGAAAGATATTCGTTAACCAAATATATTGTTAACCGTTGGATTGGAAAG 
CCCACCAGAGCGGGGATGAGGTTATTAGGGCCATGTACATACCCCCAGTCAATGACAGTG 
3181 + + + + + + 3240 
GGGTGGTCTCGCCCCTACTCCAATAATCCCGGTACATGTATGGGGGTCAGTTACTGTCAC 
TGGATTTTAACCCTGGGTTCAGACTTAGCTGGTTAAACACCCTAAGTCCGCTCTCCGATG 
3241 + + + + + + 3300 
ACCTAAAATTGGGACCCAAGTCTGAATCGACCAATTTGTGGGATTCAGGCGAGAGGCTAC 
GGCCCTATGACTCTTGGTCCCAGTGCGAGATCTGCCCCGGTCGCTTTGTGTCCAAAAGGC 
3301 + + + + + + 3360 
CCGGGATACTGAGAACCAGGGTCACGCTCTAGACGGGGCCAGCGAAACACAGGTTTTCCG 
CTGTTATTATGTCCCCCCAAAGACCTATAGCTTTCAAAACTGCTTCTTTGCCTGTAAGAA 
3361 + + + + + + 3420 
GACAATAATACAGGGGGGTTTCTGGATATCGAAAGTTTTGACGAAGAAACGGACATTCTT 
TATTTCTAAATGTTTTTATCTTTATACTCCACAGAATATAACTGATCCTTTTTTTGACCA 
3421 + + + + + + 3480 
ATAAAGATTTACAAAAATAGAAATATGAGGTGTCTTATATTGACTAGGAAAAAAACTGGT 




3481 + + + + 3528 
GTGGAATGCTCTGGTCCTATAGACCTATCCCTGAAAAAAATTTTTCGA 
224 
